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The miRNA Biogenesis Machinery Modulates Lineage Commitment
During Î±Î² T Cell Development
Abstract
This thesis investigates the role of the Dicer RNA endonuclease in promoting CD4 and CD8 lineage
commitment in developing αβ T lymphocytes. Our laboratory has previously shown that Dicer promotes
survival of developing thymocytes undergoing antigen receptor induced DNA double strand breaks. During
the course of these studies we made the unexpected observation that mice with T cell specific Dicer
inactivation and transgenic expression of the pro-survival molecule BCL2 (LckCre;Eμ;BCL2;Dicerflox/flox)
contain a population of aberrant CD4+CD8+ peripheral lymphocytes of unknown origin. I have utilized
molecular biology, cellular immunology, and complex mouse genetic models to examine the developmental
history and fate of these aberrant CD4+CD8+ cells. My results indicate that aberrant peripheral CD4+CD8+
cells arise from impaired co-receptor silencing of either CD4 or CD8 in MHCI or MHCII-restricted T cells,
respectively. Initiation of co-receptor silencing is impaired during thymic development, whereas maintenance
of co-receptor silencing in mature T cells does not appear to be defective in the absence of Dicer. Aberrant
CD4+CD8+ cells from mice expressing either MHCI or MHCII-restricted TCR transgenes exhibit reduced
expression of the master transcriptional regulators Runx3 and ThPOK, which promote commitment to the
CD8 and CD4 lineages, respectively. Thus, lineage commitment is impaired in the absence of Dicer. Impaired
co-receptor silencing was also observed in developing T cells lacking the RNA endonuclease Drosha,
suggesting that miRNAs mediate appropriate co-receptor silencing and lineage commitment during αβ T cell
development. These results identify a novel role for the miRNA biogenesis machinery in promoting
appropriate lineage commitment during αβ T cell development, and indicate that thymic egress and lineage
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THE MIRNA BIOGENESIS MACHINERY MODULATES LINEAGE COMMITMENT DURING αβ T 
CELL DEVELOPMENT 
Levi J. Rupp 
Craig H. Bassing 
 
 This thesis investigates the role of the Dicer RNA endonuclease in promoting CD4 and 
CD8 lineage commitment in developing αβ T lymphocytes.  Our laboratory has previously shown 
that Dicer promotes survival of developing thymocytes undergoing antigen receptor induced DNA 
double strand breaks.  During the course of these studies we made the unexpected observation 
that mice with T cell specific Dicer inactivation and transgenic expression of the pro-survival 
molecule BCL2 (LckCre;EµBCL2;Dicerflox/flox) contain a population of aberrant CD4+CD8+ 
peripheral lymphocytes of unknown origin.  I have utilized molecular biology, cellular immunology, 
and complex mouse genetic models to examine the developmental history and fate of these 
aberrant CD4+CD8+ cells.  My results indicate that aberrant peripheral CD4+CD8+ cells arise from 
impaired co-receptor silencing of either CD4 or CD8 in MHCI or MHCII-restricted T cells, 
respectively.  Initiation of co-receptor silencing is impaired during thymic development, whereas 
maintenance of co-receptor silencing in mature T cells does not appear to be defective in the 
absence of Dicer.  Aberrant CD4+CD8+ cells from mice expressing either MHCI or MHCII-
restricted TCR transgenes exhibit reduced expression of the master transcriptional regulators 
Runx3 and ThPOK, which promote commitment to the CD8 and CD4 lineages, respectively. 
Thus, lineage commitment is impaired in the absence of Dicer.  Impaired co-receptor silencing 
was also observed in developing T cells lacking the RNA endonuclease Drosha, suggesting that 
miRNAs mediate appropriate co-receptor silencing and lineage commitment during αβ T cell 
development.  These results identify a novel role for the miRNA biogenesis machinery in 
v	  
promoting appropriate lineage commitment during αβ T cell development, and indicate that 
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Chapter	  One:	  Introduction	  	  
	  
	   T	  cells	  as	  a	  central	  hub	  of	  the	  immune	  system.	  	  Advances	  over	  the	  last	  several	  decades	  
have	   increasingly	   illuminated	   the	   central	   role	   of	   the	   immune	   system	   in	   regulating	   diverse	  
physiologic	   processes.	   	   Excluding	   accidental	   deaths	   and	   suicides,	   every	   one	   of	   the	   CDC’s	   ten	  
leading	   causes	   of	   mortality	   involves	   an	   immune	   component	   that	   modulates	   susceptibility,	  
disease	  progression,	  or	  resolution	  (Table	  1).	  	  At	  the	  center	  of	  regulatory	  nodes	  in	  many	  of	  these	  
pathologies	   lie	   T	   lymphocytes,	   or	   T	   cells.	   	   Capable	   of	   responding	   to	   diverse	   environmental	  
stimuli	   and	   undergoing	   differentiation	   to	   distinct	   subsets	   with	   context-­‐dependent	   function,	   T	  
cells	   regulate	   numerous	   pathways	   and	   processes,	   from	   enabling	   tissue	   homeostasis	   and	  
maximal	  function	  of	  the	  innate	  immune	  system	  to	  direct	  elimination	  of	  infected	  cells	  during	  an	  
adaptive	   immune	   response.	   	   Recent	   scientific	   advances	   have	   reinforced	   the	   potential	   for	  
significant	   clinical	   benefit	   following	   T	   cell	   manipulation.	   As	   one	   example,	   “Cancer	  
Immunotherapy”	  was	  recently	  named	  Science	  Magazine’s	  2013	  “Breakthrough	  of	  the	  Year”,	  and	  
the	   vast	   majority	   of	   clinical	   trials	   falling	   under	   this	   broad	   category	   aim	   to	   manipulate	   T	   cell	  
function	  in	  situ	  or	  engineer	  T	  cells	  ex	  vivo	  for	  anticancer	  therapy.	  	  Given	  the	  central	  role	  of	  T	  cells	  
in	   the	   physiologic	   regulation	   of	   diverse	   clinically	   relevant	   processes,	   continued	   study	   of	   T	   cell	  
development,	  function,	  and	  differentiation	  is	  imperative.	  	  	  
	   The	  T	  Cell	  Receptor	  (TCR)	  and	  T	  cell	  classification.	  	  The	  defining	  characteristic	  of	  T	  cells	  
is	   expression	   of	   the	   T	   cell	   receptor	   (TCR),	   which	   mediates	   antigen	   recognition.	   	   TCRs	   are	  
heterodimers,	  with	  two	  major	  types	  of	  TCRs	  observed	  in	  humans	  and	  mice:	  αβ	  TCRs,	  consisting	  
of	  one	  TCRα	  and	  one	  TCRβ	  chain,	  and	  γδ	  TCRs,	  consisting	  of	  one	  TCRγ	  and	  one	  TCRδ	  chain.	  Cells	  
bearing	  either	  αβ	  or	  γδ	  TCRs	  are	  classified	  as	  αβ	  or	  γδ	  T	  cells,	  respectively,	  and	  possess	  distinct	  
2	  
transcriptional	   programs,	   effector	   functions,	   and	   anatomical	   distribution	   (1,	   2).	   	   αβ	   T	   cells	  
predominate	  in	  the	  circulatory	  system	  and	  lymphatic	  tissues	  (such	  as	  lymph	  nodes,	  spleen,	  and	  
blood)	   whereas	   γδ	   T	   cells	   are	  most	   common	   in	   epithelial	   layers	   including	   the	   skin,	   lung,	   and	  
mucosal	   lining	   of	   the	   digestive	   tract	   (3).	   	   Historically,	   αβ	   T	   cells	   have	   been	   considered	  
components	   of	   the	   classical	   adaptive	   immune	   system,	   while	   γδ	   T	   cells	   have	   been	   ascribed	  
innate-­‐like	   characteristics	   such	   as	   rapid	   cytokine	   release	   and	   recognition	   of	   highly	   conserved	  
non-­‐peptide	   antigens,	   analogous	   to	   pathogen	   associated	   molecular	   patterns	   (PAMPs)	  
recognized	   by	   innate	   immune	   cells	   such	   as	  macrophages	   and	  dendritic	   cells	   (3).	   	   It	   should	   be	  
noted,	   however,	   that	   recent	   advances	  have	  blurred	   the	  distinction	  between	  our	   paradigmatic	  
“innate”	  and	  “adaptive”	  definitions,	  and	  emphasized	  the	  interconnected	  nature	  of	  the	  immune	  
system	  as	  a	  whole	  (see	  (4)	  and	  accompanying	  reviews).	  	  To	  date,	  αβ	  T	  cells	  have	  been	  the	  most	  
extensively	  studied	  subset	  of	  T	  cells,	  and	  my	  dissertation	  research	  has	  similarly	  focused	  on	  the	  
development	  and	  differentiation	  of	  αβ	  T	  cells.	  	  
	   αβ	  T	  cells	  recognize	  antigen	  in	  the	  form	  of	  short	  peptides	  (~8-­‐17	  amino	  acids)	  that	  are	  
presented	  on	  host	  major	  histocompatability	  complex	  class	  I	  (MHCI)	  or	  class	  II	  (MHCII)	  molecules	  
(5,	  6).	   	  Crystal	  structures	  of	  MHC	  molecules	  revealed	  a	  peptide	  binding	  cleft	   in	   the	  membrane	  
distal	  domain	  that	  permitted	  binding	  and	  display	  of	  processed	  peptides	  in	  a	  “hot-­‐dog	  in	  a	  bun”	  
type	  of	  conformation	  (7,	  8).	   	  Co-­‐crystallization	  with	  T	  cell	  receptors	  showed	  regions	  of	  the	  TCR	  
that	  were	  previously	  described	  as	  highly	  variable	  contacting	  both	  peptide	  and	  MHC	  along	   this	  
distal	  interface	  (Fig.	  1)	  (9,	  10).	  	  These	  structures	  helped	  explain	  the	  exquisite	  specificity	  of	  T	  cell	  
receptor	  binding,	  as	  previous	  work	  had	  shown	  that	  mutation	  of	  a	  single	  amino	  acid	  in	  a	  peptide	  
antigen,	  or	  presentation	  of	  the	  identical	  antigen	  by	  a	  different	  MHC	  molecule	  (such	  as	  an	  allelic	  
variant)	  could	  ablate	  recognition	  by	  a	  given	  T	  cell	  receptor.	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   Binding	  of	  T	  cell	  receptors	  to	  host	  MHC	  is	  facilitated	  by	  the	  co-­‐receptors	  CD4	  and	  CD8,	  
where	   CD8	   typically	   consists	   of	   a	   CD8α/CD8β	   heterodimer	   (5).	   	   CD4	   and	   CD8	   bind	  MHCII	   or	  
MHCI,	   respectively,	  and	  enhance	  TCR	  signaling	  by	   stabilizing	   the	  TCR/MHC	   interaction	   (Fig.	  1).	  	  
CD4	  and	  CD8	  expression	  also	  demarcate	  two	  classes	  of	  αβ	  T	  cells	  with	  distinct	  effector	  functions:	  
so-­‐called	   “helper”	   CD4+	   T	   cells	   and	   “killer”	   or	   cytotoxic	   CD8+	   T	   cells.	   	   Following	   antigen	  
recognition	  and	  activation,	  CD4+	  T	  cells	  can	  differentiate	  to	  multiple	  subtypes	  including	  T	  helper	  
1	  (TH1),	  T	  helper	  2	  (TH2),	  T	  helper	  17	  (TH17),	  and	  T	  follicular	  helper	  (TFH)	  cells	  (11).	  Each	  subset	  is	  
characterized	  by	  expression	  of	  defining	  cytokines	  (such	  as	  IFN-­‐γ	  for	  TH1,	   IL-­‐4/IL-­‐13	  for	  TH2,	  and	  
IL-­‐17	  for	  TH17)	  and	  co-­‐receptors	  that	  help	  specify	  an	  appropriate	  response	  to	  a	  given	  pathogen	  
(for	  example,	  TH1	  cells	  activate	  macrophages	  to	  potently	   lyse	  phagocytosed	  bacteria,	  while	  TFH	  
are	  crucial	  for	  germinal	  center	  responses	  and	  generation	  of	  high	  affinity	  antibodies).	  	  In	  contrast,	  
CD8+	   T	   cells	   are	   potently	   cytotoxic,	   and	   are	   critical	   for	   elimination	   of	   host	   cells	   infected	  with	  
pathogens	  such	  as	  viruses	  or	  intracellular	  bacteria	  (12).	  	  Cancerous	  cells	  can	  also	  be	  targeted	  by	  
CD8+	  T	  cells	  in	  some	  instances,	  and	  up-­‐regulation	  of	  stress-­‐induced	  proteins	  can	  mark	  otherwise	  
normal	  cells	  for	  CD8	  mediated	  killing	  (13).	  	  
	   TCR	   rearrangement	   and	   T	   cell	   development.	   Essentially	   every	   single	   naïve	   T	   cell	  
expresses	  a	  unique	  T	  cell	  receptor,	  with	  the	  T	  cell	  population	  as	  a	  whole	  capable	  of	  recognizing	  a	  
staggeringly	  large	  array	  of	  foreign	  antigens.	  	  How	  is	  such	  receptor	  diversity	  generated?	  	  Both	  B	  
and	  T	   lymphocytes	  utilize	  a	  process	  known	  as	  V(D)J	  recombination	  to	  generate	  unique	  antigen	  
receptors	   (14).	   	   During	   T	   cell	   development,	   individual	   TCR	   chains	   are	   generated	   through	  
combinatorial	  usage	  of	  Variable	   (V),	  Diversity	   (D),	  and	  Joining	   (J)	  gene	  segments	  to	  generate	  a	  
complete	  open	  reading	  frame	  (ORF).	  Physically	  separated	  in	  the	  linear	  genome	  by	  up	  to	  several	  
megabases,	  V,	  D,	  and	  J	  segments	  are	  re-­‐combined	  via	  a	  DNA	  cut-­‐and-­‐paste	  approach	  using	  the	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lymphocyte	   specific	   Rag1/Rag2	   (RAG)	   endonuclease	   complex	   and	   ubiquitous	   non-­‐homologous	  
end-­‐joining	   (NHEJ)	   DNA	   repair	   proteins	   (14).	   	   Each	   V,	   D,	   or	   J	   sequence	   is	   flanked	   by	   a	  
recombination	   signal	   sequence	   (RSS)	   that	   consists	   of	   conserved	   heptamer	   and	   nonamer	  
sequences	   separated	   by	   a	   non-­‐conserved	   spacer	   of	   either	   12	   or	   23	   nucleotides.	   	   During	  
recombination	  RAG	  binds	  a	  single	  RSS,	  captures	  a	  second	  RSS	  to	  form	  a	  synaptic	  complex,	  and	  
then	  cleaves	  DNA	  between	  each	  RSS	  and	   its	   flanking	  gene	  segment,	   forming	  blunt	  signal	  ends	  
and	   hairpin-­‐sealed	   coding	   ends	   (15).	   	   RAG	   only	   mediates	   synapsis	   and	   cleavage	   of	   gene	  
segments	  flanked	  by	  RSSs	  of	  distinct	  spacer	  lengths,	  a	  level	  of	  regulation	  known	  as	  the	  "12/23"	  
rule	  (14).	  	  Subsequently,	  the	  RAG	  and	  NHEJ	  proteins	  cooperate	  to	  open,	  process,	  and	  then	  ligate	  
coding	  ends	  together	  to	  form	  V(D)J	  coding	  joins	  (16).	  	  Antigen	  receptor	  diversity	  is	  generated	  at	  
this	  step	  due	  to	  coding	  join	  imprecision	  that	  results	  from	  heterogeneity	  in	  nucleotide	  position	  of	  
hairpin-­‐opening,	  deletion	  of	  coding	  end	  sequences,	  and	  addition	  of	  non-­‐templated	  nucleotides.	  	  
Additional	   diversity	   arises	   from	   the	   presence	   of	   multiple	   V,	   D,	   and	   J	   gene	   segments	   in	   each	  
locus.	  The	  murine	  TCRβ	   locus,	   for	  example,	  contains	  ~20	  V	  segments	   (Vβ),	  2	  D	  segments	   (Dβ),	  
and	  12	  J	  segments	  (Jβ),	  while	  the	  TCRα	  locus	  contains	  >100	  V	  segments	  (Vα)	  and	  >40	  functional	  J	  
segments	  (Jα)	  in	  most	  mouse	  strains(17).	  	  	  
	   The	  process	  of	  V(D)J	   rearrangement	   in	   lymphocytes	   is	   exquisitely	   regulated,	  with	   cell-­‐
type	  and	  cell-­‐cycle	  specific	  expression	  of	  RAG,	  ordered	  rearrangement	  of	  antigen	  receptor	   loci	  
(DJ	  rearrangement	  almost	  always	  precedes	  VDJ,	  TCRβ	  rearrangement	  precedes	  TCRα,	  etc),	  
developmental	   stage-­‐specific	   changes	   in	   TCR	   locus	   topology	   and	   accessibility,	   and	   progress	  
through	   developmental	   checkpoints	   driven	   by	   signals	   emanating	   from	   the	   thymic	  
microenvironment	  (14,	  17-­‐19).	  	  These	  characteristics,	  in	  combination	  with	  the	  availability	  of	  cell	  
surface	   markers	   to	   delineate	   developmental	   stages	   and	   the	   relative	   ease	   of	   isolating	   and	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culturing	   lymphocytes,	   has	   made	   T	   cell	   development	   a	   powerful	   model	   for	   understanding	  
lineage	   commitment,	   fate	   decisions,	   and	   regulation	   of	   differentiation.	   	   Under	   standard	  
physiological	   conditions,	   development	   of	   T	   cells	   occurs	   primarily	   in	   the	   thymus	   (20).	  	  
Hematopoietic	  stem	  cells	  (HSCs)	  in	  the	  bone	  marrow	  progressively	  differentiate	  into	  increasingly	  
lymphoid	  biased	  progenitors,	  eventually	  giving	  rise	  to	  a	  population	  that	  settles	  in	  the	  thymus	  as	  
Early	  Thymic	  Progenitors	  (ETPs)	  (18).	  ETPs	  (sometimes	  referred	  to	  as	  double-­‐negative	  1,	  or	  DN1	  
thymocytes	   because	   they	   lack	   both	   CD4	   and	   CD8	   expression)	   retain	   B,	   NK,	   and	   myeloid	   cell	  
differentiation	   potential	   (21),	   but	   Notch	   signaling	   in	   the	   thymus,	   combined	   with	   other	  
environmental	   signals,	   results	   in	   progression	   to	   the	   DN2	   and	   subsequently	   DN3a	   stages	   of	  
thymic	   development	   (20).	   	   T	   lineage	   commitment	   completes	   as	   cells	   transition	   to	   the	   DN3a	  
stage,	  with	   alternative	   lineages	  becoming	   inaccessible.	   	   It	   is	   here	   that	   cells	   undergo	   complete	  
rearrangement	   at	   the	   TCRβ,	   γ,	   and	   δ	   loci	   and	   encounter	   a	   critical	   checkpoint	   in	   T	   cell	  
development.	   	  Cells	   that	   successfully	   rearrange	  TCRγ	  and	  TCRδ	  are	  diverted	   to	   the	  γδ	   lineage,	  
undergo	  a	  proliferative	  burst,	  and	  generally	  exit	  the	  thymus	  as	  double	  negative	  (CD4-­‐CD8-­‐)	  cells	  
(22).	   	   Alternatively,	   cells	   test	   for	   generation	   of	   a	   functional	   TCRβ	   in	   a	   process	   known	   as	   β-­‐
selection	  (19).	  	  A	  productive,	  in-­‐frame	  TCRβ	  rearrangement	  pairs	  with	  the	  pre-­‐T	  cell	  receptor	  α	  
(pre-­‐Tα)	  to	  generate	  the	  pre-­‐T	  cell	  receptor	  (pre-­‐TCR).	  The	  pre-­‐TCR	  transduces	  signals	  that	  drive	  
proliferation	   and	   differentiation	   of	   thymocytes	   to	   the	   DN3b	   stage.	   	   DN3b	   cells	   rapidly	  
differentiate	   to	  DN4	   cells,	  which	   subsequently	   undergo	  multiple	   rounds	   of	   proliferation	  while	  
up-­‐regulating	   surface	   expression	   of	   both	   CD4	   and	   CD8	   co-­‐receptors,	   becoming	   CD4+CD8+	  
“double	   positive”	   (DP)	   thymocytes	   (23).	   	   In	   the	   process,	   the	   TCRγ	   locus	   is	   silenced.	   	   DP	  
thymocytes	   then	   re-­‐enter	   a	   quiescent	   state	   and	   undergo	   rearrangement	   at	   the	   TCRα	   locus,	   a	  
process	   that	   results	   in	   excision	   of	   the	   TCRδ	   locus	   because	   it	   lies	   in	   the	   intervening	   sequence	  
between	   Vα	   and	   Jα	   segments.	   	   Cells	   subsequently	   test	   for	   generation	   of	   a	   functional	   TCR	   αβ	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heterodimer	   in	   a	   process	   known	   as	   selection.	   	   Specificities	   of	   αβ	   TCRs	   are	   selected	   through	  
interactions	   with	   self-­‐peptide/MHC	   complexes	   expressed	   on	   thymic	   epithelial	   cells,	   with	   the	  
outcome	  of	  selection	  depending	  on	  the	  affinity	  of	   the	  TCR/self-­‐peptide:MHC	   interactions	   (24).	  	  
Cells	   possessing	   TCRs	   that	   are	   incapable	   of	   binding	   MHC	   or	   bind	   MHC	   very	   weakly	   undergo	  
death	   by	   “neglect”,	   the	   default	   fate	   of	   DP	   thymocytes	   due	   to	   lack	   of	   pro-­‐survival	   signals.	   	   In	  
contrast,	   strong	   TCR	   signaling	   during	   selection	   (resulting	   from	   high	   affinity	   TCR:MHC	  
interactions)	   results	   in	   thymocyte	  death	   via	   negative	   selection,	   a	   process	   that	   eliminates	   cells	  
expressing	   potentially	   autoreactive	   TCRs.	   	   Finally,	   cells	   possessing	   TCRs	   that	   display	   an	  
intermediate	  affinity	  for	  self-­‐peptide/MHC	  are	  rescued	  from	  programmed	  cell	  death	  in	  a	  process	  
known	   as	   positive	   selection.	   Positively	   selected	   thymocytes	   subsequently	   undergo	   lineage	  
commitment	   to	   either	   the	   CD4	   or	   CD8	   lineage	   based	   upon	   intrinsic	   properties	   of	   the	   TCR:	  
thymocytes	  with	   TCRs	   that	  bind	  MHCI	  differentiate	   to	   the	  CD8	   lineage	   and	  are	   referred	   to	   as	  
MHCI-­‐restricted,	   while	   thymocytes	   with	   TCRs	   that	   recognize	   MHCII	   differentiate	   to	   the	   CD4	  
lineage	   and	   are	   denoted	   as	   MHCII-­‐restricted	   (25).	   	   Differentiation	   to	   the	   CD4	   or	   CD8	   single	  
positive	   thymocyte	   stage	   (CD4SP	   and	   CD8SP)	   involves	   down-­‐regulation	   of	   the	   reciprocal	   co-­‐
receptor	  and	   induction	  of	  a	   lineage	  specific	  transcriptional	  program	  specifying	  distinct	  effector	  
fates.	   	   Single	   positive	   thymocytes	   subsequently	   emigrate	   from	   the	   thymus	   as	   naïve	   T	   cells	   to	  
populate	  peripheral	  tissues	  (26).	  	  This	  developmental	  process	  is	  diagrammed	  in	  Fig.	  2.	  	  
	   Outside	   the	   thymus,	   naïve	   T	   cells	   become	   activated	   through	   TCR	   signaling	   in	   the	  
presence	   of	   pro-­‐inflammatory	   signals.	   This	   results	   in	   a	   massive	   proliferative	   burst	   and	  
differentiation	   to	   effector	   cells	   possessing	   helper	   or	   cytolytic	   capacity	   (27-­‐29).	   	   During	   the	  
resolution	   of	   the	   immune	   response	   the	  majority	   of	   effector	   cells	   die,	   leaving	   behind	   a	   stable	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memory	  population	  that	  provides	   immunological	   recall	  of	   foreign	  antigens	  and	   is	   the	  basis	   for	  
vaccination	  protocols	  (30,	  31).	  
	   One	  strength	  of	  using	  thymic	  development	  as	  a	  model	  system	  is	   the	  availability	  of	  cell	  
surface	  markers	  that	  define	  distinct	  developmental	  subsets.	  	  Particularly	  relevant	  for	  my	  work	  is	  
the	   changing	   expression	  pattern	  of	   surface	   T	   cell	   receptor	  β	   (TCRβ)	   and	  CD24	   (also	   known	  as	  
HSA)	   throughout	   thymocyte	   maturation.	   	   Normally,	   pre-­‐selection	   DP	   thymocytes	   are	  
CD24hiTCRβlo	  cells.	  After	  positive	  selection,	  thymocytes	  up-­‐regulate	  TCRβ	  expression	  to	  become	  
CD24hiTCRβhi	  cells.	  Cells	  subsequently	  down-­‐regulate	  CD24	  expression	  to	  become	  CD24loTCRβhi,	  
a	   process	   concomitant	   with	   development	   into	   either	   CD4SP	   or	   CD8SP	   thymocyts	   (32).	   Thus,	  
TCRβ	  and	  CD24	  expression	  can	  be	  used	  to	  delineate	  distinct	  stages	  of	  thymic	  development.	  
	   Transcriptional	  Regulation	  of	  CD4/CD8	  Fate	  and	  the	  Kinetic	  Signaling	  Model.	  	  The	  first	  
identification	  of	  transcriptional	  regulators	  of	  CD4	  and	  CD8	  fate	  arose	  from	  prior	  studies	  on	  the	  
regulation	   of	   CD4	   expression	   during	   T	   cell	   development.	   	   Littman	   and	   colleagues	   originally	  
showed	   that	   CD4	   down-­‐regulation	   in	   MHCI-­‐restricted	   T	   cells	   required	   the	   presence	   of	   an	  
intronic	   cis-­‐element	   referred	   to	   as	   the	   CD4	   silencer	   (33).	   Deletion	   of	   the	   CD4	   silencer	   in	  
developing	   thymocytes	   resulted	   in	   impaired	   transcriptional	   silencing	   of	   CD4	   and	   the	  
development	  of	  MHCI-­‐restricted,	  CD4+CD8+	  T	  cells.	  	  	  Interestingly,	  deletion	  of	  the	  CD4	  silencer	  in	  
mature	  CD8	  T	   cells	   did	   not	   result	   in	   CD4	   re-­‐expression,	   suggesting	   epigenetic	  maintenance	  of	  
silencing	  at	  the	  CD4	  locus	  (34).	  	  Taniuchi	  et	  al.	  subsequently	  performed	  a	  screen	  to	  identify	  CD4-­‐
silencer	  interacting	  factors,	  which	  led	  to	  the	  identification	  of	  the	  transcription	  factors	  Runx1	  and	  
Runx3	   as	   critical	   mediators	   of	   CD4	   silencing	   (35).	   	   Genetic	   studies	   indicated	   some	   functional	  
redundancy	   (36,	   37),	   but	   Runx1	   appears	  most	   important	   for	   CD4	   silencing	   in	  DN	   thymocytes,	  
while	  Runx3	  is	  preferentially	  utilized	  for	  CD4	  silencing	  as	  cells	  transition	  from	  DP	  thymocytes	  to	  
8	  
CD8SP	   thymocytes	   (38).	   	   Runx3	   function	   is	   not	   limited	   purely	   to	   CD4	   silencing,	   however,	   as	  
Runx3	   deficient	   mice	   exhibit	   significant	   impairment	   in	   CD8	   T	   cell	   development	   and	   function,	  
particularly	  in	  the	  form	  of	  reduced	  or	  impaired	  cytotoxicity	  (35).	  	  Given	  this	  central	  role	  in	  CD8	  T	  
cell	   development	  and	   function,	  Runx3	  has	  been	   classified	  as	  a	   so-­‐called	   “master	   regulator”	  of	  
the	  CD8	  lineage.	  	  However,	  this	  is	  likely	  an	  over-­‐statement	  or	  misnomer,	  as	  ectopic	  or	  transgenic	  
Runx3	  is	  not	  sufficient	  to	  re-­‐direct	  MHCII-­‐restricted	  T	  cells	  to	  the	  CD8	  lineage	  (39)	  (although	  this	  
experimental	   failure	   could	   result	   from	   mismatched	   stoichometry	   of	   ectopic	   Runx3	   and	   its	  
obligate	   binding	   partner	   Cbfβ,	   rather	   than	   true	   inability	   of	   Runx3	   to	   mediate	   lineage	   re-­‐
direction).	  	  	  
	   During	   this	   same	   period	   two	   groups	   converged	   on	   the	   discovery	   of	   the	   lineage	  
specifying	  factor	  for	  CD4	  T	  cells.	  	  Kappes	  and	  colleagues	  had	  previously	  identified	  a	  mouse	  strain	  
with	   a	   spontaneous	   mutation	   that	   resulted	   in	   a	   complete	   absence	   of	   CD4	   T	   cells	   (so-­‐called	  
“helper	  deficient”,	  or	  HD	  mice)	  (40).	  	  By	  crossing	  HD	  mice	  to	  an	  MHCI-­‐/-­‐	  background,	  they	  were	  
able	  to	  show	  that	  MHCII-­‐restricted	  T	  cells	  were	  re-­‐directed	  to	  the	  CD8	  lineage	  in	  the	  absence	  of	  
HD.	   	  Through	  an	  elegant	  and	   intensive	  genetic	  backcross,	   the	   investigators	  were	  subsequently	  
able	   to	  determine	   that	   the	  HD	  mutation	   resulted	   in	   an	   amino	   acid	   substitution	   in	   the	   second	  
zinc-­‐finger	  domain	  of	  the	  transcription	  factor	  encoded	  by	  the	  Zbtb7b	  gene,	  or	  cKrox,	  which	  they	  
subsequently	  named	  Th-­‐POK	  (T-­‐helper-­‐inducing	  POZ/Kruppel-­‐like	  factor)	  (41).	  	  Henceforth	  I	  will	  
refer	   to	   the	  gene	  as	  Zbtb7b	   and	   the	  protein	  product	  as	  ThPOK.	   	   Simultaneously,	  Bosselut	  and	  
colleagues	  identified	  Zbtb7b	  mRNA	  as	  being	  highly	  up-­‐regulated	  in	  microarrays	  of	  post-­‐selection	  
thymocytes,	  and	  further	  characterization	  showed	  this	  up-­‐regulation	  was	  specific	  to	  thymocytes	  
fated	  to	  the	  CD4	  lineage	  (42).	  	  Critically,	  both	  groups	  showed	  that	  transgenic	  Zbtb7b	  expression	  
was	  sufficient	  to	  promote	  CD4	  lineage	  commitment,	  as	  transgenic	  Zbtb7b	  was	  able	  to	  re-­‐direct	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cells	   expressing	   MHCI-­‐restricted	   TCR	   transgenes	   to	   the	   CD4	   lineage.	   	   Thus,	   ThPOK	   has	   been	  
shown	  to	  be	  both	  necessary	  and	  sufficient	  for	  CD4	  lineage	  commitment.	  	  
	   Ensuing	   research	  has	   identified	  some	  of	   the	  signals	  and	  mechanisms	   that	   regulate	   the	  
CD4/CD8	   fate	  decision.	   The	   current	   leading	  model	   is	   known	  as	   the	   kinetic	   signaling	  model,	   as	  
proposed	  by	  Singer	  and	  colleagues	   (25).	  According	   to	   this	  model,	   signaling	   through	  the	  TCR	   in	  
DP	   thymocytes	   undergoing	   selection	   results	   in	   transient	   down-­‐regulation	   of	   CD8	   surface	  
expression	   (43).	   	   This	   results	   in	   sustained	   TCR	   signaling	   in	   MHCII-­‐restricted	   cells	   due	   to	  
continuous	   expression	   of	   the	   CD4	   co-­‐receptor.	   	   Sustained	   TCR	   signaling	   drives	   induction	   of	  
ThPOK	  expression,	  consistent	  with	  early	  reports	  that	  showed	  ThPOK	  induction	  is	  proportional	  to	  
TCR	   signal	   strength	   (42).	   	   In	   contrast,	   positively	   selected	   thymocytes	   bearing	  MHCI-­‐restricted	  
TCRs	  will	  lose	  TCR	  signaling	  upon	  CD8	  down-­‐regulation.	  This	  disruption	  of	  TCR	  signaling	  permits	  
expression	  of	  the	  IL-­‐7	  receptor	  alpha	  (IL-­‐7Rα),	  and	  IL-­‐7	  dependent	  signaling	  promotes	  induction	  
of	  Runx3,	  down-­‐regulation	  of	  CD4,	  and	  re-­‐induction	  of	  CD8	  expression	  in	  a	  process	  know	  as	  co-­‐
receptor	  reversal.	  	  A	  number	  of	  elegant	  experiments	  have	  been	  performed	  that	  support	  aspects	  
of	  this	  model	  (43-­‐46),	  making	  it	  a	  useful	  tool	  for	  describing	  CD4/CD8	  lineage	  commitment,	  but	  it	  
should	   be	   noted	   that	   the	   model	   likely	   remains	   incomplete.	   	   Specifically,	   certain	   simplistic	  
predictions	   of	   the	   model	   have	   not	   been	   observed.	   For	   example,	   the	   kinetic	   signaling	   model	  
would	   predict	   that	   constitutive	   CD8	   expression	   would	   drive	   CD4	   lineage	   commitment	   of	  
thymocytes	   expressing	   an	   MHCI-­‐restricted	   receptor	   (47).	   	   It	   should	   be	   noted	   that	   failure	   to	  
observe	  re-­‐direction	  of	  MHCI-­‐restricted	  cells	   in	  CD8	  transgenic	  mice	  may	  have	  been	  related	  to	  
altered	  CD8α/CD8β	  stoichiometry	  in	  the	  transgenic	  animals,	  rather	  than	  a	  bona	  fide	  inability	  of	  
transgenic	  CD8	  to	  drive	  lineage	  re-­‐direction	  via	  sustained	  TCR	  signaling.	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   Within	   the	   immune	   system,	   the	   CD4/CD8	   fate	   decision	   has	   become	   a	   paradigm	   for	  
binary	  developmental	  choices.	  	  In	  many	  binary	  developmental	  systems,	  mutual	  antagonism	  and	  
positive	   feedback	   are	   utilized	   to	   enforce	   lineage	   commitment	   and	  maintain	   identity	   (48,	   49).	  	  	  
The	   same	   is	   true	   during	   the	   CD4/CD8	   fate	   decision,	   as	   Runx3	   and	   ThPOK	   can	   function	   in	   a	  
mutually	   antagonistic	   fashion.	   Runx3	   represses	   ThPOK	   expression	   by	   binding	   a	   silencer	  
upstream	  of	  the	  Zbtb7b	  promoter	  (37,	  50),	  while	  ThPOK	  represses	  Runx3	  expression	  (51-­‐53)	  and	  
antagonizes	  Runx-­‐mediated	  repression	  of	  Cd4,	  possibly	  through	  binding	  to	  the	  Cd4	  silencer	  (52,	  
54).	   	   In	   addition,	   ThPOK	   antagonizes	   Runx3-­‐mediated	   silencing	   of	   ThPOK,	   thereby	   creating	   a	  
feed-­‐forward	  loop	  promoting	  sustained	  and	  stable	  ThPOK	  expression	  (52).	  	  In	  contrast	  to	  control	  
of	  Cd4	  expression,	  lineage-­‐specific	  Cd8	  transcription	  appears	  to	  be	  regulated	  by	  developmental	  
stage	   specific	   Cd8	   enhancers,	   rather	   than	   a	   cis-­‐acting	   silencer	   element	   (55-­‐58).	   	   However,	  
ThPOK-­‐mediated	   recruitment	   of	   histone	   deacetylases	   to	  Cd8	   enhancers	   has	   been	   reported	   to	  
facilitate	   Cd8	   silencing	   in	   CD4+	   cells	   (59),	   suggesting	   some	   parallelism	   relative	   to	   Runx3-­‐
mediated	  Cd4	  silencing	  in	  CD8+	  cells.	  	  	  
	   While	  Runx3	  and	  ThPOK	  are	  central	  regulators	  of	  the	  CD4/CD8	  fate	  decision,	  additional	  
transcription	   factors	   contribute	   to	   the	   gene	   regulatory	   network	   controlling	   T	   lineage	  
commitment.	  A	  conditional	  mouse	  model	  with	  Gata3	   inactivation	   in	  DP	  thymocytes	  contained	  
almost	  no	  CD4SP	  thymocytes,	  which	  correlated	  with	  an	  inability	  to	  up-­‐regulate	  ThPOK	  following	  
TCR	   stimulation	   of	   DP	   thymocytes.	   	   However,	   ectopic	   ThPOK	   expression	   in	   Gata3-­‐deficient	  
thymocytes	   was	   not	   sufficient	   to	   rescue	   CD4	   development,	   suggesting	   ThPOK	   independent	  
functions	  for	  Gata3	  in	  promoting	  the	  CD4	  lineage	  (60,	  61).	  	  Deficiency	  of	  the	  transcription	  factor	  
TOX	   also	   results	   in	   partial	   loss	   of	   CD4	   lineage	   cells,	   while	   transgenic	   expression	   results	   in	   an	  
increased	  fraction	  of	  CD8SP	  thymocytes,	  suggesting	  a	  possible	  dose-­‐dependent	  role	  for	  TOX	  in	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regulating	  the	  CD4/CD8	  fate	  decision	  (62).	   	  MAZR,	  which	  like	  ThPOK	  is	  a	  transcription	  factor	  of	  
the	   BTB/POZ	   family,	   regulates	   the	   CD4/CD8	   ratio	   by	   maintaining	   lineage	   stability	   of	   MHCI-­‐
restricted	   thymocytes;	   in	   the	   absence	   of	   MAZR,	   MHCI-­‐restricted	   thymocytes	   undergo	   re-­‐
direction	  to	  the	  CD4	  lineage	  (63).	  Additionally,	  Ellmeier	  and	  colleagues	  have	  recently	  shown	  that	  
the	   histone	   deacetylases	   1	   and	   2	   (HDAC1	   and	   HDAC2)	   are	   required	   to	   maintain	   CD4	   T	   cell	  
lineage	   integrity;	   dual	   inactivation	   of	   these	   chromatin	   modifying	   enzymes	   in	   DP	   thymocytes	  
resulted	  in	  the	  generation	  of	  CD4	  lineage	  cells	  capable	  of	  acquiring	  CD8	  effector	  characteristics	  
such	   as	   perforin	   and	   granzyme	   expression	   (64).	   	   Thus,	   a	   complex	   gene	   regulatory	   network	  
controls	  CD4/CD8	  commitment	  and	  lineage	  fidelity	  (65).	  
	   Small	  RNA	  classification	  and	  mechanisms	  of	  action.	  	  The	  fields	  of	  cellular	  and	  molecular	  
biology	   were	   revolutionized	   in	   the	   late	   1990s	   and	   early	   2000s	   by	   the	   discovery	   of	   broadly	  
conserved	  mechanisms	  of	  gene	  regulation	  that	  utilize	  so-­‐called	  small	  RNAs	  	  (~20-­‐30	  nucleotides	  
in	  length).	  Small	  RNAs	  are	  generally	  divided	  into	  three	  major	  classes	  based	  upon	  their	  biogenesis	  
and	  partner	  binding	  proteins:	  microRNAs	   (miRNAs),	   small-­‐interfering	  RNAs	   (siRNAs),	   and	  Piwi-­‐
interacting	   RNAs	   (piRNAs)	   (66).	   	   piRNAs	   are	   processed	   in	   a	   very	   distinct	   fashion	   relative	   to	  
miRNAs	  and	  siRNAs,	  and	  are	  principally	  expressed	  in	  germ	  cells	  rather	  than	  somatic	  tissue.	  Given	  
their	   relevance	   to	  my	  work,	   I	  will	   focus	  on	  miRNAs	   and	   siRNAs	   in	   this	  overview.	   	  miRNAs	   are	  
short,	  ~22-­‐nucleotide	  RNAs	  that	  typically	  function	  by	  binding	  complementary	  sequences	  in	  the	  
3’	  un-­‐translated	  region	  (3’	  UTR)	  of	  target	  messenger	  RNAs	  (mRNAs)	  (66).	  Central	  to	  this	  process	  
is	  the	  RNA-­‐induced	  silencing	  complex	  (RISC),	  which	  contains	  an	  Argonaute	  family	  protein	  (Ago)	  
as	   the	  principal	   component	   that	  binds	   the	  miRNA	  and	   target	  mRNA.	   	  miRNA	  binding	   typically	  
results	   in	   repression	   of	   the	   target	   mRNA	   through	   a	   variety	   of	   mechanisms,	   including	  
destabilization	  or	  translational	  inhibition	  of	  the	  target	  mRNA	  (67).	  	  The	  most	  current	  version	  of	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miRbase,	   a	   community	   organized	   and	   curated	   database	   of	   miRNA	   annotation,	   documents	  
several	  hundred	  high	  confidence	  miRNAs	  described	   in	  both	  humans	  and	  mice,	  with	  small	  RNA	  
sequencing	  experiments	   suggesting	   the	  potential	  presence	  of	   thousands	  of	   additional	  miRNAs	  
expressed	   at	   low	   levels	   or	   in	   highly	   tissue	   specific	   fashions	   (68).	   	   In	   silico	   algorithms	   using	  
phylogenetic	   data	   to	   predict	   conserved	   miRNA	   target	   sites	   have	   suggested	   that	   over	   half	   of	  
human	   protein	   coding	   genes	   contain	   at	   least	   one	   miRNA	   target	   site	   under	   significant	  
evolutionary	  pressure	  (69).	  	  As	  such,	  miRNAs	  are	  clearly	  a	  widespread	  and	  critical	  mode	  of	  gene	  
regulation	  in	  metazoans.	  
	   siRNAs	  are	  the	  second	  major	  class	  of	  small	  RNAs.	  The	  difference	  between	  miRNAs	  and	  
siRNAs	  are	  contentious,	  and	  there	  are	  often	  exceptions	  to	  the	  rule,	  but	  the	  following	  distinctions	  
are	  generally	  accepted:	  	  
1.)	  miRNAs	  can	  bind	  to	  target	  RNAs	  with	  imperfect	  base-­‐pairing,	  whereas	  siRNAs	  have	  a	  
strong	  preference	  for	  perfect	  base-­‐pairing.	  
2.)	  miRNAs	   are	   produced	   from	   endogenous	   transcripts	   that	   fold	   to	   form	   a	   distinctive	  
hairpin	   structure,	   whereas	   siRNAs	   are	   produced	   from	   dsRNA	   generated	   by	   antisense	  
transcripts,	   repetitive	   elements,	   or	   exogenous	   sources	   (such	   as	   transfection	   or	   viral	  
infection).	  	  
It	   should	   be	   noted,	   however,	   that	   after	   processing	   to	   maturation	   siRNAs	   and	   miRNAs	   are	  
indistinguishable	  biochemically.	   	   Like	  miRNAs,	   siRNAs	  were	   initially	   shown	   to	   function	   in	  post-­‐
transcriptional	   inhibition	  of	   target	  mRNAs,	  often	  via	  direct	  degradation	  of	   target	  mRNA	  by	  the	  
slicer	   activity	   of	   Argonaute	   proteins	   that	   bind	   siRNAs	   (67).	   Further	   research,	   however,	   has	  
revealed	   additional	   roles	   for	   siRNAs	   in	   transcriptional	   silencing	   in	   multiple	   organisms.	   In	   the	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fission	  yeast	  Schizosaccharomyces	  pombe	  (S.	  pombe),	  for	  example,	  siRNAs	  are	  required	  for	  the	  
maintenance	   of	   heterochromatin	   structure	   and	   gene	   silencing	   at	   sites	   of	   constitutive	  
heterochromatin	  such	  as	  centromeric	  repeats.	  This	  connection	  was	  first	  noted	  when	  Volpe	  et	  al.	  
reported	  that	  yeast	  deficient	  in	  enzymes	  required	  for	  siRNA	  biogenesis	  phenocopied	  previously	  
described	   mutants	   with	   defective	   heterochromatin;	   all	   of	   these	   strains	   exhibited	   aberrant	  
chromosome	   segregation	   during	  mitosis	   and	  massive	   genomic	   instability	   as	   a	   consequence	  of	  
impaired	  heterochromatin	  formation	  at	  centromeres	  (70).	  Follow-­‐up	  studies	  indicated	  that	  in	  S.	  
pombe,	   antisense	   transcription	   at	   centromeric	   repeats	   (or	   activity	   of	   an	   RNA-­‐dependent	   RNA	  
polymerase	  complex	  (RDRC))	  results	  in	  the	  generation	  of	  dsRNAs	  that	  are	  processed	  to	  siRNAs.	  	  
Subsequently,	   Argonaute	   proteins	   in	   the	   RNA-­‐induced	   transcriptional	   silencing	   (RITS)	   complex	  
bind	  siRNAs	  and	  use	  them	  as	  guides	  to	  target	  the	  histone	  methyltransferase	  Clr4	  (a	  homolog	  of	  
mammalian	   Suv39	   proteins)	   to	   DNA,	   which	   leads	   to	   methylation	   of	   histone	   H3	   at	   lysine	   9	  
(H3K9me).	  	  H3K9me	  is	  bound	  by	  chromodomain	  containing	  proteins	  such	  as	  Swi6	  (the	  S.	  pombe	  
ortholog	   of	   heterochromatin	   protein	   1	   (HP1)	   in	   mammals),	   whose	   binding	   is	   a	   hallmark	   of	  
heterochromatic	  regions	  and	  is	  critical	  for	  appropriate	  heterochromatin	  structure	  and	  function	  
(71,	   72).	   	   Maintenance	   of	   the	   heterochromatic	   state	   is	   promoted	   via	   a	   feed-­‐forward	   loop	  
wherein	   proteins	   that	   bind	   the	   heterochromatin	   complex	   recruit	   additional	   siRNA	   biogenesis	  
machinery	  and	  the	  RDRC,	  ensuring	  constant	  generation	  of	  guide	  siRNAs	  (72).	  	  	  
	   Compared	  to	  S.	  pombe,	  the	  relative	  importance	  of	  siRNAs	  in	  heterochromatin	  structure	  
and	   function	   is	   less	   clear	   in	  mammals.	   	  Regardless,	   there	  are	   several	   reports	   that	   cells	   lacking	  
components	  of	  the	  siRNA	  biogenesis	  pathway	  exhibit	  defects	  in	  heterochromatin	  structure	  and	  
function,	   including	   impaired	   chromosome	   segregation	   in	   a	   chicken	   cell	   line	   (73)	   and	   loss	   of	  
centromeric	   silencing	   in	   murine	   embryonic	   stem	   (ES)	   cells	   (74).	   Additionally,	   multiple	   groups	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have	  identified	  endogenous	  siRNAs	  (endo-­‐siRNAs)	  that	  regulate	  gene	  expression	  in	  murine	  stem	  
cells	   and	   germ	   tissue	   (75-­‐77).	   	   More	   broadly,	   plants	   have	   been	   shown	   to	   utilize	   siRNAs	   to	  
mediate	   transcriptional	   silencing	   in	   a	   process	   known	   as	   RNA-­‐dependent	   DNA	   methylation	  
(RdDM)	  (78);	  here,	  siRNAs	  function	  to	  target	  the	  DNA	  methylation	  machinery	  to	  genomic	  loci	  in	  
a	   sequence	   specific	   manner.	   	   Combined,	   these	   results	   reveal	   a	   diverse	   array	   of	   potential	  
mechanisms	  by	  which	  small	  RNAs	  can	  regulate	  gene	  expression	  at	  multiple	  levels.	  
	   miRNA	  and	   siRNA	  biogenesis.	   	   The	   shared	  biochemical	   characteristics	   of	  miRNAs	   and	  
siRNAs	   originally	   suggested	   similar	   pathways	   of	   generation,	   and	   indeed	   significant	   overlap	   in	  
miRNA	  and	  siRNA	  biogenesis	  has	  since	  been	  confirmed.	  	  These	  processes	  are	  summarized	  in	  Fig.	  
3.	   	  miRNAs	   typically	   originate	   from	  DNA	  Polymerase	   II	   (PolII)	   dependent	   transcriptional	   units.	  
These	   transcriptional	   units	   are	   often	   intergenic,	   non-­‐coding	   elements,	   but	   intronic	  miRNAs	   in	  
protein-­‐coding	   transcripts	   are	   also	   common.	   	   Each	   transcriptional	   unit	   can	   contain	   multiple	  
miRNAs,	   and	   indeed	   many	   miRNAs	   seem	   to	   cluster	   near	   others	   in	   the	   genome	   (66).	   These	  
primary	   transcripts	   (pri-­‐miRNAs)	   range	   in	   size	   up	   to	   several	   kilobases	   but	   invariably	   contain	   a	  
critical	  stem-­‐loop	  motif	  of	  ~70	  nucleotides.	  	  	  The	  stem	  loop	  typically	  contains	  an	  ~33	  nucleotide	  
imperfectly	  paired	  stem,	  a	  terminal	  loop,	  and	  flanking	  single-­‐stranded	  RNA	  (ssRNA)	  both	  5’	  and	  
3’	   of	   the	   stem-­‐loop.	   	   The	   initial	   processing	   step	   in	   miRNA	   biogenesis	   is	   carried	   out	   by	   the	  
Microprocessor	   complex,	   which	   contains	   the	   RNAseII	   enzyme	   Drosha	   and	   the	   dsRNA	   binding	  
protein	  DiGeorge	  syndrome	  critical	   region	  gene	  8	   (DGCR8).	   	  DGCR8	  binds	  both	   the	  ssRNA	  and	  
stem	   components	   of	   the	   stem-­‐loop	   structure,	   guiding	   precise	   positioning	   of	   Drosha,	   which	  
cleaves	  the	  pri-­‐miRNA	  ~11	  nucleotides	  from	  the	  ssRNA-­‐dsRNA	  junction.	  	  The	  resulting	  precursor	  
miRNA	   (pre-­‐miRNA)	   contains	   a	   distinctive	   two-­‐nucleotide	   overhang	   at	   the	   3’	   end,	   with	   3’	  
hydroxyl	  and	  5’	  phosphate	  groups.	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   Following	   cleavage	   by	   Drosha,	   pre-­‐miRNAs	   are	   exported	   from	   the	   nucleus	   in	   an	  
Exportin-­‐5	   dependent	   manner.	   	   In	   the	   cytoplasm	   the	   pre-­‐miRNA	   is	   then	   cleaved	   near	   the	  
terminal	   loop	   by	   the	   RNAse	   III	   enzyme	   Dicer.	   This	   cleavage	   occurs	   ~22	   nucleotides	   from	   the	  
cleavage	   site	   generated	   by	   Drosha,	   as	   a	   result	   of	   structural	   constraints	   of	   the	   Dicer	   protein.	  	  
Following	  Dicer	  cleavage,	  the	  ~22	  nucleotides	  dsRNA	  is	  passed	  to	  an	  Argonaute	  family	  protein.	  	  
Here,	   one	   strand	   is	   selected	   as	   the	   “guide”	   strand	   or	   mature	   miRNA,	   while	   the	   other	  
“passenger”	   strand,	   or	   miRNA*,	   is	   degraded.	   	   The	   resultant	   mature	   miRNA	   then	   guides	   the	  
Argonaute-­‐containing	  RISC	  complex	  to	  target	  mRNAs.	  	  miRNA:mRNA	  pairing	  typically	  relies	  upon	  
perfect	  Watson-­‐Crick	  base	  pairing	  of	  the	  “seed	  sequence”,	  a	  stretch	  of	  6	  nucleotides	  at	  positions	  
2-­‐8	  of	  the	  miRNA	  relative	  to	  the	  5’	  end,	  but	  mismatches	  are	  permitted	  at	  other	  locations	  (67).	  
	   Similarly	   to	  miRNAs,	   siRNAs	   require	  Dicer	   for	   their	  biogenesis.	   	   In	   contrast	   to	  miRNAs,	  
however,	   siRNAs	  do	  not	   require	  Drosha	   function.	   	  Thus,	  one	  method	  to	  differentiate	  between	  
miRNA	  effects	   and	   those	  mediated	  by	  endogenous	   siRNAs	  has	  been	   to	   compare	   the	  effect	  of	  
Drosha	  or	  Dicer	  deletion	  for	  a	  given	  phenotype.	  	  
	   Dicer,	   Drosha,	   and	   miRNAs	   in	   T	   cell	   development	   and	   function.	   The	   discovery	   of	  
miRNAs	  and	  the	  components	  required	  for	   their	  biogenesis	   led	  multiple	  groups	  to	  examine	  the	  
role	  of	  miRNAs	  in	  T	  cell	  development.	  	  The	  laboratory	  of	  Matthias	  Merkenschlager	  was	  the	  first	  
to	   describe	   a	   T	   cell	   specific	   Dicer	   knockout	   mouse	   model	   (necessitated	   by	   the	   embryonic	  
lethality	   of	   germline	   Dicer-­‐/-­‐	   mice)	   (79).	   	   This	   group	   generated	   a	   conditional	   Dicer	   allele	   by	  
flanking	  exons	  20	   and	  21,	   containing	   the	   catalytic	   endonuclease	  domain,	  with	   LoxP	   sites	   such	  
that	  expression	  of	  Cre	  recombinase	  drives	  LoxP	  recombination	  and	  excision	  of	   the	   intervening	  
sequence.	  	  Mice	  homozygous	  for	  the	  conditional	  Dicer	  allele	  (Dicerflox/flox)	  were	  bred	  to	  animals	  
bearing	  a	   transgene	  with	  Cre	   recombinase	  under	  control	  of	   the	  Lck	  promoter,	  a	  T	  cell	   specific	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molecule	  that	  is	  expressed	  beginning	  at	  the	  DN2/3	  stage	  of	  thymic	  development.	  	  	  This	  resulted	  
in	  efficient	  deletion	  of	  Dicer	  and	  loss	  of	  miRNAs	  beginning	  in	  DN3	  thymocytes,	  with	  >90%	  loss	  of	  
representative	  miRNAs	  in	  DP	  thymocytes.	  	  Despite	  the	  large	  number	  of	  murine	  genes	  predicted	  
to	  be	  regulated	  by	  miRNAs,	  Cobb	  et	  al	  reported	  only	  modest	  impacts	  on	  T	  cell	  development	  and	  
differentiation	  in	  mice	  with	  T	  cell	  specific	  Dicer	  deficiency.	  	  Mice	  with	  Dicer	  deficiency	  initiating	  
in	  DN2/3	  thymocytes	  were	  able	  to	  generate	  DP,	  CD4SP,	  and	  CD8SP	  thymocytes	  that	  expressed	  
normal	  levels	  of	  canonical	  markers	  of	  differentiation	  such	  as	  ThPOK	  in	  CD4	  T	  cells	  and	  perforin,	  a	  
key	  cytolytic	  effector,	  in	  CD8	  T	  cells.	  	  However,	  there	  was	  a	  striking	  decrease	  (~90%)	  in	  the	  total	  
number	   of	   developing	   thymocytes,	   principally	   resulting	   from	   decreased	   numbers	   of	   DP	  
thymocytes.	  	  This	  correlated	  with	  an	  increase	  in	  apoptosis	  of	  Dicer-­‐/-­‐	  thymocytes	  both	  directly	  ex	  
vivo	   and	   following	   in	   vitro	   culture.	   	   Combined,	   these	   results	   suggested	   a	   role	   for	   Dicer	   in	  
mediating	   survival	   of	   developing	   thymocytes,	   particularly	   following	   β-­‐selection	   induced	  
proliferation,	  but	  not	  in	  differentiation	  or	  lineage	  commitment	  during	  thymic	  development.	  
	   The	   next	   report	   of	   Dicer	   deficiency	   came	   from	   Muljo	   et	   al,	   who	   described	   a	   similar	  
conditional	  Dicer	  knockout,	  this	  time	  using	  Cd4Cre	  to	  drive	  Dicer	  deletion	  (80).	  Cd4	  expression	  is	  
up-­‐regulated	  as	  cells	  transition	  to	  the	  DP	  stage	  of	  thymic	  development,	  mediating	  later	  deletion	  
than	   the	   LckCre	   transgene	   used	   by	   Merkenschlager’s	   group.	   	   Muljo	   et	   al	   focused	   on	   the	  
development	   and	   function	   of	   peripheral	   T	   cells,	   and	   reported	   reduced	   T	   cell	   numbers	   in	  
Cd4Cre;Dicerflox/flox	  mice,	  similar	  to	  what	  was	  observed	  in	  the	  thymus	  of	  LckCre;Dicerflox/flox	  mice.	  	  
Dicer-­‐/-­‐	   splenic	   T	   cells	   exhibited	   impaired	   proliferation	   and	   survival	   following	   antigenic	  
stimulation,	   again	   consistent	   with	   a	   role	   for	   Dicer	   in	   survival,	   particularly	   in	   T	   lineage	   cells	  
undergoing	   proliferation.	   	   Dicer	   did	   not	   appear	   to	   be	   required	   for	   CD4	   T	   cell	   polarization	  
following	  antigenic	  challenge,	  as	  stimulated	  CD4	  T	  cells	  appropriately	  differentiated	  to	  the	  TH1	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and	   TH2	   lineages	   in	   vitro.	   	   However,	  Dicer
-­‐/-­‐	   cells	   polarized	   under	   TH2	   conditions	  were	   able	   to	  
make	   significant	   amounts	   of	   the	   IFN-­‐γ	   upon	   restimulation	   in	   TH1	   promoting	   conditions,	   in	  
contrast	  to	  Dicer	  sufficient	  control	  cells	  that	  permanently	  silenced	  IFN-­‐γ	  during	  TH2	  polarization.	  	  
This	   result	   suggested	   a	   possible	   impairment	   in	   appropriate	   silencing	   of	   alternative	   lineages	   in	  
Dicer-­‐/-­‐	  CD4	  T	  cells.	  
	   The	  Merkenschlager	  lab	  subsequently	  extended	  their	  initial	  study	  and	  showed	  that	  aged	  
Cd4Cre;Dicerflox/flox	   	   mice	   exhibited	   inflammatory	   pathology,	   including	   colitis	   and	   immune	  
infiltrates	  in	  the	  lamina	  propria	  (81).	  	  This	  inflammatory	  phenotype	  was	  attributed	  to	  a	  reduced	  
frequency	   of	   regulatory	   T	   cells	   (Tregs)	   in	   the	  Cd4Cre;Dicer
flox/flox	   	   mice.	   Chong	   et	   al	   described	   a	  
similar	  result	  for	  mice	  with	  T	  cell	  specific	  Drosha	  deficiency	  (Cd4Cre;Droshaflox/flox),	  suggesting	  a	  
role	   for	   miRNAs	   in	   promoting	   Treg	   development	   and	   function	   (82).	   	   Consistent	   with	   these	  
observations,	  specific	  deletion	  of	  Dicer	  in	  regulatory	  T	  cells	  (using	  a	  Foxp3Cre	  transgenic	  mouse	  
strain,	   in	  which	   all	   Tregs	   express	  Cre)	   resulted	   in	   pathology	   similar	   to	  Foxp3	   null	   (Scurfy)	  mice;	  
namely,	   severe	   autoimmune	   pathology	   resulting	   in	   eventual	   death	   of	   the	   animals	   (83).	  	  
However,	  this	  study	  was	  confounded	  by	  the	  fact	  that	  Dicer	  regulates	  T	  cell	  survival	  as	  suggested	  
by	   previous	   reports.	   	   As	   such,	   the	   observed	   phenotype	   might	   have	   resulted	   simply	   from	  
selective	   cell	   death	   of	   Treg	   cells,	   rather	   than	   a	   defined	   role	   for	   miRNAs	   in	   promoting	   Treg	  
development	  or	  function.	  
	   Zhang	  and	  Bevan	  performed	  the	  first	  detailed	  study	  of	  mature	  CD8	  lineage	  T	  cells	  with	  
Dicer	  deficiency	  (84).	  	  The	  authors	  utilized	  a	  Tat-­‐Cre	  fusion	  to	  delete	  Dicer	  in	  splenic	  T	  cells	  that	  
were	  otherwise	  Dicer	  sufficient	  throughout	  thymic	  development	  (the	  HIV	  Tat	  protein	  contains	  a	  
cell	  permeable	  protein	  transduction	  domain,	  which	  when	  fused	  to	  Cre	  recombinase	  generates	  a	  
cell-­‐permeable	  recombinant	  protein	  that	  can	  be	  added	  to	  cells	  to	  mediate	  LoxP	  recombination	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at	  a	  defined	  time).	  	  Consistent	  with	  previous	  suggestions	  that	  Dicer	  null	  T	  cells	  are	  susceptible	  to	  
cell	  death,	  particularly	  during	  proliferation,	  the	  authors	  were	  essentially	  unable	  to	  recover	  any	  
Dicer-­‐/-­‐	   CD8+	   T	   cells	   following	   pathogen	   challenge	   in	   vivo.	   	   However,	   in	   vitro	   stimulation	  
suggested	  that	  Dicer-­‐/-­‐	  CD8	  T	  cells	  actually	  underwent	  greater	  proliferation	  and	  faster	  activation	  
following	  antigenic	  challenge,	  which	  also	  included	  sustained	  expression	  of	  the	  activation	  marker	  
CD69.	  This	  defect	  was	  attributed	  to	   loss	  of	  miR-­‐130	  and	  miR-­‐301,	  which	  were	  hypothesized	  to	  
suppress	  CD69	  expression	   late	  following	  T	  cell	  activation.	  A	  rescue	  experiment	  revealed	  only	  a	  
modest	   impact	   in	   CD69	   expression	   upon	   ectopic	   miR-­‐130	   and	  miR-­‐301	   expression,	   however,	  
leaving	   it	   unclear	   precisely	   how	   critical	   miR-­‐130	   and	   miR-­‐301	   are	   in	   mediating	   normal	   CD69	  
regulation	   following	   CD8	   activation.	   	   Regardless,	   the	   authors	   demonstrated	   a	   clear	   role	   for	  
Dicer,	  and	  presumably	  miRNAs,	  in	  regulating	  CD8	  T	  cell	  activation	  and	  survival.	  
	   Chong	   et	   al	   subsequently	   performed	   a	   detailed	   transcriptional	   and	   proteomic	  
comparison	   between	   mice	   lacking	   either	   Dicer	   or	   Drosha	   in	   T	   cells	   (LckCre;Dicerflox/flox	   and	  
LckCre;Droshaflox/flox,	   respectively)	   (85).	   	   A	   significant	   overlap	   in	   phenotypes	   was	   observed	   in	  
most	   of	   the	   cell	   populations	   studied,	   but	   it	   is	   worth	   noting	   that	   the	   authors	   identified	   both	  
Dicer-­‐dependent,	  Drosha	  independent	  mirtrons	  (short	  pre-­‐miRNA-­‐like	  stem-­‐loop	  structures	  that	  
are	  encoded	  in	   introns	  of	  protein-­‐coding	  genes	  and	  released	  following	  RNA	  splicing)	  as	  well	  as	  
target	  mRNAs	  with	  putative	  stem	  loop	  structures	  that	  are	  cleaved	  by	  Drosha	  but	  not	  Dicer.	  Thus,	  
both	  Dicer	  and	  Drosha	  deficiency	  in	  T	  cells	  can	  result	  in	  gene	  expression	  changes	  independent	  of	  
the	  reciprocal,	  canonical	  miRNA	  biogenesis	  enzyme.	  
	   Examining	  the	  role	  of	  Dicer	   in	  antigen	  receptor	  rearrangement.	   	  Our	   laboratory	  has	  a	  
long-­‐standing	   interest	   in	   understanding	   the	   mechanisms	   that	   regulate	   antigen	   receptor	  
rearrangement,	  with	  a	  particular	  focus	  on	  TCRβ	  rearrangement	  in	  DN	  thymocytes.	  	  One	  striking	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property	  of	  TCRβ	  rearrangement	  is	  allelic	  exclusion	  –	  the	  observation	  that	  essentially	  all	  T	  cells	  
express	   a	   single	   functional	   TCRβ	   rearrangement,	  with	   successful	   rearrangement	   on	   one	   allele	  
preventing	   rearrangement	   at	   the	   second	   allele	   (86).	   	   The	  mechanisms	  mediating	   this	   process	  
remain	  unclear,	  but	  previous	  reports	  have	  suggested	  the	  existence	  of	  antisense	  transcripts	  that	  
regulate	  rearrangement	  in	  the	  immunoglobulin	  heavy	  chain	  (IgH)	  locus,	  another	  locus	  exhibiting	  
allelic	  exclusion	  (87,	  88).	   	  Brenna	  Brady,	  a	  former	  student	  in	  our	  laboratory,	  similarly	  identified	  
antisense	  transcripts	  at	  the	  TCRβ	  locus	  in	  mice	  bearing	  a	  pre-­‐rearranged	  TCRβ	  allele	  knocked-­‐in	  
to	   the	  endogenous	  TCRβ	   locus	   (86).	   	   	  Given	   the	  ability	  of	  Dicer	   to	  process	  dsRNA	   to	  generate	  
siRNAs	   that	   promote	   transcriptional	   silencing	   in	   other	   organisms,	  we	   hypothesized	   that	   Dicer	  
might	  regulate	  allelic	  exclusion	  during	  T	  cell	  development	  via	  siRNAs	  generated	  from	  antisense	  
transcripts.	  	  Thus,	  we	  generated	  and	  analyzed	  LckCre;Dicerflox/flox	  mice	  using	  the	  conditional	  Dicer	  
allele	   generated	   by	   the	   Merkenschlager	   group.	   	   We	   found	   no	   evidence	   of	   impaired	   allelic	  
exclusion	   in	   Dicer	   deficient	   mice,	   although	   we	   did	   identify	   a	   role	   for	   Dicer	   in	   regulating	  
thymocyte	  survival	   following	  production	  of	  DNA	  double	  strand	  breaks	  during	  antigen	  receptor	  
rearrangement	   (89).	   	   In	   the	   course	   of	   these	   studies	   we	   also	   generated	   T	   cell	   specific	   Dicer	  
knockouts	   on	   a	   background	   expressing	   transgenic	   human	   BCL-­‐2	   under	   control	   of	   the	   IgH	  
enhancer	   (90),	   resulting	   in	   BCL-­‐2	   expression	   in	   B	   cells	   and	   developing	   T	   cells	  
(LckCre;EμBCL2;Dicerflox/flox).	   BCL-­‐2	   expression	   promotes	   thymocyte	   survival	   and	   we	  
hypothesized	   it	   would	   partially	   rescue	   thymocyte	   apoptosis	   resulting	   from	   Dicer	   deficiency.	  	  	  
Unexpectedly,	  and	  in	  contrast	  to	  all	  previous	  reports	  of	  T	  cell	  specific	  Dicer	  or	  Drosha	  deficiency,	  
LckCre;EμBCL2;Dicerflox/flox	  mice	  contained	  a	  population	  of	  aberrant	  splenic	  CD4+CD8+	  T	  cells.	   	  In	  
order	   to	   better	   understand	   the	   mechanisms	   by	   which	   Dicer	   regulates	   normal	   T	   cell	  
development,	  I	  have	  devoted	  my	  thesis	  research	  to	  characterizing	  the	  development	  and	  fate	  of	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these	  aberrant	  CD4+CD8+	  T	   cells,	   and	   investigating	   the	  mechanisms	  by	  which	   they	  arise	   in	   the	  




Chapter	  Two:	  The	  microRNA	  biogenesis	  machinery	  regulates	  lineage	  
commitment	  during	  αβ	  T	  cell	  development	  
	  
	   Characterization	  of	  LckCre:EμBCL2:Dicerflox/flox	   	  mice.	  Our	   initial	   studies	  were	  begun	  by	  
generating	   and	   analyzing	   LckCre:EμBCL2:Dicerflox/flox	   (LBD),	   LckCre:Dicerflox/flox	   (LD),	  
EμBCL2:Dicerflox/flox	   (BCL2),	   and	   Dicerflox/flox	   (wild-­‐type	   or	   WT)	   mice.	   	   I	   first	   performed	   a	  
quantitative	   polymerase	   chain	   reaction	   (qPCR)	   assay	   on	   genomic	   DNA	   and	   showed	   that	   the	  
efficiency	   of	  Dicer	   deletion	  was	   equivalent	   in	  DN	   thymocytes	   from	   LD	   and	   LBD	  mice	   (Fig.	   4A)	  
(89).	  Similarly,	  sorted	  pre-­‐selection	  DP	  thymocytes	  from	  LD	  and	  LBD	  mice	  both	  exhibited	  >90%	  
reduction	   in	   miR-­‐181a	   and	   let-­‐7c	   (Fig.	   4B),	   two	   representative	   miRNAs	   highly	   expressed	   in	  
developing	   thymocytes	   and	   T	   cells	   (91).	   Combined,	   these	   results	   suggest	   that	   phenotypic	  
differences	   between	   LBD	   and	   LD	   mice	   are	   unlikely	   to	   result	   from	   differential	   levels	   of	   Dicer	  
deletion/miRNA	  expression	  between	  the	  genotypes	  during	  early	  thymic	  development.	  
	   Consistent	  with	   previous	   reports,	   we	   noted	   a	   statistically	   significant	   decrease	   in	   total	  
thymic	   cellularity	   of	   LD	  mice	   relative	   to	  WT	   controls	   (Fig.	   5A)	   (89).	   	   Thymic	   cellularity	   was	  
rescued	   in	   LBD	   mice,	   however,	   consistent	   with	   a	   role	   for	   BCL2	   in	   rescuing	   survival	   of	   Dicer-­‐/-­‐	  
thymocytes	  (Fig.	  5A)	  (89).	  	  Interestingly,	  both	  LD	  and	  LBD	  mice	  exhibited	  decreased	  numbers	  of	  
splenic	   TCRβ+	   cells	   relative	   to	   controls	   (Fig.	   5B),	   likely	   because	   expression	   of	   transgenic	   BCL2	  
peaks	  in	  early	  thymocytes	  before	  declining	  to	  background	  levels	  in	  mature	  T	  cells	  (Fig.	  6).	  	  	  
	   We	   next	   performed	   a	   general	   characterization	   of	   LBD	  mice,	   including	   flow	   cytometry	  
analysis	  of	  splenic	  T	  cell	  subsets.	   	  Unexpectedly,	  we	  observed	  that	  ~15%	  of	  splenic	  TCRβ+	  cells	  
from	   LBD	   mice	   were	   CD4+CD8+,	   whereas	   control	   mice	   contained	   only	   CD4+CD8-­‐	   or	   CD4-­‐CD8+	  
cells,	  as	  expected	  (Fig.	  7A,	  B).	  	  Thymic	  egress	  is	  controlled	  by	  sphingosine	  1	  phosphate	  receptor	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1	   (S1pr1),	   which	   is	   expressed	   on	   mature	   single	   positive	   thymocytes	   following	   lineage	  
commitment	   (92).	   Loss	   of	   S1pr1	   significantly	   impairs	   thymic	   egress,	   and	   transgenic	   S1pr1	   is	  
sufficient	   to	  drive	  premature	  egress	  of	  DP	   thymocytes	   (93);	   thus,	  peripheral	  CD4+CD8+	   cells	   in	  
LBD	  mice	  could	  arise	   from	  premature	  expression	  of	  S1PR1	   in	  developing	   thymocytes,	  perhaps	  
due	  to	  loss	  of	  miRNA-­‐mediated	  repression	  of	  S1pr1	  mRNA.	  	  As	  described	  in	  Chapter	  One	  (p.	  7),	  
positive	   selection	   and	  differentiation	  of	   thymocytes	   can	  be	   tracked	  by	   changes	   in	   cell	   surface	  
expression	  of	  TCRβ	  and	  CD24	  (32).	  	  Examination	  of	  pre	  and	  post-­‐selection	  thymic	  subsets	  did	  not	  
reveal	   premature	   expression	  of	   surface	   S1PR1	   in	   LBD	   thymocytes	   (Fig	   8).	   Consistent	  with	   this	  
result,	  further	  characterization	  revealed	  that	  splenic	  CD4+CD8+	  cells	  were	  phenotypically	  mature	  
(CD24loTCRβhi),	   as	   opposed	   to	   pre-­‐selection	   DP	   thymocytes	   (CD24hiTCRβlo)	   (Fig.	   9),	   suggesting	  
that	   premature	   egress	   of	   pre-­‐selection	  DP	   thymocytes	   could	   not	   account	   for	   the	   presence	   of	  
splenic	  CD4+CD8+	  T	  cells	  in	  LBD	  mice.	  	  Henceforth	  I	  will	  sometimes	  refer	  to	  the	  splenic	  CD4+CD8+	  
cells	  from	  LBD	  mice	  as	  “aberrant	  DPs”	  or	  “aberrant	  CD4+CD8+”	  cells	  to	  differentiate	  them	  from	  
normal	  DP	  thymocytes.	  	  	  
	   Aberrant	  CD4+CD8+	  cells	  were	  also	  present	  amongst	  TCRβ+	  cells	   from	  the	   lymph	  nodes	  
and	   blood	   of	   LBD	   mice	   (Fig.	   10),	   indicating	   this	   population	   was	   not	   restricted	   to	   the	   spleen.	  	  
Further	  characterization	  showed	  that	  aberrant	  CD4+CD8+	  cells	  were	  CD8α+CD8β+	  (Fig.	  11A),	  and	  
were	  therefore	  not	  similar	  to	  CD8αα+	  intraepithelial	  lymphocytes	  (IEL)	  that	  have	  been	  reported	  
(94);	   as	   such,	   I	   will	   continue	   to	   refer	   to	   them	   as	   simply	   CD8+.	   	   Additional	   characterization	  
indicated	   that	   both	  CD4	   and	  CD8	   T	   cells	   from	   LBD	  mice	   expressed	  higher	   levels	   of	   CD44	   (Fig.	  
11B)	  than	  control	  cells.	   	  CD44	  is	  a	  surface	  marker	  that	  denotes	  previously	  activated	  or	  antigen	  
experienced	  cells,	  but	  is	  also	  up-­‐regulated	  following	  homeostatic	  proliferation	  of	  T	  cells	  (95,	  96).	  	  
As	  such,	  I	  hypothesize	  that	  increased	  CD44	  expression	  on	  T	  cells	  from	  LBD	  and	  LD	  mice	  is	  likely	  a	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consequence	   of	   splenic	   T	   cell	   lymphopenia	   in	   these	   mice	   as	   shown	   in	   Fig.	   5,	   rather	   than	  
indicating	  that	  T	  cells	  of	  LBD	  and	  LD	  mice	  are	  more	  likely	  to	  be	  antigen	  experienced.	  Consistent	  
with	  this	  hypothesis,	  I	  found	  no	  evidence	  of	  CD69	  up-­‐regulation	  in	  any	  subset	  of	  splenic	  T	  cells	  
from	   LBD	  mice,	   suggesting	   that	   these	   cells	  were	   not	   recently	   activated	   (Fig.	   11C).	   	   To	   further	  
validate	   that	   aberrant	   peripheral	   CD4+CD8+	   T	   cells	   in	   LBD	   mice	   represented	   mature	   T	   cells,	  
rather	   than	   immature	   thymocytes,	   I	   isolated	   CD4+CD8+	   splenic	   T	   cells	   from	   LBD	   mice	   by	  
fluorescence	  activated	  cell	  sorting	  (FACS)	  and	  performed	  quantitative	  reverse	  transcription	  PCR	  
(qRT-­‐PCR)	   for	   Rag1	   and	   Ptcra	   (the	   gene	   encoding	   the	   pre-­‐TCRα	   chain)	   mRNA,	   which	   are	  
expressed	   in	   DN	   and/or	   DP	   thymocytes	   but	   not	   mature	   T	   cells.	   	   In	   contrast	   with	   control	  
thymocytes,	   I	   could	   not	   detect	   significant	   levels	   of	   either	   Rag1	   or	   Ptcra	   mRNA	   in	   sorted	  
CD4+CD8+	  splenic	  T	  cells	  from	  LBD	  mice	  (Fig.	  12),	  lending	  credence	  to	  the	  hypothesis	  that	  these	  
cells	  are	  phenotypically	  mature	  T	  cells	  rather	  than	  “escaped”	  thymocytes.	  	  	  
	   The	  fact	  that	  only	  	  ~20%	  of	  splenic	  T	  cells	  from	  LBD	  mice	  exhibited	  altered	  CD4	  or	  CD8	  
expression	   suggested	   that	   incomplete	   Dicer	   deletion	   could	   account	   for	   the	   putative	   partial	  
penetrance	  of	   the	  phenotype.	   	   To	  examine	   this	  possibility,	   I	   isolated	  CD4+,	  CD8+,	  or	  CD4+CD8+	  
splenic	  T	  cells	   from	  LBD	  mice	  and	  performed	  qPCR	  to	  quantify	  the	  efficiency	  of	  Dicer	  deletion.	  	  
While	  only	  50-­‐70%	  of	  Dicer	  alleles	  were	  deleted	  on	  average,	  the	  frequency	  of	  deleted	  alleles	  was	  
similar	   between	   all	   three	   populations	   (Fig.	   13A),	   suggesting	   that	   differential	   levels	   of	   Dicer	  
deletion	   could	   not	   account	   for	   the	   observation	   that	   only	   ~20%	   of	   peripheral	   cells	   exhibited	  
altered	  CD4/CD8	  expression.	  	  To	  more	  directly	  assess	  miRNA	  levels	  in	  the	  Dicer	  deficient	  cells,	  I	  
performed	   Taqman	   qPCR	   for	   miR-­‐181a	   and	   let-­‐7c	   as	   described	   above.	   	   I	   again	   found	   no	  
difference	  in	  the	  levels	  of	  miRNAs	  between	  CD4+,	  CD8+,	  and	  CD4+CD8+	  splenic	  T	  cells	  from	  LBD	  
mice,	  although	  each	  population	  exhibited	  a	  60-­‐80%	  reduction	  in	  miRNA	  levels	  relative	  to	  control	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cells	   (Fig.	   13B,	   C).	   	   Additionally,	   sorted	   splenic	   CD4+	   and	   CD8+	   cells	   from	   LD	   and	   LBD	   mice	  
exhibited	  similar	  reductions	  in	  miRNA	  levels,	  suggesting	  that	  the	  absence	  of	  aberrant	  DP	  cells	  in	  
LD	   mice	   did	   not	   result	   from	   difference	   in	   miRNA	   expression.	   	   The	   observation	   that	   DP	  
thymocytes	   from	   LD	   and	   LBD	  mice	   exhibited	   >90%	   reduction	   in	   miR-­‐181a	   and	   let-­‐7c	   levels	  
relative	  to	  controls,	  versus	  only	  60-­‐80%	  reduction	  in	  peripheral	  cells	  (compare	  Fig.	  4B,	  C	  and	  Fig.	  
13B,	  C)	   suggests	   the	   splenic	  T	   cell	   population	   is	   enriched	   for	   “escapee”	   cells	   incomplete	  Dicer	  
deletion.	  	  Regardless,	  these	  results	  combined	  suggest	  equivalent	  Dicer	  deletion	  and	  miRNA	  loss	  
across	  CD4+,	  CD8+	  and	  CD4+CD8+	   splenic	  T	   cells	   from	  LBD	  mice,	   as	  well	   as	   similar	   reduction	   in	  
miRNA	  levels	  between	  splenic	  T	  cells	  of	  LD	  and	  LBD	  mice.	  
	   	  In	  addition	  to	  promoting	  survival,	  ectopic	  BCL2	  expression	  affects	  other	  pathways	  and	  
processes	   that	   regulate	  αβ	  T	   lymphocyte	  differentiation,	   including	  NFAT	   signaling	   and	  αβ	  TCR	  
selection	   (97,	  98).	   	  Thus,	   to	   rule	  out	   the	  possibility	   that	  peripheral	  CD4+CD8+	  αβ	  T	  cells	   in	  LBD	  
mice	  arise	  from	  effects	  of	  BCL2	  expression	  other	  than	  promoting	  survival	  of	  Dicer-­‐deficient	  cells,	  
I	  generated	  and	  analyzed	  LckCre:p53flox/flox:Dicerflox/flox	   (LPD)	  mice	  with	  combined	   inactivation	  of	  
Dicer	  and	  p53	   initiating	   in	  DN	  thymocytes.	   	  The	  p53	  protein	  activates	  cell	   cycle	  checkpoints	   in	  
response	  to	  DNA	  damage	  and	  other	  cellular	  stresses,	  and	  induces	  apoptosis	  when	  such	  stresses	  
are	   too	   severe	   (99).	   	   Similar	   to	   the	   case	   for	   LBD	   mice,	   I	   found	   higher	   frequencies	   of	  mature	  
splenic	  CD4+CD8+	  αβ	  T	  cells	   in	  LPD	  mice	  relative	  to	  WT	  mice	  (Fig.	  14A,	  B).	   	  This	  result	   indicates	  
that	   inactivation	   of	   the	   pro-­‐apoptotic	   p53	   protein	   in	  Dicer-­‐deficient	   thymocytes	   also	   permits	  
accumulation	  of	  aberrant	  splenic	  CD4+CD8+	  αβ	  T	  cells.	  
	   Finally,	   I	   could	  not	  exclude	  the	  possibility	   that	  combined	  Cre	  and	  BCL2	  expression	  was	  
responsible	  for	  the	  observed	  phenotype,	  with	  Dicer	  status	  playing	  no	  role.	  	  To	  clarify	  this	  issue,	  I	  
generated	   Dicer	   sufficient,	   LckCre:EμBCL2	   (LB)	   mice.	   These	   animals	   lacked	   aberrant	   splenic	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CD4+CD8+	  cells	   (Fig.	  15A,	  B),	   indicating	  that	  this	  phenotype	  of	  LBD	  mice	  was	  not	  simply	  due	  to	  
combined	   expression	   of	   Cre	   and	   BCL2.	   	   Consequently,	   I	   conclude	   that	   inhibiting	   apoptosis	   of	  
Dicer-­‐deficient	   αβ	   T	   lineage	   cells	   unmasks	   a	   requirement	   for	   Dicer	   in	   appropriate	   CD4/CD8	  
expression	  in	  mature	  αβ	  T	  cells.	  	  
	   Dicer	   regulates	   initiation	   of	   CD4	   and	   CD8	   silencing.	   In	   wild-­‐type	  mice	   splenic	   T	   cells	  
express	  either	  CD4	  or	  CD8	  exclusively,	  with	  the	  reciprocal	  co-­‐receptor	  being	  silenced.	  	  Aberrant	  
CD4+CD8+	   splenic	   T	   cells	   of	   LBD	   mice	   could	   thus	   be	   thought	   of	   as	   cells	   that	   have	   failed	   to	  
appropriately	   silence	  either	  CD4	  or	  CD8.	   	   In	   this	   regard,	  aberrant	   splenic	  CD4+CD8+	  cells	   could	  
arise	  from	  failure	  of	  DP	  thymocytes	  to	  appropriately	  initiate	  CD4	  or	  CD8	  silencing	  follow	  positive	  
selection	   in	   the	   thymus.	   	   Alternatively,	   CD4SP	   or	   CD8SP	   thymocytes	   and	   splenic	   T	   cells	   could	  
arise	  normally	   in	   the	  absence	  of	  Dicer	  but	   subsequently	   fail	   to	  maintain	  co-­‐receptor	   silencing,	  
perhaps	   due	   to	   failure	   of	   an	   epigenetic	   process.	   	   Notably,	   these	   processes	   are	   not	   mutually	  
exclusive,	  so	  I	  employed	  a	  number	  of	  experimental	  approaches	  to	  test	  these	  hypotheses.	  
	   I	   first	   examined	   CD4	   and	   CD8	   expression	   on	   LBD	   and	   control	   thymocytes	   before	   and	  
after	   positive	   selection.	   Similar	   to	   what	   was	   observed	   in	   the	   spleen,	   I	   found	   that	   18%	   of	  
CD24loTCRβhi	  mature	  thymocytes	  in	  LBD	  mice	  express	  both	  CD4	  and	  CD8,	  whereas	  WT	  and	  BCL2	  
mice	  contained	  essentially	  no	  CD4+CD8+	  cells	  in	  the	  mature	  thymocyte	  gate	  (Fig.	  16A,	  B).	  	  I	  found	  
similar	   increased	   frequencies	  of	  CD4+CD8+CD24loTCRβhi	   thymocytes	   in	  LPD	  mice	   relative	   to	  WT	  
mice	  (11.5%	  versus	  <1%;	  Fig.	  17A,	  B),	  indicating	  this	  was	  not	  a	  BCL2	  specific	  effect.	  	  In	  addition,	  I	  
found	  that	  5%	  of	  CD24loTCRβhi	  mature	  thymocytes	  in	  LD	  mice	  express	  both	  CD4	  and	  CD8.	  While	  
this	  frequency	  is	  above	  background	  levels	  observed	  in	  mature	  thymocytes	  of	  WT	  and	  BCL2	  mice	  
(p<0.01;	   Fig.	   16),	   the	   limited	   numbers	   of	   these	   cells	   (<1%	   of	   total	   thymocytes	   in	   LD	   mice)	  
probably	   explains	  why	   they	  were	  not	   found	   in	  previous	   analyses	  of	  LD	  mice	   (79,	   85).	   	   Finally,	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both	   SP	   mature	   thymocytes	   and	   aberrant	   CD4+CD8+	   mature	   thymocytes	   in	   LD	   and	   LBD	   mice	  
exhibited	  similar	  reductions	  in	  the	  level	  of	  miR-­‐181a	  and	  let-­‐7c	  (Fig.	  18),	   implying	  similar	  levels	  
of	  Dicer	   deletion	   between	   the	   populations.	  My	   data	   indicate	   that	   aberrant	   CD4+CD8+	  mature	  
thymocytes	  arise	  following	  positive	  selection	  of	  Dicer-­‐deficient	  thymocytes,	  and	  that	  expression	  
of	  BCL2	  or	   inactivation	  of	  p53	   is	  not	  required	  for	  development	  of	   these	  cells,	  but	  merely	  their	  
peripheral	  accumulation.	  	  	  In	  sum,	  I	  conclude	  that	  Dicer	  is	  required	  for	  appropriate	  initiation	  of	  
Cd4	  and	  Cd8	  silencing	  during	  intrathymic	  αβ	  T	  cell	  differentiation.	  	  	  
	   No	  evidence	  for	  Dicer-­‐mediated	  maintenance	  of	  co-­‐receptor	  silencing.	   	  As	  mentioned	  
previously,	  a	  requirement	  for	  Dicer	   in	   initiation	  of	  Cd4	  and	  Cd8	  silencing	  does	  not	  preclude	  an	  
additional	   role	   for	   Dicer	   in	   maintenance	   of	   Cd4	   and	   Cd8	   silencing	   in	   mature	   αβ	   T	   cells.	   	   To	  
determine	  whether	  Dicer	  is	  required	  for	  appropriate	  maintenance	  of	  Cd4	  and	  Cd8	  silencing	  I	  first	  
utilized	   a	   genetic	   approach.	   	   The	  Cd4Cre	   transgene	  drives	   expression	  of	  Cre	   recombinase	   and	  
deletion	  of	  Dicerflox	  alleles	  initiating	  in	  DP	  thymocytes	  (80,	  85).	  	  However,	  published	  reports	  have	  
shown	   that	   Cd4Cre-­‐mediated	   Dicer	   deletion	   does	   not	   lead	   to	   appreciable	   loss	   of	   Dicer-­‐
dependent	   miRNAs	   until	   after	   the	   initiation	   of	   Cd4	   and	   Cd8	   silencing	   and	   CD4/CD8	   lineage	  
commitment	   (80,	  81,	  85).	   	   In	  contrast,	  mature	  peripheral	  αβ	  T	  cells	  of	  Cd4Cre:Dicerflox/flox	  mice	  
exhibit	   near	   complete	   deletion	   of	  Dicerflox	  alleles,	   low	   expression	   of	  miRNAs,	   and	   phenotypes	  
indicative	   of	   Dicer	   inactivation	   (80,	   81,	   85).	   	   Based	   on	   these	   observations,	   I	   reasoned	   that	  
Cd4Cre-­‐mediated	   deletion	   of	  Dicer	   starting	   in	   CD4+CD8+	   thymocytes	   would	   allow	   initiation	   of	  
Cd4	  and	  Cd8	  silencing	  before	  the	  loss	  of	  Dicer-­‐dependent	  RNAs,	  and	  thereby	  permit	  evaluation	  
of	  whether	  Dicer	  has	  a	  role	  in	  maintenance	  of	  co-­‐receptor	  silencing	  in	  CD4+	  and	  CD8+	  αβ	  T	  cells.	  	  
Thus,	   I	   generated	   and	   analyzed	   Cd4Cre:EμBCL2:Dicerflox/flox	   (CBD)	   and	   Cd4Cre:Dicerflox/flox	   (CD)	  
mice.	   	   Consistent	  with	  previous	   reports,	   I	   observed	   that	  miR-­‐181a	  and	   let-­‐7c	  expression	  were	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only	   reduced	  ~50%	   in	  DP	   thymocyte	  of	  CD	   and	  CBD	  mice	   relative	   to	   controls	   (Fig.	   18A,	  B),	   as	  
opposed	   to	  a	  >90%	  reduction	   in	  LD	  and	  LBD	  mice	   (Fig.	  18A,	  B).	  SP	   thymocytes	  of	  CD	  and	  CBD	  
mice	  also	  exhibited	  higher	  levels	  of	  miR-­‐181a	  and	  let-­‐7c	  expression	  relative	  to	  LD	  and	  LBD	  mice,	  
indicating	  a	  lesser	  extent	  of	  Dicer	  deletion	  (Fig.	  18A,	  B).	  	  However,	  splenic	  CD4+	  and	  CD8+	  T	  cells	  
of	  CD	  and	  CBD	  mice	  generally	  exhibited	  similarly	  low	  levels	  of	  miR-­‐181a	  and	  let-­‐7c	  relative	  to	  LD	  
and	  LBD	  mice	  (Fig.	  13B,	  C),	   implying	  similar	  efficiency	  of	  Dicer	  deletion	  in	  splenic	  T	  cells	  across	  
the	   genotypes.	   In	   striking	   contrast	   to	   LBD	   mice,	   CBD	   mice	   had	   neither	   aberrant	   mature	  
CD4+CD8+	   thymocytes	   (Fig.	   19A,	   B)	   nor	   aberrant	   CD4+CD8+	   splenic	   αβ	   T	   cells	   (Fig.	   19C,	   D),	  
indicating	   that	  maintenance	  of	  Cd4	   and	  Cd8	  silencing	   is	  not	  detectably	   impaired	   in	  CBD	  or	  CD	  
mice.	  	  	   	  
	   Maintenance	  of	  gene	  expression	  and	  transcriptional	  silencing	  each	  require	  propagation	  
of	   epigenetic	  marks	   to	   daughter	   cells	   following	   proliferation	   (100).	   	   Thus,	   to	  more	   rigorously	  
determine	  whether	   Dicer	   is	   required	   for	  maintenance	   of	  Cd4	   and	  Cd8	   silencing,	   I	   transferred	  
carboxyfluorescein	   succinimidyl	  ester	   (CFSE)-­‐labeled	  CD4+	  or	  CD8+	  mature	  αβ	  T	  cells	   from	  LBD	  
mice	  into	  Rag1-­‐/-­‐	  mice	  (Fig.	  20).	  	  Rag1-­‐/-­‐	  mice	  lack	  all	  lymphocytes,	  so	  adoptive	  transfer	  results	  in	  
extensive	   cytokine-­‐driven	   homeostatic	   proliferation	   of	   donor	   cells	   to	   fill	   the	   otherwise	   empty	  
niche	   (96).	   	   The	   fluorescent	   CFSE	   dye	   binds	   intracellular	   molecules	   and	   is	   diluted	   by	  
approximately	  one-­‐half	  every	  time	  a	  cell	  divides,	  due	  to	  equal	  partitioning	  of	  labeled	  molecules	  
amongst	  daughter	  cells.	   	  This	  dilution	  allows	  confirmation	  of	  cell	  division	  and	  quantification	  of	  
the	  number	  of	  cell	  divisions,	  up	  until	  the	  dye	  is	  diluted	  below	  the	  level	  of	  detection	  (typically	  >5-­‐
7	  cell	  divisions).	  	  Three	  weeks	  post-­‐transfer,	  CFSE	  fluorescence	  was	  undetectable	  on	  transferred	  
LBD	   cells	   (Fig.	   20A),	   indicating	  extensive	   cellular	  proliferation.	   	  Despite	   such	  proliferation,	   less	  
than	  1%	  of	  transferred	  LBD	  CD4+	  and	  CD8+	  αβ	  T	  cells	  were	  CD4+CD8+	  (Fig.	  20A,	  B),	  similar	  to	  their	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WT	  or	  BCL2	  transgenic	  counterparts	  (compare	  Fig.	  20A,	  B	  and	  Fig.	  7A,	  B).	  	  qRT-­‐PCR	  for	  miR-­‐181a	  
and	  let-­‐7c	  revealed	  similar	  levels	  of	  expression	  in	  pre-­‐	  and	  post-­‐transfer	  cells,	  indicating	  that	  the	  
recovered	  CD4+	  or	  CD8+	  cells	  were	  not	  simply	  Dicer	  sufficient	  cells	  that	  outcompeted	  bona	  fide	  
Dicer-­‐/-­‐	   cells	   (Fig.	   21).	   	   I	   conclude	   that	   Dicer	   is	   not	   required	   for	   maintenance	   of	   Cd4	   or	   Cd8	  
silencing	  in	  mature	  CD8+	  or	  CD4+	  αβ	  T	  cells,	  respectively.	  	  	  	  
	   Dicer	  controls	  initiation	  of	  both	  Cd4	  and	  Cd8	  silencing.	   	  The	  next	  question	  I	  wished	  to	  
address	  was	  the	  developmental	  origin	  of	  the	  aberrant	  CD4+CD8+	  splenic	  T	  cells	  in	  LBD	  mice.	  	  The	  
aberrant	   CD4+CD8+	  αβ	   T	   cells	   could	  have	   arisen	   from	  MHCI-­‐restricted	   cells	  with	   impaired	  Cd4	  
silencing,	  MHCII-­‐restricted	   cells	  with	   impaired	  Cd8	   silencing,	   or	   a	   combination	   of	   both.	   It	  was	  
also	   formally	   possible	   that	   the	   cells	   switched	   between	   CD4+	   and	   CD8+	   states	   via	   a	   CD4+CD8+	  
intermediate.	  	  To	  address	  this	  issue	  I	  restricted	  the	  ability	  of	  thymocytes	  to	  develop	  on	  MHCI	  or	  
MHCII	   through	   transfer	  of	  bone	  marrow	  cells	   from	   LBD	   or	  BCL2	  mice	   into	   irradiated	   recipient	  
mice	  that	  lack	  MHCI	  or	  MHCII	  expression	  on	  thymic	  epithelium.	  	  
	   To	  determine	  whether	  Dicer	  is	  required	  for	  appropriate	  initiation	  of	  Cd8	  silencing	  during	  
development	   of	   MHCII-­‐restricted	   CD4+	   αβ	   T	   cells,	   I	   analyzed	   irradiated	   MHCI-­‐/-­‐	   mice	   (101)	  
reconstituted	  with	  LBD	  or	  BCL2	  bone	  marrow	  cells.	  	  	  I	  observed	  that	  15%	  of	  CD24loTCRβhi	  mature	  
thymocytes	  expressed	  both	  CD4	  and	  CD8	  in	  MHCI-­‐/-­‐	  mice	  reconstituted	  with	  LBD	  bone	  marrow	  
cells,	   while	   only	   2%	   of	   CD24loTCRβhi	   mature	   thymocytes	   were	   CD4+CD8+	   in	   MHCI-­‐/-­‐	   mice	  
reconstituted	  from	  BCL2	  cells	   (Fig.	  22A,	  B).	   	   I	  also	   found	  that	  15%	  of	  mature	  splenic	  αβ	  T	  cells	  
were	  CD4+CD8+	   in	  MHCI-­‐/-­‐	  mice	   reconstituted	  with	  LBD	   bone	  marrow	  cells,	  while	  only	  0.5%	  of	  
mature	  splenic	  αβ	  T	  cells	  expressed	  both	  CD4	  and	  CD8	  in	  MHCI-­‐/-­‐	  mice	  reconstituted	  with	  BCL2	  
cells	   (Fig.	   22C,	   D).	   It	   has	   previously	   been	   reported	   that	   transgenic	   BCL2	   expression	   in	  MHCI-­‐/-­‐	  
mice	  allows	  development	  of	  small	  numbers	  of	  splenic	  CD8+	  T	  cells	  that	  are	  non-­‐functional	  and	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undergo	   rapid	   turnover	   (102).	   	   A	   similar	   CD8+	   population	   was	   present	   in	   MHCI-­‐/-­‐	   mice	  
reconstituted	  with	  LBD	  bone	  marrow	  (Fig.	  22C).	  	  These	  data	  demonstrate	  that	  Dicer	  inactivation	  
in	  DN	  thymocytes	  leads	  to	  impaired	  initiation	  of	  Cd8	  silencing	  during	  intrathymic	  differentiation	  
of	  MHCII-­‐restricted	  αβ	  T	  cells.	  	  	  
	   To	  determine	  whether	  Dicer	  is	  required	  for	  appropriate	  initiation	  of	  Cd4	  silencing	  during	  
development	   of	   MHCI-­‐restricted	   CD8+	   αβ	   T	   cells,	   I	   analyzed	   irradiated	   MHCII-­‐/-­‐	   mice	   (103)	  
reconstituted	  with	  bone	  marrow	  from	  LBD	  or	  BCL2	  mice.	  	  The	  MHCII-­‐/-­‐	  strain	  I	  utilized	  lacks	  most	  
classical	  MHCII	  molecules,	  resulting	  in	  a	  preponderance	  of	  MHCI-­‐restricted,	  CD8	  lineage	  T	  cells,	  
but	  a	  few	  CD4+	  cells	  do	  develop	  in	  these	  animals	  and	  are	  thought	  to	  be	  selected	  on	  non-­‐classical	  
MHCII-­‐like	  molecules	  (103).	  	  Regardless	  of	  this	  caveat,	  I	  found	  that	  16%	  of	  CD24loTCRβhi	  mature	  
thymocytes	  expressed	  both	  CD4	  and	  CD8	  in	  MHCII-­‐/-­‐	  mice	  reconstituted	  with	  LBD	  bone	  marrow,	  
while	   only	   4%	  of	   CD24loTCRβhi	   thymocytes	  were	  CD4+CD8+	   in	  MHCII-­‐/-­‐	  mice	   reconstituted	  with	  
BCL2	  cells	   (Fig.	   23A,	  B).	   	   I	   also	   found	   that	  10%	  of	  mature	   splenic	  αβ	  T	   cells	  were	  CD4+CD8+	   in	  
MHCII-­‐/-­‐	  mice	  reconstituted	  from	  LBD	  bone	  marrow,	  but	  only	  2.5%	  of	  mature	  splenic	  αβ	  T	  cells	  
expressed	  both	  CD4	  and	  CD8	  in	  MHCII-­‐/-­‐	  mice	  reconstituted	  from	  donor	  BCL2	  cells	  (Fig.	  23C,	  D).	  
These	  data	  demonstrate	  that	  Dicer	  inactivation	  in	  DN	  thymocytes	  leads	  to	  impaired	  initiation	  of	  
Cd4	   silencing	   during	   intrathymic	   differentiation	   of	   MHCI-­‐restricted	   αβ	   T	   cells.	   	   Based	   on	   my	  
analyses	   of	  MHCI-­‐/-­‐	   and	  MHCII-­‐/-­‐	   mice	   reconstituted	   with	   LBD	   or	   BCL2	   cells,	   I	   conclude	   that	  
expression	  of	  Dicer	  in	  immature	  DP	  thymocytes	  is	  required	  for	  appropriate	  initiation	  of	  both	  Cd4	  
and	  Cd8	  silencing.	  
	   My	  finding	  that	  both	  Cd4	  silencing	   in	  MHCI-­‐restricted	  cells	  and	  Cd8	  silencing	   in	  MHCII-­‐
restricted	   cells	   were	   impaired	   in	   the	   absence	   of	   Dicer	   suggested	   that	   the	   aberrant	   CD4+CD8+	  
population	  of	  splenic	  T	  cells	  in	  LBD	  mice	  contains	  a	  heterogeneous	  mixture	  of	  MHCI	  and	  MHCII-­‐
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restricted	  cells.	  	  This	  could	  greatly	  confound	  population	  studies,	  such	  as	  RNA-­‐sequencing	  (RNA-­‐
seq)	   in	   sorted	   CD4+CD8+	   cells,	   because	   lineage	   specific	   differences	   in	   Dicer	   deletion	  might	   be	  
obscured	  due	  to	  population	  averaging	  effects.	   	  Additionally,	   it	  was	  possible	   that	   the	  CD4+CD8+	  
cells	   from	  LBD	  mice	  expressed	  TCRs	  of	   insufficient	  avidity	  for	  self-­‐peptide/MHC	  interactions	  to	  
permit	  normal	  positive	  selection,	  but	  were	  able	  to	  bypass	  this	  checkpoint	  due	  to	  the	  absence	  of	  
Dicer	  and	  expression	  of	   transgenic	  BCL2.	   	   In	  order	   to	  begin	  addressing	   these	  questions,	   I	  bred	  
different	   TCR	   transgenes	   onto	   the	   LBD	   background	   in	   order	   to	   generate	   pure	   populations	   of	  
Dicer-­‐/-­‐	  MHCI	  or	  MHCII-­‐restricted	  T	  cells	  expressing	  TCRs	  known	  to	  promote	  positive	  selection.	  
Specifically,	   I	   generated	   and	   characterized	   LckCre:EμBCL2:Dicerflox/flox:Rag1-­‐/-­‐:OT-­‐I	   (LBD	  R1	  OT-­‐I)	  
mice,	  which	  express	  the	  MHCI-­‐restricted	  OT-­‐I	  transgenic	  TCR	  on	  all	  developing	  thymocytes	  and	  T	  
cells,	  and	  LckCre:EμBCL2:Dicerflox/flox:Rag1-­‐/-­‐:OT-­‐I	   (LBD	  R1	  OT-­‐II)	  mice,	  which	  express	   the	  MHCII-­‐
restricted	  OT-­‐II	   transgenic	  TCR	  on	  all	  developing	   thymocytes	  and	  T	   cells.	   	  Notably,	   these	  mice	  
lacked	  the	  endonuclease	  Rag1,	  thereby	  precluding	  the	  possibility	  of	  secondary	  antigen	  receptor	  
rearrangements	  that	  could	  replace	  the	  transgenic	  TCR.	  	  
	   Using	   flow	  cytometry	   I	   found	   that	  positively-­‐selected	  LBD	  R1	  OT-­‐I	   αβ	  T	   cells	   exhibited	  
impaired	  Cd4	   silencing,	  with	   ~45%	  of	  mature	   splenic	  αβ	   T	   cells	   expressing	   both	  CD4	   and	  CD8	  
(Fig.	   24A,	  B),	   indicating	   that	  Dicer	   is	   required	   for	   appropriate	  Cd4	   silencing	   in	  MHCI-­‐restricted	  
cells	   expressing	   an	   αβ	   TCR	   transgene	   that	   promotes	   positive	   selection.	   Similarly,	   I	   found	   that	  
positively-­‐selected	  LBD	  R1	  OT-­‐II	  αβ	  T	  cells	  exhibited	  impaired	  Cd8	  silencing,	  with	  ~25%	  of	  mature	  
splenic	  αβ	  T	  cells	  expressing	  both	  CD4	  and	  CD8	  (Fig.	  24C,	  D),	  indicating	  that	  Dicer	  is	  also	  required	  
for	  normal	  Cd8	  silencing	  in	  MHCII-­‐restricted	  cells	  expressing	  an	  αβ	  TCR	  transgene	  that	  promotes	  
positive	  selection.	  	  Collectively,	  these	  data	  demonstrate	  that	  Dicer	  ensures	  appropriate	  silencing	  
of	  both	  Cd4	  and	  Cd8	  in	  positively-­‐selected	  αβ	  T	  cells.	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   Re-­‐direction	  of	  MHCI-­‐restricted	  T	  cells	   to	   the	  CD4	   lineage	   in	  LBD	  R1	  OT-­‐I	  mice.	   I	  also	  
noted	   a	   statistically	   significant	   increase	   in	   the	   frequency	   of	   CD4+	   cells	   in	   LBD	   R1	   OT-­‐I	   mice	  
relative	   to	   controls	   (Fig.	   24A,	   B).	   	   To	   determine	   if	   these	   cells	   resembled	   CD4	   lineage	   cells	  
transcriptionally,	   I	   sorted	   CD4+	   cells	   from	   LBD	   R1	   OT-­‐I	   mice	   and	   performed	   qRT-­‐PCR	   for	  
expression	  of	  Zbtb7b	  (which	  encodes	  ThPOK,	  a	  critical	  regulator	  of	  CD4	  lineage	  commitment	  and	  
fidelity).	  	  I	  observed	  similar	  levels	  of	  Zbtb7b	  mRNA	  in	  sorted	  CD4+	  cells	  from	  LBD	  R1	  OT-­‐I	  and	  WT	  
controls	  (Fig.	  25),	  suggesting	  that	  CD4+	  cells	  from	  LBD	  R1	  OT-­‐I	  represented	  bona	  fide	  CD4	  lineage	  
cells	  that	  arose	  from	  re-­‐direction	  of	  MHCI-­‐restricted	  thymocytes.	  
	   Dicer	  mediates	   transcriptional	   silencing	  of	  Cd4	   in	  MHCI-­‐restricted	  T	  cells.	  Dicer	  could	  
regulate	  appropriate	  Cd4	  and	  Cd8	  silencing	  via	  a	  variety	  of	  mechanisms.	  	  Destabilization	  of	  Cd4	  
and	  Cd8	  mRNA	  following	  positive	  selection	  could	  be	  regulated	  by	  Dicer	  either	  directly	  through	  
cleavage	  of	  dsRNA	  in	  Cd4	  or	  Cd8	  mRNAs,	  or	  indirectly	  through	  biogenesis	  of	  miRNAs	  that	  repress	  
translation	  or	  reduce	  stability	  of	  co-­‐receptor	  mRNA.	  Alternatively,	  Dicer	  dependent	  siRNAs	  could	  
mediate	   transcriptional	   gene	   silencing	  of	  Cd4	   and	  Cd8,	   or	   guide	   slicer	   activity	   to	  Cd4	   and	  Cd8	  
mRNAs	  to	  mediate	  degradation.	  I	  began	  by	  evaluating	  the	  role	  of	  Dicer	  in	  control	  of	  co-­‐receptor	  
transcriptional	   silencing	   by	   performing	   qRT-­‐PCR	   for	   primary	   (un-­‐spliced)	   Cd4	   transcripts	   as	   a	  
surrogate	  for	  active	  transcription.	  Sorted	  splenic	  T	  cells	  from	  LBD	  R1	  OT-­‐I	  and	  control	  mice	  were	  
utilized	  because	  all	  T	  cells	  in	  these	  mice	  express	  identical	  MHCI-­‐restricted	  TCRs.	  	  I	  was	  unable	  to	  
detect	   primary	   Cd4	   transcripts	   in	   CD8+	   cells	   of	  WT,	   R1	   OT-­‐1,	   or	   LBD	   R1	   OT-­‐I	   mice	   (Fig.	   26),	  
confirming	   appropriate	   transcriptional	   silencing	   in	   these	   populations.	   	   In	   contrast,	   I	   detected	  
similarly	  high	  levels	  of	  primary	  Cd4	  transcripts	  in	  LBD	  R1	  OT-­‐I	  CD4+CD8+	  cells	  and	  WT	  CD4+	  cells	  
(Fig.	  26).	  	  While	  these	  data	  cannot	  rule	  out	  an	  additional	  role	  for	  the	  Dicer	  RNA	  endonuclease	  in	  
destabilization	   of	   Cd4	   mRNA,	   they	   demonstrate	   that	   Dicer	   is	   required	   for	   appropriate	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transcriptional	   silencing	   of	   Cd4	   in	   MHCI-­‐restricted	   αβ	   T	   cells.	   Unfortunately,	   I	   was	   unable	   to	  
obtain	   sufficient	   numbers	   of	   sorted	   cells	   from	   LBD	   R1	   OT-­‐II	   mice	   to	   perform	   the	   parallel	  
experiment	  examining	  primary	  Cd8	  transcripts	  in	  Dicer-­‐/-­‐	  MHCII-­‐restricted	  cells	  (see	  discussion).	  
Runx3	  expression	  is	  reduced	  in	  MHCI-­‐restricted	  CD4+CD8+	  splenic	  T	  cells	  of	  LBD	  R1	  OT-­‐I	  
mice.	  Given	  the	  central	  role	  of	  Runx3	  in	  transcriptional	  silencing	  of	  Cd4	  in	  MHCI-­‐restricted	  cells	  
(see	  Chapter	  One,	  p.	  7-­‐8),	  I	  hypothesized	  that	  impaired	  transcriptional	  silencing	  of	  Cd4	  in	  LBD	  R1	  
OT-­‐I	  T	  cells	  could	  result	  from	  impaired	  Runx3	  expression.	  	  To	  test	  this	  hypothesis	  I	  collaborated	  
with	   the	   laboratory	   of	   Remy	   Bosselut	   to	   conduct	  Western	   blot	   analyses	   of	   Runx3	   protein	   in	  
mature	   αβ	   T	   cells	   sorted	   from	   spleens	   of	   LBD	   R1	   OT-­‐I	   and	   control	   mice.	   	   We	   detected	   a	  
decreased	   level	   of	   Runx3	  protein	   in	   CD4+CD8+	   cells	   of	  LBD	  R1	  OT-­‐I	  mice	   as	   compared	   to	  CD8+	  
cells	   of	  WT	   and	   LBD	  R1	  OT-­‐I	  mice	   (Fig.	   27A),	   indicating	   that	   Dicer	   is	   required	   for	   appropriate	  
expression	   of	   Runx3	   in	   positively-­‐selected,	  MHCI-­‐restricted	   αβ	   T	   cells.	   	   Given	   that	   ThPOK	   can	  
repress	  Runx3	  expression	  (51-­‐53),	  I	  wondered	  whether	  aberrant	  ThPOK	  expression	  in	  CD4+CD8+	  
cells	  of	  LBD	  R1	  OT-­‐I	  mice	  could	  account	   for	   impaired	  Runx3	  expression.	   	  However,	   I	   could	  not	  
detect	   increased	   Zbtb7b	   mRNA	   in	   sorted	   CD4+CD8+	   cells	   from	   LBD	   R1	   OT-­‐I	   mice	   (Fig.	   27B),	  
suggesting	   that	   inappropriate	  ThPOK	  expression	  explain	   the	   impaired	  Runx3	  expression	   in	   the	  
absence	  of	  Dicer.	  	  	  	  
	   ThPOK	   expression	   is	   reduced	   in	   CD4+CD8+	   splenic	   T	   cells	   from	   LBD	   R1	   OT-­‐II	   mice.	  	  
Analogous	  to	  Runx3	  up-­‐regulation	  in	  MHCI-­‐restricted	  cells,	  positive	  selection	  of	  MHCII-­‐restricted	  
cells	   induces	   ThPOK	   expression,	   which	   drives	   CD4	   lineage	   commitment	   and	   facilitates	   Cd8	  
silencing	   (41,	   42,	   59).	   Given	   that	   Runx3	   expression	   was	   impaired	   in	   Dicer-­‐deficient	   MHCI-­‐
restricted	  αβ	   T	   cells,	   I	   hypothesized	   that	  Dicer	  might	   similarly	   control	   expression	   of	   ThPOK	   in	  
MHCII-­‐restricted	  cells.	  	  To	  test	  this	  hypothesis,	  I	  performed	  qRT-­‐PCR	  analyses	  for	  Zbtb7b	  mRNA	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(since	  I	  was	  unable	  to	  isolate	  enough	  cells	  for	  Western	  blot	  with	  available	  ThPOK	  antibodies)	  in	  
sorted	   cells	   from	   LBD	  R1	  OT-­‐II	   and	   control	  mice.	   	   I	   found	   a	   reduced	   level	   of	  Zbtb7b	  mRNA	   in	  
CD4+CD8+	   cells	   from	   LBD	   R1	  OT-­‐II	  mice	   relative	   to	   CD4+	   cells	   from	   control	  R1	  OT-­‐II	  mice	   (Fig.	  
27C),	  revealing	  that	  Dicer	  is	  also	  required	  for	  normal	  expression	  of	  Zbtb7b	  in	  positively-­‐selected,	  
MHCII-­‐restricted	   αβ	   T	   cells.	   	   Collectively,	   these	   data	   demonstrate	   that	   Dicer	   promotes	  
appropriate	   expression	   of	   “master”	   transcriptional	   regulators	   of	   the	   CD4	   and	   CD8	   αβ	   T	   cell	  
lineages	  in	  MHC	  II-­‐	  or	  MHCI-­‐restricted	  cells,	  respectively,	  following	  positive	  selection.	  
	   Drosha	   is	   also	   required	   for	   normal	   Cd4	   and	   Cd8	   silencing	   during	   αβ	   T	   cell	  
development.	   	  Dicer	   could	   regulate	  Cd4	   and	  Cd8	   silencing	   through	   generation	   of	   siRNAs	   that	  
directly	  halt	  transcription	  of	  these	  loci	  and/or	  via	  biogenesis	  of	  miRNAs	  that	  indirectly	  increase	  
expression	   of	   Runx3,	   ThPOK,	   and	   other	   factors	   that	   control	   CD4	   and	   CD8	   expression.	   	   To	  
determine	   if	   Dicer-­‐dependent	   siRNAs	   and/or	   miRNAs	   regulate	   initiation	   of	   Cd4	   and	   Cd8	  
silencing,	   we	   collaborated	   with	   the	   laboratory	   of	   Stefan	   Muljo	   to	   generate	   and	   analyze	  
LckCre:EμBCL2:Droshaflox/flox	   (LBDr)	  mice	  because	   the	  Drosha	  RNA	  endonuclease	   is	   required	   for	  
production	   of	  miRNAs,	   but	   not	   siRNAs	   (77).	   	  We	   observed	   that	   ~40%	  of	  mature	   CD24loTCRβhi	  
mature	  thymocytes	  in	  LBDr	  mice	  express	  both	  CD4	  and	  CD8	  (Fig.	  28A,	  B),	  revealing	  that	  Drosha	  
is	  required	  for	  appropriate	   initiation	  of	  Cd4	  and/or	  Cd8	  silencing.	   	  We	  also	  found	  that	  ~20%	  of	  
mature	  splenic	  αβ	  T	  cells	   in	  LBDr	  mice	  express	  both	  CD4	  and	  CD8	  (Fig.	  28C,	  D),	   indicating	  that	  
ectopic	  expression	  of	  BCL2	  throughout	  development	  of	  Drosha-­‐deficient	  αβ	  T	  cells	  permits	  the	  
accumulation	   of	  mature	   aberrant	   splenic	   CD4+CD8+	  αβ	   T	   cells.	   	   Since	   these	   data	   demonstrate	  
that	  both	  Drosha	  and	  Dicer	  are	  required	  for	  normal	  expression	  of	  CD4	  and	  CD8	  in	  mature	  αβ	  T	  
cells,	   I	   conclude	   that	  miRNAs	   likely	   control	   the	  appropriate	   initiation	  of	  Cd4	   and	  Cd8	   silencing	  
during	  αβ	  T	  cell	  differentiation.	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   The	  developmental	  fate	  of	  aberrant	  CD4+CD8+	  splenic	  T	  cells.	  Examination	  of	  LBD	  mice	  
at	  ages	  ranging	  from	  10	  days	  to	  6	  months	  revealed	  that	  the	  frequency	  of	  splenic	  CD4+CD8+	  cells	  
decreased	  with	   age	   (Fig.	   29A),	   despite	   being	   aberrant	   CD4+CD8+	   cells	   being	   generated	   at	   the	  
same	  frequency	  in	  the	  thymus	  throughout	  the	  age	  range	  examined	  (Fig.	  29B).	  	  This	  observation	  
could	  partially	  result	  from	  reduced	  thymic	  output	  that	  has	  been	  documented	  in	  aged	  mice	  (104),	  
but	  also	  could	  have	  resulted	  from	  cell	  death,	  differentiation,	  or	  altered	  trafficking	  of	  CD4+CD8+	  
cells	   over	   time.	   	   To	   test	  whether	   aberrant	   CD4+CD8+	   cells	  were	   able	   to	   differentiate	   to	   either	  
CD4+	  or	  CD8+	  cells,	   I	   isolated	  aberrant	  CD4+CD8+	  splenic	  T	  cells	   from	  LBD	  mice	  and	  transferred	  
them	  to	  Rag1-­‐/-­‐	  recipients.	  	  Two	  weeks	  post-­‐transfer,	  aberrant	  CD4+CD8+	  cells	  gave	  rise	  to	  CD4+	  
or	  CD8+	  cells	  (Fig.	  30A).	  	  The	  number	  of	  recovered	  CD4+	  or	  CD8+	  cells	  was	  relatively	  low,	  and	  in	  
initial	   experiments	   could	   have	   been	   explained	   by	   proliferation	   of	   injected	   CD4+	   or	   CD8+	   cells	  
present	   at	   low	   frequency	   in	   the	   sorted	   cells	   (based	   upon	   total	   cell	   numbers	   and	   predicted	  
expansion	  following	  transfer	  of	  LBD	  CD4+	  or	  CD8+	  cells	  as	  in	  Fig.	  20).	  	  To	  address	  this	  variable,	  I	  
hypothesized	   that	   transferring	   large	   numbers	   of	   CFSE	   labeled	   aberrant	   CD4+CD8+	   cells	   and	  
analyzing	  24-­‐48	  hours	  post	  transfer	  would	  permit	  me	  to	  identify	  those	  cells	  that	  had	  undergone	  
proliferation	  based	  upon	  CFSE	  expression,	  and	  subsequently	  determine	  if	  these	  cells	  contributed	  
the	  entirety	  of	  the	  CD4+	  or	  CD8+	  population.	   	  Unfortunately,	   I	  was	  unable	  to	  recover	  sufficient	  
numbers	  of	   transferred	  cells	   for	  meaningful	  analysis	  at	   these	  early	   timepoints.	   	   I	   subsequently	  
performed	  a	  parallel	  experiment	  to	  determine	  the	  maximal	  contribution	  of	  single	  positive	  T	  cells	  
that	   could	   arise	   from	   contaminating	   CD4+	   or	   CD8+	   cells	   in	   the	   sorted	   CD4+CD8+	   transfer	  
population.	  	  After	  sorting	  aberrant	  CD4+CD8+	  cells	  from	  LBD	  mice,	  post-­‐sort	  purity	  was	  analyzed	  
and	   the	   number	   of	   potential	   contaminating	   CD4+	   or	   CD8+	   cells	   in	   the	   injection	   volume	   was	  
calculated.	   	  A	  separate	  set	  of	  Rag1-­‐/-­‐	   recipients	  was	  subsequently	   injected	  with	  this	  number	  of	  
either	  CD4+	  or	  CD8+	  cells	  sorted	  from	  LBD	  mice.	  	  Two	  weeks	  post	  transfer,	  the	  number	  of	  splenic	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TCRβ+	  cells	   recovered	  was	  analyzed	   in	  animals	  receiving	  either	  CD4+CD8+,	  CD4+,	  or	  CD8+	  donor	  
cells.	   	  Despite	   significant	  mouse-­‐to-­‐mouse	   variability	   in	   the	   LBD	   CD4+CD8+	   transfer	   group	   that	  
precluded	  statistical	  significance,	  the	  average	  number	  of	  TCRβ+	  cells	  recovered	  in	  mice	  receiving	  
aberrant	   CD4+CD8+	   cells	   was	   >10-­‐fold	   larger	   than	   the	   average	   number	   recovered	   in	   mice	  
receiving	  either	  CD4+	  or	  CD8+	  cells	  (Figure	  30B),	  indicating	  that	  CD4+	  and	  CD8+	  cells	  arising	  after	  
transfer	  of	  aberrant	  CD4+CD8+	  cells	  cannot	  be	  fully	  explained	  by	  sort	  impurity.	  Thus,	  I	  conclude	  
that	  aberrant	  CD4+CD8+	  splenic	  T	  cells	  from	  LBD	  mice	  can	  give	  rise	  to	  CD4+	  or	  CD8+	  splenic	  T	  cells	  
following	  homeostatic	  proliferation	  in	  vivo.	  
	   In	   vitro	   cultures	   of	   sorted	   CD4+CD8+	   splenic	   T	   cells	   from	   LBD	   mice	   revealed	   a	   similar	  
outcome,	  with	  a	  fraction	  of	  DP	  cells	  losing	  either	  CD4	  or	  CD8	  expression	  after	  4	  days	  in	  culture	  
with	   the	  pro-­‐survival	   cytokines	   IL-­‐2	  or	   IL-­‐7	   (Fig.	  31A).	   Sorted	  CD4+CD8+	   cells	   from	  LBD	  R1	  OT-­‐I	  
mice	  also	  silenced	  surface	  CD4	  expression	  during	  in	  vitro	  culture	  with	  IL-­‐7	  (Fig.	  31B).	  	  	  It	  has	  been	  
suggested	   that	   IL-­‐7	   signaling	  promotes	  Runx3	  expression,	  which	  drives	  Cd4	   silencing	   in	  MHCI-­‐
restricted	   thymocytes	   (45);	   thus,	  Cd4	   silencing	   in	   sorted	  CD4+CD8+	   splenic	  T	  cells	   from	  LBD	  R1	  
OT-­‐I	  mice	  could	  have	  resulted	  from	  Runx3	  induction	  due	  to	  exogenous	  IL-­‐7.	  	  However,	  I	  noted	  a	  
similar	  down-­‐regulation	  of	  Cd4	   in	  cultures	   lacking	  exogenous	  IL-­‐7	  (data	  not	  shown),	  suggesting	  
that	  aberrant	  MHCI-­‐restricted	  CD4+CD8+	  cells	  can	  down-­‐regulate	  Cd4	  in	  vitro	  without	  exogenous	  
IL-­‐7.	  	  I	  was	  unable	  to	  obtain	  sufficient	  cell	  numbers	  to	  perform	  a	  similar	  experiment	  with	  sorted	  
cells	   from	   LBD	   R1	   OT-­‐II	   mice	   (see	   discussion).	   	   Combined,	   these	   results	   suggest	   that	  
phenotypically	   mature	   CD4+CD8+	   T	   cells	   from	   Dicer	   deficient,	   BCL2	   transgenic	   mice	   can	  
eventually	  undergo	  co-­‐receptor	  silencing.	  
	   Attempts	   to	   rescue	   Cd4	   silencing	   via	   ectopic	   Runx3	   expression	   in	   Dicer-­‐/-­‐	   MHCI-­‐
restricted	  cells.	  Impaired	  transcriptional	  silencing	  of	  Cd4	  in	  MHCI-­‐restricted	  Dicer-­‐/-­‐	  T	  cells	  could	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result	  from	  reduced	  Runx3	  expression	  as	  observed	  in	  aberrant	  CD4+CD8+	  T	  cells	  from	  LBD	  R1	  OT-­‐
I	   mice.	   	   Alternatively,	   impaired	   Runx3	   expression	   could	   be	   un-­‐related	   to	   the	   observed	  
impairment	   in	   transcriptional	   silencing	  of	  Cd4.	   	   To	   test	  whether	  ectopic	  Runx3	  expression	   can	  
rescue	  Cd4	   silencing,	   I	   generated	   a	   bicistronic	  murine	   stem	   cell	   virus	   (MSCV)-­‐based	   retroviral	  
vector	   encoding	   Runx3	   upstream	   of	   an	   internal	   ribosome	   entry-­‐site	   (IRES)	   driving	   green	  
fluorescent	   protein	   (GFP)	   (hereafter	   referred	   to	   as	   Runx3-­‐MIG)	   (105).	   	   I	   first	   attempted	   the	  
rescue	   experiment	   by	   activating	   sorted	   splenic	   CD4+CD8+	   T	   cells	   from	   LBD	   R1	   OT-­‐I	   mice	  with	  
plate-­‐bound	   anti-­‐CD3	   and	   anti-­‐CD28	   antibodies	   to	   mimic	   TCR	   stimulation,	   and	   transduced	  
proliferating	  cells	  24-­‐48	  hours	  later	  with	  either	  Runx3-­‐MIG	  or	  empty	  control	  vector	  (MIG).	  	  48-­‐72	  
hours	   post-­‐transduction,	   cells	   were	   analyzed	   for	   CD4	   and	   CD8	   expression.	   	   After	   gating	   on	  
transduced	   GFP+	   cells,	   I	   observed	   no	   difference	   in	   the	   expression	   patterns	   of	   CD4	   and	   CD8	  
between	   Runx3-­‐transduced	   or	   empty	   vector	   transduced	   cells	   (Fig.	   32).	   	   This	   experiment	   is	  
confounded	  by	  the	  fact	  that	  sorted	  CD4+CD8+	  cells	  from	  LBD	  R1	  OT-­‐I	  mice	  normally	  silence	  CD4	  
during	   in	   vitro	   culture,	   potentially	   obscuring	   the	   ability	   of	  Runx3	   to	   rescue	  Cd4	   silencing.	   	   To	  
more	  directly	  test	  the	  ability	  of	  ectopic	  Runx3	  to	  rescue	  Cd4	  silencing	  in	  developing	  thymocytes,	  
I	   collaborated	  with	  Ellen	  de	  Obaldia	  and	  Avinash	  Bhandoola	   to	  perform	  an	   in	  vivo	   experiment	  
employing	   intrathymic	   injection	   of	   transduced	   T	   lineage	   progenitors	   ectopically	   expressing	  
Runx3.	  
	   Multipotent	  hematopoietic	  stem	  cells	  were	  first	   isolated	  by	  sorting	  Lineage-­‐Sca-­‐1+c-­‐kit+	  
(LSK)	  cells	  from	  either	  LBD	  R1	  OT-­‐I	  or	  WT	  mice.	  	  Sorted	  LSKs	  were	  transduced	  with	  either	  Runx3-­‐
MIG	  or	  empty	  MIG	   for	  24	  hours,	   transduction	  efficiency	  was	  analyzed	  by	   flow	  cytometry,	  and	  
donor	   cells	   (CD45.2+)	   were	   subsequently	   injected	   intra-­‐thymically	   into	   sub-­‐lethally	   irradiated,	  
congenically	  disparate	  (CD45.1+)	  hosts.	   	  CD45,	  encoded	  by	  the	  Ptprc	  gene,	   is	  a	  commonly	  used	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congenic	   marker	   because	   antibodies	   are	   available	   that	   distinguish	   the	   CD45.1	   and	   CD45.2	  
alleles.	   	  Thus,	  by	  transferring	  donor	  cells	  to	  a	  congenically	  disparate	  host,	   I	  was	  able	  to	  clearly	  
identify	  donor-­‐derived	  cells.	   Intrathymic	   injection	  of	   LSKs	  or	  other	  progenitor	  cells	   results	   in	  a	  
wave	  of	  population	  expansion	  and	  thymocyte	  development,	  thereby	  allowing	  the	  investigator	  to	  
determine	   the	   effect	   of	   experimental	   manipulations	   on	   thymic	   development	   in	   vivo.	   	   I	  
hypothesized	  that	  constitutive	  Runx3	  expression	   in	  developing	  thymocytes	  from	  donor	  LBD	  R1	  
OT-­‐I	  progenitors	  would	  rescue	  Dicer-­‐dependent	  induction	  of	  Runx3	  expression,	  thereby	  rescuing	  
Cd4	   silencing	   in	   mature	   thymocytes	   and	   reducing	   the	   number	   and	   frequency	   of	   aberrant	  
CD4+CD8+	   mature	   thymocytes.	   	   This	   was	   not	   the	   case,	   however,	   as	   I	   was	   unable	   to	   recover	  
significant	   numbers	   of	   Runx3-­‐transduced	   cells	   21	   or	   28	   days	   post-­‐transfer	   in	   mice	   receiving	  
either	  WT	   or	   LBD	  R1	  OT-­‐I	   donor	   cells	   (Fig.	   33A,	   B).	   	   In	   contrast,	   transduced	   (GFP+)	   cells	  were	  
readily	  identified	  in	  mice	  receiving	  either	  WT	  or	  LBD	  R1	  OT-­‐I	  donor	  cells	  transduced	  with	  empty	  
MIG	   (Fig.	  33A,	  B).	   	   It	   should	  be	  noted,	  however,	   that	   the	   input	   transduction	   frequencies	  were	  
similar	  for	  cells	  transduced	  with	  Runx3-­‐MIG	  or	  empty	  MIG	  (Fig.	  33A).	   	  As	  such,	   I	  conclude	  that	  
ectopic	   Runx3	   expression	   in	   progenitor	   cells	   is	   either	   toxic	   or	   provides	   a	   competitive	  
disadvantage	   to	   transduced	   cells;	   consistent	  with	   this	   observation,	   the	   Rothenberg	   group	   has	  
previously	  reported	  that	  transduction	  of	  Runx1,	  a	  closely	  related	  Runx	  family	  transcription	  factor	  
that	  also	  promotes	  Cd4	  silencing,	  inhibited	  cell	  growth	  in	  fetal	  thymocytes	  (106).	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Chapter	  Three:	  Discussion	  and	  Future	  Directions	  
 
 My	   thesis	   work	   describes	   a	   novel	   role	   for	   the	   Dicer	   and	   Drosha	   endonucleases	   in	  
regulating	   CD4/CD8	   co-­‐receptor	   silencing	   and	   lineage	   commitment	   during	   αβ	   T	   cell	  
development.	   	   In	   the	   absence	   of	   Dicer	   or	   Drosha,	   both	   Cd4	   silencing	   in	   MHCI-­‐restricted	  
thymocytes	   and	   Cd8	   silencing	   in	   MHCII-­‐restricted	   thymocytes	   are	   impaired,	   giving	   rise	   to	  
aberrant	   CD4+CD8+CD24loTCRβhi	   thymocytes.	   Inactivation	   of	   the	   p53	   tumor	   suppressor	   or	  
transgenic	  expression	  of	  the	  anti-­‐apoptotic	  protein	  BCL2	  allows	  accumulation	  of	  these	  aberrant	  
CD4+CD8+	  cells	   in	  peripheral	   tissues	   including	   spleen,	   lymph	  nodes,	  and	  blood.	   	  Notably,	  Dicer	  
appears	   to	   play	   a	   role	   in	   kinetically	   appropriate	   co-­‐receptor	   silencing,	   as	   aberrant	   splenic	  
CD4+CD8+	   T	   cells	   from	   LBD	   mice	   are	   capable	   of	   undergoing	   co-­‐receptor	   silencing	   following	  
lymphopenia-­‐driven	   homeostatic	   proliferation.	   	   Impaired	   co-­‐receptor	   silencing	   is	   observed	   in	  
the	   absence	   of	   either	   Dicer	   or	   Drosha,	   both	   of	   which	   are	   required	   for	   miRNA	   biogenesis,	  
suggesting	   that	  miRNAs	   are	   required	   to	  mediate	   normal	   co-­‐receptor	   silencing.	   	   In	   addition	   to	  
impaired	  Cd4	   and	  Cd8	   silencing,	  Dicer-­‐/-­‐	   aberrant	  CD4+CD8+	   T	   cells	   expressing	  MHCI	   or	  MHCII-­‐
restricted	   TCR	   transgenes	   exhibit	   reduced	   expression	   of	   the	   lineage	   specifying	   transcription	  
factors	  Runx3	  and	  Zbtb7b	  (ThPOK),	  respectively.	  	  These	  results	  suggest	  that	  miRNAs	  are	  required	  
for	  appropriate	  lineage	  commitment	  of	  αβ	  T	  cells	  following	  positive	  selection.	   	  My	  findings	  are	  
summarized	  in	  the	  model	  shown	  in	  Fig.	  34.	  	  This	  work	  raises	  a	  number	  of	  additional	  mechanistic	  
questions	  regarding	  the	  role	  of	  Dicer,	  Drosha,	  and	  miRNAs	  in	  development,	  survival,	  and	  lineage	  
commitment	  of	  αβ	  T	  cells,	  several	  of	  which	  I	  will	  highlight	  here.	  
	   Dicer	   deficiency	   and	   cell	   death.	   One	   of	   the	   most	   striking	   and	   consistently	   reported	  
phenotypes	  in	  T	  cell	  specific	  models	  of	  Dicer	  deficiency	  is	  impaired	  survival/increased	  cell	  death.	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However,	   the	  mechanisms	   by	  which	  Dicer	   deficiency	   results	   in	   increased	   susceptibility	   to	   cell	  
death	   and	   apoptosis	   remain	   unclear.	   	   One	   open	   question	   concerns	   how	   much	   of	   this	  
susceptibility	   is	   T	   cell	   specific	   as	   opposed	   to	   a	   general	   feature	   of	  Dicer	   deficient	   cells.	   	  Dicer	  
deficiency	  in	  a	  number	  of	  other	  cell	  types	  has	  been	  reported	  to	  result	  in	  either	  impaired	  growth	  
rates,	  increased	  cell	  death,	  or	  impaired	  proliferation	  (107);	  different	  analysis	  techniques	  make	  it	  
difficult	  to	  directly	  compare	  and	  contrast	  these	  papers,	  but	  these	  results	  are	  consistent	  with	  a	  
general	  role	  for	  Dicer	  in	  promoting	  cell	  survival,	  particularly	  during	  proliferation.	  	  Such	  a	  defect	  
could	  be	  related	  to	  impairment	  in	  general	  housekeeping	  pathways.	  	  For	  example,	  Wei	  et	  al.	  have	  
reported	  that	  small	  RNAs	  mapping	  to	  adjacent	  sequences	  are	  generated	  following	  induction	  of	  a	  
DNA	   double	   strand	   break	   in	   a	   human	   cell	   line,	   and	   homology	   directed	   double	   strand	   break	  
repair	   is	   impaired	   in	   the	  absence	  of	  Dicer	  or	  Argonaute	  proteins	   (108).	  One	  could	  hypothesize	  
that	   increased	   sensitivity	   to	  DNA	  double	   strand	  breaks	   generated	  during	  DNA	   synthesis	   could	  
sensitize	  proliferating	  Dicer-­‐/-­‐	  cells	  to	  apoptosis,	  although	  this	  remains	  to	  be	  shown.	  	  	  
	   Alternatively,	   cell	   death	   could	   arise	   from	   impaired	   silencing	  of	   repetitive	   elements.	   	  A	  
series	   of	   papers	   from	   the	   Ambati	   lab	   has	   shown	   that	  Dicer	   deficiency	   in	   human	   and	  murine	  
retinal	  pigment	  epithelial	  (RPE)	  cells	  results	  in	  impaired	  silencing	  of	  Alu	  repeats	  (109).	  	  Typically,	  
antisense	  transcription	  of	  repetitive	  elements	  results	  in	  dsRNA	  formation,	  which	  is	  processed	  by	  
Dicer	  to	  preclude	  repeat	  accumulation.	   	   In	  the	  absence	  of	  Dicer,	  however,	  dsRNA	  accumulates	  
and	   activates	   the	   NLRP3	   inflammasome	   (110).	   This	   activation	   results	   in	   Caspase1	   (Casp1)	  
dependent	   death	   of	   the	   target	   cells,	   and	   can	   be	   a	   cause	   of	  macular	   degeneration.	   	   A	   similar	  
mechanism	  could	  be	  responsible	  for	  the	  observed	  sensitivity	  to	  apoptosis	  in	  Dicer-­‐/-­‐	  thymocytes	  
or	  T	  cells.	  This	  mechanism	  is	  particularly	  intriguing	  because	  Casp1	  mRNA	  was	  increased	  in	  Dicer-­‐
/-­‐	   thymocytes	   in	   preliminary	   RNA-­‐seq	   data	   obtained	   in	   collaboration	   with	   Brenna	   Brady	   and	  
Stefan	  Muljo.	   	  Specifically,	  Casp1	  mRNA	  was	   increased	  almost	  1,000-­‐fold	   in	  RNA	   isolated	   from	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sorted	  pre-­‐selection	  DP	   thymocytes	  of	  LBD	   relative	   to	  control	  BD	  mice.	   	  However,	  preliminary	  
experiments	   I	   performed	   on	   bulk	   splenic	   T	   cells	   from	   LBD	  mice	   did	   not	   reveal	   an	   increase	   in	  
Caspase1	  activation	  as	   judged	  by	  Western	  blot	   (data	  not	  shown),	  although	  this	  negative	  result	  
may	  have	  been	  due	  to	  technical	  issues	  related	  to	  cell	  numbers	  and	  the	  limit	  of	  detection	  for	  the	  
anti-­‐Caspase1	  antibody.	  	  Notably,	  Alu	  repeat	  dependent	  cell	  death	  in	  RPE	  cells	  does	  not	  require	  
Drosha	   or	   Argonaute,	   indicating	   that	   canonical	   miRNAs	   are	   not	   involved.	   Both	   T	   cell	   specific	  
Dicer	  and	  Drosha	  deficiency	  result	   in	   increased	  susceptibility	   to	  cell	  death,	  however,	  making	   it	  
difficult	   to	   reconcile	   the	   idea	   that	   impaired	  Alu	   repeat	   silencing	   regulates	   survival	   in	  Dicer-­‐/-­‐	   T	  
cells	   a	   la	   RPE	   cells.	   	   It	   remains	   formally	   possible,	   however,	   that	   Dicer	   and	   Drosha	   mediated	  
sensitization	   to	   cell	   death	   in	   T	   cells	   are	  mediated	  by	  distinct	  mechanisms,	   and	   impaired	  Dicer	  
dependent	  Alu	  repeat	  silencing	  does	  in	  fact	  promote	  cell	  death	  in	  Dicer	  deficient	  T	  lineage	  cells.	  
	   In	   addition	   to	   Alu	   repeats,	   Dicer	   deficiency	   has	   been	   reported	   to	   result	   in	   impaired	  
centromeric	  silencing	  and	  concomitant	  chromosomal	   instability	   in	  murine	  embryonic	  stem	  (ES)	  
cells	   and	   a	   chicken	   cell	   line	   (73,	   74).	   However,	   another	   group	   examining	   tissue	   specific	   Dicer	  
deficiency	  did	  not	  report	  a	  defect	  in	  centromeric	  silencing	  or	  chromosome	  segregation	  (79),	  and	  
a	   third	   group	   reported	   loss	   of	   transcriptional	   silencing	   of	   centromeric	   repeats	   but	   intact	  
heterochromatin	  structure	  in	  murine	  ES	  cells	  (111).	  	  We	  considered	  the	  possibility	  that	  cells	  with	  
aberrant	   centromeric	   silencing	   and	   chromosome	   instability	   might	   normally	   be	   eliminated	   by	  
apoptosis	   in	  vivo,	  and	  that	   transgenic	  BCL2	  expression	  could	  uncover	  this	  defect.	   	  To	  this	  end,	  
we	   performed	   metaphase	   staining	   of	   stimulated	   splenocytes	   and	   thymocytes	   from	   LBD	   and	  
control	   mice	   to	   examine	   gross	   chromosomal	   structure.	   	   We	   found	   no	   evidence	   of	   gross	  
chromosomal	  defects	  (data	  not	  shown),	  suggesting	  that	  Dicer	  deficiency	  in	  T	  cells	  does	  not	  lead	  
to	   altered	   chromosome	   segregation	   that	   is	   masked	   by	   cell	   death.	   	   This	   result	   also	   makes	   it	  
unlikely	   that	   defects	   in	   chromosome	   segregation	   are	   primarily	   responsible	   for	   cell	   death	   of	  
41	  
Dicer-­‐/-­‐	   thymocytes,	   as	   transgenic	   BCL2	   expression	   rescues	   thymocyte	   numbers	   in	   LBD	   mice	  
relative	  to	  LD	  mice.	  
	   A	  T	  cell	  specific	  role	  for	  Dicer	  in	  promoting	  survival	  is	  also	  a	  formal	  possibility.	  	  Indeed,	  
we	  have	  previously	  reported	  that	  Dicer	  promotes	  survival	  of	  thymocytes	  following	  DNA	  double	  
strand	  break	  generation	  during	  antigen	  receptor	  rearrangement	  (89),	  although	  we	  did	  not	  clarify	  
whether	   this	   resulted	   from	   a	   direct	   role	   for	   small	   RNAs	   at	   DNA	   double	   strand	   breaks	   or	   an	  
indirect	   effect	   on	   survival,	   such	   as	   promoting	   expression	   of	   pro-­‐survival	   factors	   or	   repressing	  
pro-­‐apoptotic	   genes.	   	   The	   observed	   peripheral	   T	   cell	   lymphopenia	   in	   both	   LBD	   and	   LD	   mice	  
suggests	   that	  Dicer	   deficient	   T	   cells	   continue	   to	   exhibit	   increased	   susceptibility	   to	   cell	   death	  
outside	   of	   periods	   of	   antigen	   receptor	   rearrangement,	   however,	   implying	   multiple	   roles	   for	  
Dicer	  in	  T	  cell	  survival.	  Naive	  peripheral	  T	  cells	  rely	  upon	  cytokine	  mediated	  signals	  and	  tonic	  TCR	  
signaling	   to	   survive	   (96);	   impairment	   in	   either	   could	   result	   in	   increased	   susceptibility	   to	   cell	  
death.	  	  Additionally,	  both	  the	  original	  reports	  and	  my	  own	  findings	  have	  confirmed	  that	  LD	  mice	  
exhibit	   a	   skewing	   of	   the	   CD4/CD8	   ratio	   from	   60:40	   in	  WT	  mice	   to	   80:20	   in	   Dicer	   deficient	  
animals.	  	  This	  skewing	  could	  result	  from	  re-­‐direction	  of	  MHCI-­‐restricted	  cells	  to	  the	  CD8	  lineage,	  
a	   finding	   consistent	  with	  my	   results	   indicating	  potential	   re-­‐direction	   in	  LBD	  R1	  OT-­‐I	  mice	   (Fig.	  
24A,	   B	   and	   Fig.	   25),	   but	   could	   also	   result	   from	  preferential	   susceptibility	   to	   cell	   death	   in	   CD8	  
lineage	  cells.	   	  CD8	  T	  cells	  are	   reported	   to	  be	  more	   sensitive	   to	  pro-­‐survival	   IL-­‐7	   signaling	   than	  
CD4	  T	  cells	   (96),	   indicating	  that	   impaired	  IL-­‐7	  or	   IL-­‐7	  receptor	  (IL-­‐7R)	  signaling	   in	  Dicer-­‐/-­‐	  T	  cells	  
could	  account	  for	  the	  observed	  skewing	  of	  the	  CD4/CD8	  ratio.	  	  However,	  I	  found	  no	  difference	  in	  
IL-­‐7Rα	  expression	  on	  Dicer-­‐/-­‐	  mature	  thymocytes	  relative	  to	  WT	  mice	  (Fig.	  35).	  This	  result	  does	  
not	   preclude	   defects	   in	   downstream	   components	   of	   the	   signaling	   pathway;	   signal	   transducer	  
and	   activator	   of	   transcription	   5	   (STAT5)	   is	   phosphorylated	   downstream	   of	   IL-­‐7Rα	   signaling	   in	  
normal	  T	  cells,	  for	  example,	  and	  this	  process	  could	  be	  impaired	  in	  the	  absence	  of	  Dicer	  and/or	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miRNAs.	   Intracellular	   staining	   experiments	   to	   examine	   STAT5	   phosphorylation	   after	   IL-­‐7	  
treatment	   in	  WT	  and	  Dicer-­‐/-­‐	  T	  cells	  could	   further	  clarify	   the	  role	  of	   this	  pathway	   in	  promoting	  
survival	  of	  Dicer-­‐/-­‐	  cells.	  
	   A	  recent	  report	  from	  Henao-­‐Mejia	  et	  al.	  has	  suggested	  an	  additional	  pathway	  that	  could	  
regulate	  T	  cell	  survival	  in	  the	  absence	  of	  Dicer	  (112).	  	  	  CD4Cre;Dicerflox/flox	  mice	  display	  a	  profound	  
defect	  in	  development	  of	  	  invariant	  NKT	  cells	  (iNKT	  cells)	  (113).	  iNKT	  cells	  are	  a	  subset	  of	  T	  cells	  
that	   expresses	   a	   limited	   αβ	   TCR	   repertoire,	   display	   innate-­‐like	   effector	   traits	   (rapid	   activation	  
and	  cyotokine	  release),	  and	  diverge	  from	  αβ	  T	  cell	  development	  at	  the	  DP	  thymocyte	  stage.	  	  The	  
observed	  iNKT	  defect	  in	  CD4Cre;Dicerflox/flox	  mice	  is	  correlated	  with	  an	  almost	  complete	  blockade	  
in	   development	   at	   a	   highly	   proliferative	   developmental	   stage.	   	   Henao-­‐Mejia	  et	   al.	   found	   that	  
miR-­‐181a/b	   knockout	  mice	   displayed	   an	   almost	   identical	   phenotype,	  which	  was	   attributed	   to	  
metabolic	  defects	  resulting	  from	  mis-­‐regulated	  expression	  of	  PTEN,	  whose	  over-­‐expression	  had	  
previously	  been	  reported	  to	  inhibit	  iNKT	  development.	  	  Indeed,	  conditional	  Pten	  deletion	  in	  miR-­‐
181a/b-­‐/-­‐	   mice	   rescued	   NKT	   cell	   development.	   	   Given	   that	   miR-­‐181a/b-­‐/-­‐	   mice	   also	   exhibit	  
reduced	  thymic	  cellularity	  for	  αβ	  T	  cells	  (although	  not	  to	  the	  same	  degree	  a	  LD	  mice),	  a	  similar	  
experiment	   examining	   Pten	   deletion	   mediated	   by	   LckCre	   might	   clarify	   the	   mechanisms	   that	  
result	  in	  impaired	  survival	  of	  Dicer-­‐/-­‐	  αβ	  T	  cells.	  	  Pten	  deficiency	  driven	  by	  LckCre	  has	  previously	  
been	   shown	   to	   increase	   thymic	   cellularity	  due	   to	   increased	  proliferation,	  however,	  potentially	  
confounding	   the	   interpretation	   of	   this	   experiment	   (114).	   	   A	   conditional	   Pten	   knock-­‐in	   allele	  
lacking	   a	  mir-­‐181a/b	   target	   site	  would	   allow	   determination	   of	   the	   specific	   effect	   loss	   of	  miR-­‐
181a/b	  plays	  in	  regulating	  Pten-­‐dependent	  T	  cell	  survival.	  	  	  
	   Finally,	  it	  must	  be	  noted	  that	  work	  from	  our	  laboratory	  clearly	  shows	  the	  importance	  of	  
considering	  effects	  of	  cell	  death	  when	  analyzing	  Dicer	  deficient	  phenotypes.	  Multiple	  groups	  had	  
previously	  generated	  and	  characterized	  T	  cell	   specific	  Dicer	   knockout	  mice,	  but	  none	  reported	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defects	   in	  co-­‐receptor	  silencing	  or	   lineage	  commitment.	   	  These	  defects	  were	  only	  noted	  when	  
cell	   survival	   was	   rescued	   using	   transgenic	  BCL2	   expression;	   similar	   analyses	   in	   other	   lineages	  
could	  reveal	  additional	  cell	  type	  specific	  Dicer/miRNA	  functions	  in	  development.	  	  
	   Direct	   miRNA	   mediated	   post-­‐translational	   silencing	   of	   co-­‐receptor	   mRNA	   appears	  
unlikely.	  While	  I	  have	  demonstrated	  that	  Dicer	  deficiency	  impairs	  Cd4	  transcriptional	  silencing,	  
and	   impaired	   induction	   of	   ThPOK	   and/or	   Runx3	   expression	   could	   account	   for	   impaired	  
transcriptional	  silencing	  of	  Cd8	  and	  Cd4,	  respectively,	  my	  results	  do	  not	  rule	  out	  additional	  roles	  
for	  Dicer	  (or	  Drosha)	  in	  regulating	  post-­‐transcriptional	  silencing	  of	  Cd4	  and/or	  Cd8.	  	  For	  example,	  
miRNAs	   could	   bind	   to	   and	   induce	   degradation	   or	   block	   translation	   of	   Cd4	   or	   Cd8	   transcripts	  
during	   initiation	   of	   CD4	   and	   CD8	   silencing,	   respectively.	   	   Consistent	  with	   this	   notion,	   positive	  
selection	  decreases	  the	  half-­‐lives	  of	  Cd4	  and	  Cd8a	  mRNAs	  (115).	  	  Yet,	  these	  changes	  depend	  on	  
protein	   synthesis	   (115),	  Cd8α	   and	  Cd8β	  mRNAs	   lack	   conserved	  miRNA	   seed	   sequences	   (116),	  
and	  Cd4	   reporters	   that	   lack	  the	  Cd4	  3’UTR	  exhibit	  normal	  silencing	   (33),	  which	  together	  argue	  
against	  a	  role	  for	  miRNAs	  in	  control	  of	  Cd4	  and	  Cd8	  silencing	  via	  direct	  inhibition	  of	  Cd4	  and	  Cd8	  
mRNAs.	  	  	  
	   Determining	  the	  effect	  of	  Drosha	  deficiency	  on	  lineage	  commitment.	   	  Notably,	   I	  have	  
not	   determined	  whether	  Drosha	   deficiency	   on	   an	  MHCI	   or	  MHCII	   TCR	   transgenic	   background	  
(LBDr	  R1	  OT-­‐I	  or	  LBDr	  R1	  OT-­‐II)	  will	  precisely	  phenocopy	  Dicer	  deletion,	  particularly	  in	  regards	  to	  
impaired	  induction	  of	  the	  transcription	  factors	  Runx3	  and	  ThPOK	  in	  the	  appropriate	  lineages.	  	  It	  
is	  formally	  possible	  that	  the	  aberrant	  CD4+CD8+	  mature	  thymocytes	  and	  splenic	  T	  cells	  observed	  
in	  LBDr	  mice	  arise	  by	  a	  mechanism	  completely	  distinct	  from	  that	  of	  Dicer	  deficiency.	  	  I	  consider	  
this	  possibility	  unlikely	  due	  to	  the	  fact	  that	  the	  primary	  overlapping	  function	  of	  both	  Drosha	  and	  
Dicer	   appears	   to	   be	  miRNA	   generation,	   but	   this	   should	   be	   tested	   in	   the	   future	   by	   generating	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LBDr	   R1	   OT-­‐I	   and	   LBDr	   R1	   OT-­‐II	   mice	   and	   examining	   co-­‐receptor	   silencing	   and	   lineage	  
commitment	  in	  MHCI	  and	  MHCII-­‐restricted	  Drosha	  deficient	  T	  cells.	  
	   Determining	  whether	  RNA	  endonuclease	  activity	  is	  required	  for	  appropriate	  αβ	  T	  cell	  
lineage	   commitment.	  Another	   caveat	   is	   that	   I	   have	   not	   formally	   shown	   that	   appropriate	   co-­‐
receptor	   silencing	   and	   lineage	   commitment	   actually	   require	   endonuclease	   activity	   of	   either	  
Dicer	   or	   Drosha;	   rather,	   it	   is	   formally	   possible	   that	   non-­‐cleavage	   functions	   of	   Dicer	   and/or	  
Drosha	  are	  required	  for	  appropriate	  co-­‐receptor	  silencing	  and	  lineage	  commitment	  during	  αβ	  T	  
cell	   development.	   	   The	   role	   of	   the	   catalytic	   endonuclease	   domain	   in	   promoting	   co-­‐receptor	  
silencing	  and	  lineage	  commitment	  could	  be	  examined	  by	  performing	  a	  rescue	  experiment	  with	  
ectopic	   expression	   of	   either	   wild-­‐type	   Dicer	   or	   a	   catalytically	   inactive	   mutant	   in	   developing	  
thymocytes	  that	  are	  genetically	  Dicer-­‐/-­‐	   (117).	  Conceptually,	  the	  simplest	  approach	  would	  be	  to	  
transduce	   donor	   bone	   marrow	   of	   LBD,	   LBD	   R1	   OT-­‐I,	   or	   LBD	   R1	   OT-­‐II	  mice	   with	   retroviral	   or	  
lentiviral	   vectors	   encoding	   wild-­‐type	   or	   mutant	   Dicer,	   generate	   bone	   marrow	   chimeras,	   and	  
examine	   co-­‐receptor	   silencing	   and	   lineage	   commitment	   in	   the	   transduced	   donor	   cells.	   	   This	  
experiment	   is	   technically	   challenging,	   however,	   as	   the	   catalytically	   inactive	   Dicer	   mutant	  
functions	  as	  a	  dominant	  negative	   (Zissimos	  Mourelatos,	  personal	  communication).	   	  Given	   that	  
Dicer	   function	   is	   critical	   for	   multiple	   steps	   in	   hematopoiesis,	   including	   erythropoiesis	   (118),	  
ectopic	  Dicer	   expression	   would	   likely	   have	   to	   be	   restricted	   either	   temporally	   or	   in	   a	   lineage	  
specific	   fashion	   to	   prevent	   bone	   marrow	   failure	   and	   death	   of	   treated	   animals	   (or	   death	   of	  
transduced	   cells	  with	   concomitant	  outgrowth	  of	   un-­‐transduced	   cells).	   To	   this	   end	   I	   generated	  
doxycycline	   inducible	   lentivrial	   vectors	   (119)	   encoding	   either	   wild-­‐type	   Dicer	   or	   the	   catalytic	  
mutant.	   	   I	   found	  these	  vectors	  were	  poor	   transducers	  of	  activated	  T	  cells	   in	  pilot	  experiments	  
(data	   not	   shown);	   recent	   literature	   searches	   suggest	   that	   this	   likely	   results	   from	   the	   use	   of	  
vesicular	  stomatitis	  virus	  glycoprotein	  (VSV-­‐g)	  as	  the	  pseudotyped	  enveloped	  protein,	  as	  VSV-­‐g	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does	  not	  mediate	  efficient	  transduction	  of	  primary	  murine	  cells	  (120).	  	  Revisiting	  this	  issue	  with	  
an	   alternative	   envelope	   protein,	   such	   as	   ecotropic	   envelope	   from	  murine	  Moloney	   leukemia	  
virus	  (MMLV),	  might	  permit	  efficient	  transduction	  of	  murine	  cells.	  
	   Impaired	  transcriptional	  or	  post-­‐transcriptional	  silencing	  of	  Cd8.	   It	  also	  remains	  to	  be	  
determined	  whether	   impaired	  Cd8	   silencing	   results	   from	   impaired	   transcriptional	   silencing	   of	  
the	   Cd8	   locus	   as	   opposed	   to	   alternative	   effects	   (for	   example,	   post-­‐transcriptional	   silencing	  
effects).	  	  This	  could	  be	  tested	  by	  performing	  qRT-­‐PCR	  for	  primary	  (un-­‐spliced)	  Cd8	  transcripts	  in	  
sorted	  CD4+CD8+	   cells	   from	  LBD	  R1	  OT-­‐II	  mice.	   	   To	  date,	  attempts	   to	  perform	   this	  experiment	  
have	  proven	  un-­‐successful	  due	  to	  technical	  limitations.	  	  There	  are	  relatively	  few	  splenic	  T	  cells	  in	  
LBD	  R1	  OT-­‐II	  mice,	  with	   cell	   sorting	   yielding	   fewer	   than	  1x104	   cells,	   and	  often	   closer	   to	   2x103	  
from	   a	   single	   mouse.	   	   Modification	   of	   RNA	   isolation	   procedures	   to	   incorporate	   overnight	  
glycogen	  precipitation	  yielded	  sufficient	  RNA	  to	  detect	  transcription	  factors	  such	  as	  Zbtb7b	  (Fig.	  
27C),	  but	   I	  have	  been	  unable	   to	  detect	  primary	  Cd8	   transcripts	   from	  2x103	   control	  WT	  CD8+	  T	  
cells	   (data	   not	   shown),	   suggesting	   the	   input	   cell	   numbers	   available	   lie	   below	   the	   level	   of	  
detection.	  	  Pooling	  multiple	  mice	  would	  seem	  to	  be	  a	  simple	  solution	  to	  this	  issue,	  but	  multiple	  
facts	  have	  made	  this	  challenging.	  	  First,	  LBD	  R1	  OT-­‐II	  mice	  are	  generated	  at	  a	  frequency	  of	  0.125	  
given	   that	   I	  breed	  parents	  who	  are	  heterozygous	   for	  LckCre,	  BCL2,	   and	  OT-­‐II	   in	  order	   to	  avoid	  
potential	  phenotypic	  differences	  in	  mice	  homozygous	  for	  any	  of	  the	  transgenes.	  	  Second,	  LBD	  R1	  
OT-­‐II	  mice	  exhibit	  a	  spontaneous	  lethal	  inflammatory	  disease	  between	  3-­‐4	  weeks	  of	  age	  in	  >80%	  
of	   pups	   (data	   not	   shown).	   	   Thus,	   obtaining	   sufficient	   numbers	   of	   age-­‐matched	   experimental	  
controls	  that	  survive	  to	  analysis	  age	  requires	  maintenance	  of	  an	  extremely	  large	  mouse	  colony.	  	  
It	   is	   possible	   that	   breeding	   a	   different	   MHCII-­‐restricted	   TCR	   transgene	   onto	   the	   LBD	   R1	  
background	   could	   solve	   the	   issue	   of	   cell	   numbers	   (depending	   on	   the	   relative	   efficiency	   of	  
selection	   for	   the	   given	   TCR).	   Alternatively,	  mice	   bearing	   a	   different	   TCR	   transgene	  might	   not	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succumb	  to	  the	  inflammatory	  condition	  observed	  in	  LBD	  R1	  OT-­‐II	  mice,	  thereby	  allowing	  ready	  
pooling	  of	  multiple	  animals.	  
	   Determining	   the	   level	   at	   which	   Runx3	   expression	   is	   mis-­‐regulated	   in	  Dicer-­‐/-­‐	   MHCI-­‐
restricted	   T	   lineage	   cells.	   Building	   upon	   my	   results	   in	   the	   LBD	   R1	   OT-­‐I	   model,	   it	   could	   be	  
informative	  to	  determine	  the	  level	  at	  which	  Runx3	  expression	  is	  impaired	  in	  aberrant	  CD4+CD8+	  
cells.	   	   I	  have	  observed	  reduced	  expression	  of	  Runx3	  protein	  in	  aberrant	  CD4+CD8+	  cells	  relative	  
to	   control	   CD8+	   cells,	   but	   this	   could	   result	   from	   either	   impaired	   transcription	   of	   Runx3	   or	  
reduced	   translation	  of	  Runx3	  mRNA.	   	  There	  are	  at	   least	   two	  Runx3	   isoforms,	  with	   the	  shorter	  
form	  expressed	  in	  DN,	  CD4SP,	  and	  CD8SP	  thymocytes,	  whereas	  CD8+	  thymocytes	  and	  splenic	  T	  
cells	  express	  the	   longer	   isoform	  deriving	  from	  an	  upstream	  transcriptional	  start	  site	  (TSS)	  (36).	  	  
Thus,	   qRT-­‐PCR	   to	   identify	   the	   CD8	   specific	  Runx3	   isoform	  must	   focus	   on	   this	   upstream	   exon,	  
which	  is	  extremely	  GC	  rich.	  Multiple	  attempts	  to	  quantify	  Runx3	  mRNA	  using	  published	  RT-­‐PCR	  
or	  qRT-­‐PCR	  protocols	  have	  been	  unsuccessful	  (data	  not	  shown)	  (36,	  46),	  including	  an	  optimized	  
method	   utilizing	   PCR	   kits	   specifically	   designed	   for	   GC	   rich	   regions	   (Takeshi	   Egawa,	   personal	  
communication).	  	  As	  an	  alternative	  to	  direct	  measurement	  by	  qRT-­‐PCR,	  crossing	  a	  Runx3	  knock-­‐
in	   reporter	   allele	   onto	   the	   LBD	   R1	   OT-­‐I	   background	   could	   permit	   resolution	   of	   this	   question	  
(such	  a	  construct	  would	  be	  controlled	  by	  endogenous	  Runx3	  regulatory	  elements	  but	  would	  be	  
constitutively	  translated	  to	  produce	  a	  fluorescent	  reporter	  protein	  such	  as	  GFP).	  
	   Rescuing	   T	   lineage	   commitment	   by	   ectopic	   transcription	   factor	   expression	   in	  Dicer-­‐/-­‐	  
thymocytes.	  Determining	  whether	  ectopic	  Runx3	  or	  ThPOK	  expression	  can	  rescue	  impaired	  co-­‐
receptor	  silencing	  and	  lineage	  commitment	  in	  MHCI-­‐	  and	  MHCII-­‐restricted	  Dicer-­‐/-­‐	  thymocytes/T	  
cells	  is	  also	  a	  high	  priority.	  	  As	  detailed	  in	  the	  Results	  Section	  (p.	  38-­‐40),	  attempts	  to	  rescue	  Cd4	  
silencing	   in	   developing	   LBD	   R1	   OT-­‐I	   thymocytes	   via	   retroviral	   Runx3	   expression	   were	  
unsuccessful.	   	   This	   appeared	   to	  be	  due	   to	   a	   growth	  disadvantage	   conferred	  by	  ectopic	  Runx3	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expression,	  consistent	  with	  previous	  results	  examining	  Runx1	  expression	  in	  thymocyte	  cultures	  
(106).	  	  It	  is	  possible	  that	  re-­‐sorting	  transduced	  LSKs	  following	  transduction	  would	  permit	  growth	  
of	  Runx3-­‐transduced	  cells	  due	  to	  the	  absence	  of	  competing	  un-­‐transduced	  cells.	  	  However,	  this	  
could	  also	  simply	  result	  in	  outgrowth	  of	  transduced	  cells	  that	  silence	  the	  retroviral	  transgene	  (as	  
always	   occurs	   at	   some	   low	   frequency	   over	   time	   (121)).	   	   I	   have	   also	   attempted	   to	   generate	  
conditional	   retroviral	   vectors	   by	   flanking	   a	   transcriptional	   stop	   sequence	   with	   LoxP	   sites	  
upstream	  of	  Runx3.	  	  Theoretically,	  transduction	  in	  LBD	  R1	  OT-­‐I	  progenitors	  would	  have	  resulted	  
in	  Cre-­‐mediated	  LoxP	   recombination	  and	  excision	  of	   the	   stop	   sequence	   in	  DN2/3	   thymocytes,	  
permitting	  more	  precise	   induction	  of	  Runx3	   expression.	   	  However,	   retroviral	   titers	   from	   these	  
constructs	  were	   essentially	   un-­‐detectable	   (data	   not	   shown),	   likely	   because	   the	   transcriptional	  
stop	   sequence	   was	   too	   successful	   in	   terminating	   transcription	   and	   resulted	   in	   generation	   of	  
truncated	  retroviral	   transcripts	   lacking	   the	  3’	   long-­‐terminal	   repeat	   (3’	   LTR)	   that	   is	   required	   for	  
functional	   vector.	   	   The	   best	   approach	   to	   formally	   test	   whether	   Runx3	   expression	   can	   rescue	  
impaired	  Cd4	   silencing	  and	   lineage	  commitment	   in	  Dicer-­‐deficient	  MHCI-­‐restricted	  cells	  would	  
be	   to	   generate	   an	   inducible	   Runx3	   transgene	   that	   is	   expressed	   following	   positive	   selection;	  
breeding	   this	   transgene	   on	   the	   LBD	   R1	   OT-­‐I	   background	   should	   provide	   unequivocal	   results	  
regarding	  the	  importance	  of	  Runx3	  in	  Dicer	  mediated	  CD4	  silencing.	  
	   Parallel	  ThPOK	  rescue	  experiments	  in	  LBD	  R1	  OT-­‐II	  mice	  are	  also	  of	  significant	  interest.	  	  
While	   bone	   marrow	   chimeras	   with	   ectopic	   Zbtb7b	   expression	   driven	   via	   retroviral	   construct	  
have	  been	  reported,	  the	  authors	  noted	  a	  significant	  decrease	  in	  total	  thymic	  cellularity	  relative	  
to	  vector	  control	  (41).	  	  Combined	  with	  the	  low	  thymocyte	  and	  splenic	  T	  cells	  numbers	  observed	  
in	   LBD	   R1	   OT-­‐II	   mice,	   as	   well	   as	   the	   aforementioned	   difficulties	   in	   generating	   multiple	   age-­‐
matched	   donor	   LBD	   R1	   OT-­‐II	   mice,	   retroviral	   rescue	   experiments	   by	   either	   BM	   chimera	   or	  
intrathymic	   injection	   seem	   less	   than	   ideal.	   	   Here	   again	   an	   inducible	   Zbtb7b	   transgene	   that	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expresses	  specifically	  in	  post-­‐selection	  thymocytes	  would	  provide	  the	  cleanest	  means	  by	  which	  
to	   analyze	   whether	   ectopic	   Zbtb7b	   expression	   can	   rescue	   Cd8	   silencing	   in	   Dicer-­‐/-­‐	   MHCII-­‐
restricted	  thymocytes	  and	  T	  cells.	  	  Alternatively,	  employment	  of	  a	  different	  MHCII-­‐restricted	  TCR	  
transgene	  might	  circumvent	  these	  issues.	  
	   Identifying	  the	  mechanisms	  by	  which	  Dicer	  promotes	  αβ	  T	  lineage	  commitment.	  	  
Assuming	  that	  appropriate	  co-­‐receptor	  silencing	  and	  lineage	  commitment	  are	  regulated	  by	  
miRNAs,	  the	  identification	  of	  the	  miRNAs	  responsible	  for	  the	  phenotype	  is	  of	  utmost	  priority.	  	  
Loss	  of	  miRNAs	  that	  bind	  Runx3	  and/or	  Zbtb7b	  mRNAs	  should	  increase	  expression	  of	  their	  
encoded	  proteins,	  but	  I	  observed	  decreased	  Runx3	  and	  Zbtb7b	  expression	  in	  aberrant	  CD4+CD8+	  
cells	  from	  LBD	  R1	  OT-­‐I	  and	  LBD	  R1	  OT-­‐II	  mice,	  respectively.	  	  Accordingly,	  Dicer	  likely	  controls	  
expression	  of	  these	  lineage-­‐specifying	  factors	  through	  miRNAs	  that	  enhance	  signaling	  pathways	  
or	  transcriptional	  networks	  that	  induce	  Runx3	  and	  ThPOK	  expression,	  and/or	  through	  miRNAs	  
that	  inhibit	  repressors	  of	  Runx3	  and	  Zbtb7b	  transcription.	  	  However,	  the	  lack	  of	  clearly	  defined	  
factors	  that	  mediate	  such	  effects	  mitigates	  the	  efficacy	  of	  a	  candidate-­‐based	  approach.	  
	   Identification	   of	   the	   relevant	   miRNAs	   is	   also	   made	   challenging	   by	   the	   fact	   that	   both	  
Dicer	  and	  Drosha	  deletion	  presumably	  impair	  expression	  of	  essentially	  all	  miRNAs.	  	  Kirigin	  et	  al.	  
have	   reported	   that	   DP,	   CD4SP,	   and	   CD8SP	   thymocytes	   each	   express	   >400	   unique	  miRNAs	   as	  
detected	  by	  small	  RNA-­‐sequencing	  (91).	  	  This	  number	  is	  too	  large	  to	  readily	  screen	  individually	  in	  
vivo.	   	  Moreover,	   the	   fact	   that	  Dicer/Drosha	  deficiency	  presumably	  reduces	  expression	  of	  most	  
miRNAs,	  the	  phenotype	  could	  readily	  result	  from	  combinatorial	  effects	  of	  multiple	  miRNAs	  that	  
would	  be	  missed	   in	   large-­‐scale	  screens	  examining	  single	  miRNAs.	   	  Regardless,	   in	  theory	  an	  un-­‐
biased	  screen	  could	  be	  sufficient	  to	  identify	  the	  critical	  miRNAs.	  	  I	  hypothesize	  that	  the	  best	  way	  
to	   perform	   such	   an	   experiment	   would	   be	   to	   use	   a	   commercial	   anti-­‐miRNA	   library	   known	   as	  
mIRZip™.	   	   This	   lentiviral	   library	   encodes	   antisense	   oligonucleotides	   that	   bind	   to	   and	   inhibit	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murine	  miRNAs,	  analogous	  to	  the	  effect	  of	  Dicer	  deficiency.	  	  One	  could	  transduce	  bone	  marrow	  
of	   BCL2	   mice	   (used	   to	   enhance	   cell	   viability	   and	   permit	   peripheral	   accumulation	   of	   aberrant	  
CD4+CD8+	  cells)	  and	  generate	  bone	  marrow	  chimeras	  in	  irradiated	  recipient	  animals.	  	  Following	  
reconstitution,	  animals	  could	  be	  examined	  for	  the	  presence	  of	  aberrant	  CD4+CD8+	  peripheral	  T	  
cells	   and	   the	  CD4+CD8+	   cells	   could	   be	   isolated	   for	  DNA	   sequencing	   to	   identify	   the	   transduced	  
anti-­‐miRNAs.	   	   This	   approach	   has	   many	   experimental	   and	   technical	   challenges,	   however.	  
Constitutive	   miRNA	   knockdown	   throughout	   hematopoiesis	   could	   have	   deleterious	  
consequences,	  so	  an	  inducible	  or	  tissue	  specific	  promoter	  would	  likely	  need	  to	  be	  incorporated.	  	  
As	  alluded	  to	  above,	  multiple	  miRNAs	  might	  need	  to	  be	  inactivated	  concurrently;	  simultaneous	  
transduction	   with	   two,	   three,	   or	   four	   lentiviral	   vectors	   may	   not	   be	   feasible	   in	   donor	   cells.	  	  
Additionally,	   the	   detection	   limit	   may	   be	   of	   concern,	   particularly	   if	   multiple	   miRNAs	   must	   be	  
inactivated	   concurrently.	   Only	   ~20%	   of	   Dicer-­‐/-­‐	   mature	   thymocytes	   and	   splenic	   T	   cells	   exhibit	  
aberrant	  CD4	  and	  CD8	  expression	   in	  LBD	  mice	  where	   there	   is	   a	  >90%	   reduction	   in	  expression	  
levels	   of	   multiple	   miRNAs	   at	   the	   DP	   thymocyte	   stage.	   	   Knockdown	   of	   single	   miRNAs	   would	  
presumably	  generate	  a	  much	  smaller	  fraction	  of	  aberrant	  CD4+CD8+	  cells.	   	  Even	   if	  one	  were	  to	  
restrict	   the	   library	   to	   the	   ~400	  miRNAs	   present	   in	   DP	   thymocytes,	   inactivating	   three	  miRNAs	  
concurrently	   gives	  64	  million	   (4003)	  possible	   combinations;	   assuming	  equal	   reconstitution	  and	  
potential	   to	   generate	   T	   cells,	   this	   is	   almost	   assuredly	   below	   the	   limit	   of	   detection	   for	   flow	  
cytometry.	   	   Finally,	   extensive	   validation	  will	   also	   be	   required	   to	   demonstrate	   similar	   levels	   of	  
miRNA	  knockdown	  in	  miRZip	  treated	  cells	  relative	  to	  thymocytes	  from	  LBD	  or	  LD	  mice,	  in	  order	  
to	  minimize	  false	  negatives.	  	  	  
	   The	   reverse	   experiment	   (over-­‐expressing	   miRNAs	   in	   LBD	   mice	   to	   identify	   miRNAs	  
permitting	  rescue	  of	  co-­‐receptor	  silencing)	  is	  hypothetically	  possible	  but	  even	  more	  technically	  
challenging.	  	  Because	  the	  donor	  cells	  are	  Dicer	  deficient,	  supplying	  pre-­‐miRNAs	  or	  other	  dsRNA	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substrates	   is	   not	   sufficient	   because	   no	   Dicer	   protein	   is	   present	   to	   process	   these	   species	   and	  
generate	   the	   appropriate	   overhangs	   necessary	   for	   efficient	   RISC	   loading.	   	   Thus,	   perfectly	  
tailored	   oligonucleotides	   must	   be	   supplied,	   for	   example	   by	   transfection.	   	   This	   essentially	  
eliminates	   the	  possibility	   to	   study	   this	  phenomenon	   in	  vivo,	   and	  a	   robust	  model	   system	  for	   in	  
vitro	  co-­‐receptor	  silencing	  in	  positively	  selected	  cells	  has	  yet	  to	  be	  demonstrated	  (122).	  
	   Understanding	   the	   differentiation	   status	   of	   aberrant	   CD4+CD8+	   cells	   in	  Dicer-­‐/-­‐	   mice.	  	  
The	   issues	   discussed	   so	   far	   all	   hint	   at	   the	   central	   thread	   underlying	   the	   presence	   of	   aberrant	  
CD4+CD8+	  cells:	  what,	  precisely,	  do	  the	  aberrant	  CD4+CD8+	  cells	  represent	  from	  a	  developmental	  
standpoint?	   	   Are	   they	   closest	   transcriptionally	   to	   pre-­‐selection	   thymocytes,	   or	   do	   they	   most	  
resemble	  peripheral	  T	  cells	  that	  simply	  lack	  expression	  of	  ThPOK	  and	  Runx3?	  	  Are	  their	  survival	  
requirements	  more	  similar	  to	  thymocytes	  or	  peripheral	  T	  cells,	  or	  a	  hybrid	  of	  both?	  	  Are	  the	  cells	  
fated	   to	  either	   the	  CD4	  or	  CD8	   lineage,	  or	  do	   they	   retain	   lineage	  plasticity?	   	   The	  next	   several	  
Discussion	  sections	  will	  address	  these	  inter-­‐related	  issues.	  
	   Examining	  the	  global	  impact	  of	  Dicer	  deficiency	  on	  transcriptomes	  of	  developing	  αβ	  T	  
cells.	  	  Given	  the	  challenges	  described	  above	  regarding	  un-­‐biased	  screens	  to	  identify	  miRNAs	  
mediating	  αβ	  T	  lineage	  commitment,	  a	  global	  examination	  of	  the	  impact	  of	  Dicer	  deficiency	  on	  
the	  differentiation	  status	  and	  transcriptome	  of	  developing	  thymocytes	  might	  identify	  candidate	  
pathways	  (and	  the	  miRNAs	  that	  regulate	  them)	  that	  are	  altered	  in	  the	  absence	  of	  Dicer.	  	  The	  
Immunological	  Genome	  Consortium	  has	  performed	  microarray	  experiments	  on	  an	  extensive	  
number	  of	  thymocyte	  and	  T	  cell	  subsets	  sorted	  and	  processed	  using	  a	  standardized	  and	  
validated	  pipeline.	  	  Their	  results	  suggest	  that	  ~500	  genes	  are	  up-­‐regulated	  (defined	  as	  >2-­‐fold	  
change)	  and	  ~500	  genes	  down-­‐regulated	  between	  pre-­‐selection	  DP	  thymocytes	  and	  early	  post-­‐
selection	  DPs	  (CD4+CD8+TCRβlo/intCD69+),	  which	  subsequently	  up-­‐regulate	  ~200	  additional	  genes	  
and	  silence	  fewer	  than	  100	  while	  differentiating	  to	  mature	  SP	  thymocytes	  (CD4+CD8-­‐
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TCRβhiCD24lo	  or	  CD4-­‐CD8+TCRβhiCD24lo).	  	  Transition	  from	  mature	  SP	  thymocytes	  to	  naïve	  cells	  
similarly	  involves	  a	  relatively	  small	  number	  of	  gene	  changes	  (>100,	  with	  most	  being	  down-­‐
regulated)	  (123).	  	  	  	  Given	  this	  detailed	  reference	  map,	  what	  fraction	  of	  expressed	  transcripts	  and	  
developmental	  stage-­‐specific	  transcriptional	  changes	  are	  altered	  in	  the	  absence	  of	  Dicer	  in	  post-­‐
selection	  thymocytes?	  Do	  these	  cells	  most	  closely	  resemble	  pre-­‐selection	  or	  early	  post-­‐selection	  
DP	  thymocytes,	  or	  are	  they	  closer	  to	  mature	  single	  positive	  thymocytes	  or	  peripheral	  T	  cells?	  	  	  	  
Answering	  these	  questions	  could	  provide	  significant	  insight	  into	  putative	  mechanisms	  by	  which	  
Dicer	  regulates	  normal	  lineage	  commitment	  and	  co-­‐receptor	  silencing	  in	  developing	  αβ	  T	  cells.	  
	   RNA-­‐seq	  experiments	  performed	  in	  sorted	  populations	  from	  LBD	  R1	  OT-­‐I	  and	  LBD	  R1	  OT-­‐
II	   mice	   could	   be	   extremely	   powerful	   in	   further	   investigating	   these	   questions.	   	   Specifically,	   it	  
would	   be	   interesting	   to	   compare	   the	   transcriptomes	   of	   the	   following	   six	   populations:	   splenic	  
CD4+CD8+	   cells	   from	  LBD	  R1	  OT-­‐I,	   splenic	  CD8+	   cells	   from	  LBD	  R1	  OT-­‐I,	   splenic	  CD8+	   cells	   from	  
control	  BD	  R1	  OT-­‐I,	  splenic	  CD4+CD8+	  cells	  from	  LBD	  R1	  OT-­‐II,	  splenic	  CD4+	  cells	  from	  LBD	  R1	  OT-­‐
II,	  and	  splenic	  CD4+	  cells	   from	  control	  BD	  R1	  OT-­‐II.	   	   	   I	  have	  proposed	  the	  use	  of	  splenic	  T	  cells	  
here	   due	   to	   complications	   present	   in	   identifying	   mature	   thyocytes	   (CD24loTCRβhi)	   in	   TCR	  
transgenic	  mice;	  ideally,	  one	  would	  wish	  to	  examine	  aberrant	  CD4+CD8+	  mature	  thymocytes,	  as	  
this	   is	   closest	  developmentally	   to	   the	   stage	   in	  which	  normal	   co-­‐receptor	   silencing	  and	   lineage	  
commitment	  occurs.	   In	  my	  experiments,	  however,	   the	   staining	  profiles	  of	  CD24	  and	  TCRβ	  are	  
“blurred”	  as	  a	  result	  of	  transgenic	  TCR	  expression,	  making	  isolation	  of	  pure	  mature	  thymocytes	  
populations	   impossible.	   	   Thus,	   I	   have	   proposed	   to	   utilize	   splenic	   cells	   for	   these	   experiments.	  	  
Given	   that	   for	   LBD	  R1	  OT-­‐I	  mice	   I	   have	   shown	   that	   splenic	   CD4+CD8+	   cells	   are	   still	   capable	   of	  
undergoing	   co-­‐receptor	   silencing,	   and	   literature	   reports	   indicate	   a	   relatively	   low	   number	   of	  
genes	  expression	  changes	  between	  mature	  thymocytes	  and	  naïve	  T	  cells	   (123),	   I	  believe	  these	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populations	   likely	  display	  many	  of	   the	   same	  properties	   as	  mature	   thymocytes	   and	   sufficiently	  
recapitulate	  the	  thymocyte	  population.	  
	   RNA-­‐seq	  analysis	  on	  the	  six	  populations	  described	  above	  would	  allow	  many	  meaningful	  
and	   potentially	   informative	   comparisons.	   	   For	   example,	   how	   many	   genes	   are	   differentially	  
regulated	  between	  “normal”	  CD8+	  splenic	  T	  cells	  from	  LBD	  R1	  OT-­‐I	  mice	  and	  control	  CD8+	  cells	  
(i.e.,	  what	  is	  the	  effect	  of	  Dicer	  deficiency	  on	  the	  mature	  CD8	  transcriptional	  program).	  	  A	  similar	  
comparison	  could	  be	  made	  in	  CD4+	  cells	  from	  LBD	  R1	  OT-­‐II	  and	  control	  BD	  R1	  OT-­‐II	  mice.	  	  	  The	  
most	  interesting	  differences,	  however,	  likely	  lie	  in	  the	  aberrant	  CD4+CD8+	  cells	  from	  LBD	  R1	  OT-­‐I	  
and	  LBD	  R1	  OT-­‐II	  mice.	  	  How	  similar	  are	  the	  aberrant	  CD4+CD8+	  cells	  that	  are	  MHCI-­‐restricted	  vs.	  
MHCII-­‐restricted?	   	   Have	   they	   begun	   to	   up-­‐regulate	   components	   of	   the	   CD4	   or	   CD8	   lineage	  
(despite	   their	   relative	   impairment	   in	   ThPOK/Runx3	   induction)	   and	   silence	   portions	   of	   the	  
thymocyte	  genetic	  program,	  or	  do	  they	  more	  closely	  resemble	  either	  bona	  fide	  DP	  thymocytes	  
or	  early	  post-­‐selection	  cells?	  	  The	  TCR	  transgenic	  Dicer	  deficient	  models	  I	  have	  generated	  would	  
provide	   an	   un-­‐paralleled	  model	   in	  which	   to	   study	   the	   global	   effect	   of	  Dicer	   deficiency	   during	  
thymocyte	   commitment	   because	   they	   avoid	  many	   of	   the	   potential	   caveats	   of	  Dicer	   deficient	  
mice	   with	   a	   polyclonal	   TCR	   repertoire	   (for	   example,	   differences	   in	   TCR	   affinity	   within	   the	  
population	   and	   an	   inability	   to	   distinguish	   MHCI	   and	   MHCII-­‐restricted	   cells	   in	   the	   aberrant	  
CD4+CD8+	   populations.)	   	   Once	   differentially	   identified	   gene	   sets	   are	   identified	   in	   the	   Dicer	  
deficient	  cells,	  computational	  approaches	  (such	  as	  DAVID	  analysis)	  could	  be	  applied	  to	  identify	  
pathways	   that	   are	   enriched	   in	   the	   differential	   gene	   sets,	   such	   as	   TCR	   signaling	   or	   cytokine	  
response	   signatures.	   	   Furthermore,	  miRNA	   seed	   sequences	   that	   are	   enriched	   in	   differentially	  
expressed	   genes	   might	   identify	   putative	   miRNAs	   that	   are	   central	   regulators	   of	   the	   Dicer	  
deficient	  phenotypes.	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   Extrathymic	  survival	  of	  aberrant	  CD4+CD8+	  cells.	  The	  differentiation	  status	  of	  aberrant	  
CD4+CD8+	  cells	  also	  relates	  to	  their	  potential	  ability	  to	  survive	  in	  the	  periphery.	  	  Specifically,	  why	  
do	  aberrant	  CD4+CD8+	  cells	  only	  accumulate	  in	  the	  periphery	  of	  LBD	  and	  LPD	  mice,	  despite	  the	  
presence	  of	  aberrant	  CD4+CD8+	  mature	   thymocytes	   in	  LD	  mice?	   	  Presumably	   some	   fraction	  of	  
aberrant	   CD4+CD8+	   cells	   from	   LD	  mice	   emigrate	   from	   the	   thymus,	   as	   neither	   transgenic	  BCL2	  
expression	   or	   p53	   deficiency	   is	   predicted	   to	   regulate	   trafficking,	   but	   these	   cells	   likely	   do	   not	  
survive	   long	   enough	   to	   enable	   robust	   detection.	   	   Although	   the	   reasons	   for	   this	   are	   unclear,	   I	  
hypothesize	  that	   it	  relates	  to	  the	  relative	  differentiation	  status	  of	  the	  aberrant	  CD4+CD8+	  cells.	  	  
Careful	   examination	   of	   CD4	   and	   CD8	   staining	   in	   LD	   mice	   indicates	   that	   both	   CD4+	   and	   CD8+	  
splenic	   T	   cell	   populations	   exhibit	   a	   “shoulder”	   of	   broadening	   CD8	   or	   CD4	   expression,	  
respectively,	  relative	  to	  WT	  cells	  (Fig.	  7A).	   	  Thus,	  there	  appear	  to	  be	  small	  populations	  of	  both	  
CD4+CD8lo	  and	  CD4loCD8+	  splenic	  T	  cells	   in	  LD	  mice.	   	  Based	  on	   this	   result,	  and	   the	  observation	  
that	  aberrant	  CD4+CD8+	  cells	  can	  become	  CD4SP	  or	  CD8SP	  both	  in	  vitro	  and	  in	  vivo,	  I	  hypothesize	  
that	   the	  “aberrant	  CD4+CD8+”	  population	   is	  a	  highly	  heterogenous	  mixture	  of	  cells	   in	  different	  
states	  of	  differentiation/lineage	  commitment.	  	  The	  true	  CD4hiCD8hi	  cells	  are	  the	  most	  immature	  
developmentally,	   and	  most	   closely	   resemble	   DP	   thymocytes.	   	   The	   CD4+CD8int	   and	   CD4intCD8+	  
cells	   are	   in	   the	   process	   of	   silencing	   co-­‐receptor	   and	   differentiating	   to	   either	   the	   CD4	   or	   CD8	  
lineage,	   and	   the	  CD4+CD8lo	   and	  CD4loCD8+	   cells	   have	   almost	   completed	   lineage	  differentiation	  
and	  commitment.	  	  Critically,	  it	  has	  been	  known	  for	  years	  that	  thymocytes	  and	  peripheral	  T	  cells	  
rely	   upon	   distinct	   survival	   signals.	   Thymocytes	   require	   a	   number	   of	   complex	   environmental	  
stimuli	   for	   maximal	   viability,	   many	   of	   which	   remain	   to	   be	   completely	   elucidated,	   whereas	  
peripheral	  T	  cells	  require	  cytokine	  signaling,	  particularly	   IL-­‐7	  (96).	   	  Given	  these	  requirements,	   I	  
hypothesize	  that	  aberrant	  CD4hiCD8hi	  cells	  from	  LD	  mice	  are	  still	  dependent	  upon	  thymic	  survival	  
signals,	  resulting	  in	  their	  rapid	  death	  upon	  migration	  to	  the	  periphery.	   	  This	   inability	  to	  survive	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on	  peripheral	  homeostatic	  signals	  is	  bypassed	  by	  transgenic	  BCL2	  expression	  or	  p53	  deficiency	  in	  
LBD	  and	  LPD	  mice,	  however.	   	  Alternatively,	  the	  CD4+CD8lo	  and	  CD4loCD8+	  cells	   in	  LD	  mice	  have	  
differentiated	  sufficiently	  to	  switch	  to	  reliance	  upon	  peripheral	  survival	  signals,	  allowing	  them	  to	  
survive	  sufficiently	  long	  enough	  to	  be	  detected	  in	  the	  periphery.	  They	  presumably	  are	  also	  able	  
to	   finish	   differentiating	   to	   CD4SP	   or	   CD8SP	   cells,	   although	   this	   has	   not	   been	   formally	   tested.	  	  
Transcriptional	   profiling	   of	   sorted	   CD4hiCD8hi,	   CD4hiCD8int,	   CD4intCD8hi,	   CD4hiCD8lo,	   and	  
CD4loCD8hi	  splenic	  T	  cells	  from	  the	  Dicer-­‐/-­‐	  TCR	  transgenic	  models	  I	  have	  generated	  might	  provide	  
insight	   into	   the	   pathways	   and	   genetic	   circuits	   that	   regulate	   distinct	   survival	   programs	   in	  
thymocytes	  and	  splenic	  T	  cells,	  which	  would	  be	  a	  boon	  to	  the	  field.	  
	   The	   link	   between	   TCR	   signaling,	   thymic	   egress,	   and	   lineage	   commitment.	   	   Current	  
dogma	  stipulates	  that	  positive	  selection,	  lineage	  commitment,	  and	  thymic	  egress	  are	  linked	  via	  
TCR	  signaling.	  	  Following	  positive	  selection,	  thymocytes	  reduce	  surface	  CD8	  expression	  and	  the	  
ensuing	  presence	  or	  absence	  of	  sustained	  TCR	  signaling	  promotes	  differentiation	  to	  either	   the	  
CD4	  or	   CD8	   lineages,	   respectively.	   	   Concomitant	  with	   lineage	   commitment	   is	   up-­‐regulation	  of	  
S1pr1	  and	  subsequent	  thymic	  egress.	  	  However,	  my	  observation	  that	  Dicer-­‐/-­‐	  αβ	  T	  cells	  can	  exit	  
the	  thymus	  as	  phenotypically	  mature	  (CD24loTCRβhiS1PR1+)	  T	  cells	  that	  exhibit	  reduced	  or	  absent	  
Zbtb7b	   or	   Runx3	   expression	   suggests	   that	   these	   processes	   can	   function	   independently,	   a	  
completely	   novel	   finding.	   	   Moreover,	   the	   observation	   that	   aberrant	   CD4+CD8+	   cells	   can	  
eventually	  undergo	  co-­‐receptor	  silencing	  and	  differentiation	  to	  the	  CD4+	  or	  CD8+	  lineage	  implies	  
that	   aberrant	   CD4+CD8+	   cells	   either	   receive	   pro-­‐differentiation	   signals	   in	   the	   periphery	   or	  
maintain	  a	  memory	  of	  such	  signals	  received	  in	  the	  thymus.	  	  It	  will	  be	  of	  great	  interest	  to	  the	  field	  
to	  further	  understand	  this	  result,	  specifically	  the	  types	  of	  signals	  that	  are	  sufficient	  to	  promote	  
positive	  selection	  and	  thymic	  egress	  yet	  do	  not	  promote	  rapid	  lineage	  commitment.	  	  My	  results	  
are	   particularly	   striking	   because	   impaired	   co-­‐receptor	   silencing	   and	   lineage	   commitment	   are	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observed	   in	  both	  MHCI-­‐	  and	  MHCII-­‐restricted	  cells,	  where	  most	   results	   to	  date	  have	   reported	  
defects	   in	  other	   lineage	  or	   the	  other	   (65).	   	   Furthermore,	  previous	   results	  have	   suggested	   that	  
Cd4	   and	   Cd8	   co-­‐receptor	   silencing	   are	   mediated	   by	   distinct	   molecular	   processes	   (124).	   	   My	  
results,	   however,	   argue	   that	   a	   shared	  upstream	  pathway	  might	   regulate	   co-­‐receptor	   silencing	  
and	   lineage	   commitment	   in	   both	   MHCI-­‐	   and	   MHCII-­‐restricted	   thymocytes/T	   cells.	   Given	   our	  
current	   knowledge,	   a	   role	   for	   TCR	   signaling/selection	   signals	   would	   seem	   to	   be	   a	   likely	  
candidate.	   	   In	   this	   regard,	   I	   have	   not	   done	   any	   formal	   characterization	   of	   TCR	   signaling	   and	  
positive/negative	   selection	   in	   Dicer-­‐/-­‐	   developing	   thymocytes.	   	   These	   experiments	   are	  
challenging	  in	  mice	  with	  polyclonal	  TCR	  repertoires,	  such	  as	  LBD	  mice,	  but	  are	  more	  tractable	  in	  
the	  TCR	  transgenic	  models	  such	  as	  the	  LBD	  R1	  OT-­‐I	  and	  LBD	  R1	  OT-­‐II	  mice	  I	  have	  generated.	  	  By	  
crossing	   these	   mice	   to	   animals	   expressing	   agonist	   peptides	   of	   varying	   strength,	   it	   would	   be	  
possible	  to	  examine	  positive	  and	  negative	  selection	  in	  developing	  thymocytes	  in	  the	  absence	  of	  
Dicer.	  	  Additionally,	  fetal	  thymic	  organ	  cultures	  (FTOC)	  or	  OP9	  stromal	  cultures	  could	  be	  utilized	  
to	   assess	   downstream	   TCR	   signaling	   events	   in	   the	  Dicer	   deficient	   background	   (including	   Ca2+	  
signaling	   and	   phosphorylation/localization	   of	   well-­‐characterized	   downstream	   targets	   such	   as	  
Lck,	  SLP-­‐76,	  and	  Erk)	  (125).	  	  These	  analyses	  could	  shed	  light	  on	  potential	  defects	  in	  TCR	  signaling	  
that	   delay	   or	   impair	   lineage	   commitment	   in	   Dicer-­‐/-­‐	   cells	   that	   otherwise	   appear	   to	   have	  
undergone	  positive	  selection	  based	  on	  TCRβ	  and	  CD24	  expression.	  	  It	  should	  be	  noted,	  however,	  
that	   defects	   in	   these	   pathways	   have	   not	   been	   reported	   to	   permit	   generation	   of	   aberrant	  
CD4+CD8+	  cells	  (although	  analysis	  in	  the	  absence	  of	  a	  BCL2	  transgene	  may	  have	  precluded	  facile	  
identification	  of	   these	   cells).	   	   Thus,	   non-­‐biased	  approaches	   such	   as	  phosphoproteomics	  might	  
aid	   in	   the	   identification	   of	   novel	   Dicer-­‐dependent	   downstream	   signaling	   events	   that	   are	  
required	  for	  normal	  lineage	  commitment	  of	  developing	  thymocytes.	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   Similarly,	  it	  will	  be	  important	  to	  determine	  the	  mechanisms	  by	  which	  aberrant	  CD4+CD8+	  
cells	  eventually	  become	  CD4+	  or	  CD8+	  T	  cells.	  	  Is	  this	  delayed	  silencing	  mediated	  by	  eventual	  up-­‐
regulation	   of	   Zbtb7b	   and	   Runx3	   (or	   other	   critical	   regulators	   of	   lineage	   commitment),	   or	   are	  
there	   ThPOK	   or	   Runx3	   independent	   compensatory	  mechanisms	   that	   can	   eventually	   drive	   co-­‐
receptor	  silencing?	  In	  the	  case	  of	  CD4	  silencing	   in	  MHCI-­‐restricted	  cells,	  this	  question	  could	  be	  
addressed	  by	  repeating	  the	  in	  vitro	  culture	  experiment	  shown	  in	  Fig.	  31B,	  isolating	  the	  resultant	  
CD8+	   cells	   that	   develop,	   and	   assaying	   for	   Runx3	   expression	   via	   Western	   blot.	   	   A	   similar	  
experiment	  could	  be	  performed	  to	  assess	  Zbt7b	  levels	  following	  culture	  of	  sorted	  CD4+CD8+	  LBD	  
R1	  OT-­‐II	  cells,	  assuming	  they	  do	  become	  CD4+	  and	  sufficient	  cell	  numbers	  could	  be	  obtained.	  	  If	  
up-­‐regulation	   of	   master	   regulators	   was	   not	   observed	   in	   cells	   that	   eventually	   silence	   co-­‐
receptors,	   RNA-­‐seq	   or	   microarray	   experiments	   could	   be	   conducted	   to	   identify	   candidate	  
regulatory	   genes	  whose	   expression	   changes	   in	   cells	   that	   undergo	   silencing	   relative	   to	   freshly	  
isolated	  aberrant	  CD4+CD8+	  cells.	  
	   Lineage	   plasticity	   in	   aberrant	   CD4+CD8+	   cells	   from	   Dicer-­‐/-­‐	   mice.	   Related	   to	   the	  
transcriptional	   identity	  of	   aberrant	  CD4+CD8+	   cells,	   it	   is	  unknown	  whether	   these	   cells	   are	   fully	  
committed	  to	  either	  the	  CD4	  or	  CD8	  lineage	  and	  merely	  delayed	  in	  their	  up-­‐regulation	  of	  Zbtb7b	  
and	  Runx3,	  or	  if	  these	  cells	  retain	  lineage	  plasticity.	  	  Would	  strong	  TCR	  signaling	  (a	  driver	  of	  CD4	  
lineage	   commitment)	   re-­‐direct	   aberrant	   CD4+CD8+	   cells	   from	   LBD	   R1	   OT-­‐I	   mice	   to	   the	   CD4	  
lineage?	   	   Alternatively,	   would	   sustained	   IL-­‐7	   signaling	   (which	   promotes	   CD8	   lineage	  
commitment)	  drive	  aberrant	  CD4+CD8+	  cells	   from	  LBD	  R1	  OT-­‐II	  mice	   to	  up-­‐regulate	  Runx3	   and	  
other	  components	  of	  the	  CD8	   lineage	  program?	   	  Preliminary	  experiments	  have	  suggested	  that	  
TCR	  signaling	   in	  sorted	  CD4+CD8+	  cells	   from	  LBD	  R1	  OT-­‐I	  mice	  can	  drive	  development	  of	   some	  
CD4+	   cells	   (data	   not	   shown),	   suggesting	   lineage	   plasticity,	   but	   the	   transcriptional	   status	   of	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Zbtb7b	  and	  CD4	  effector	  functions	  have	  not	  been	  examined	  to	  validate	  that	  these	  cells	  are	  bona	  
fide	  CD4	  lineage	  cells.	  	  	  
	   Effector	  functions	  of	  aberrant	  CD4+CD8+	  cells.	  Several	  reports	  have	  previously	  described	  
human	  and	  murine	  CD4+CD8+	  peripheral	  T	  cells	  with	  effector	  capacity,	  particularly	  in	  settings	  of	  
chronic	   infection	  or	  autoimmunity	   (126,	  127).	   	  The	  precise	  origins	  of	   these	  cells	  are	  a	   topic	  of	  
continued	  debate,	  but	  at	   least	  some	  of	  these	  cells	  appear	  to	  arise	  from	  MHCI-­‐restricted	  CD8	  T	  
cells	   that	   up-­‐regulate	   CD4	   expression	   following	   activation.	   The	   sum	  of	  my	   data	   indicates	   that	  
aberrant	  CD4+CD8+	  cells	  arising	  from	  impaired	  lineage	  commitment	  in	  the	  absence	  of	  Dicer	  are	  
distinct	   from	   previously	   reported	   mature,	   antigen	   experienced	   CD4+CD8+	   cells,	   but	   it	   will	   be	  
critical	  going	  forward	  to	  test	  the	  effector	  capacities	  of	  the	  aberrant	  CD4+CD8+	  cells	   in	  LBD,	  LBD	  
R1	   OT-­‐I,	   and	   LBD	   R1	   OT-­‐II	   mice.	   	   Strong	   in	   vitro	   TCR	   signaling	   results	   in	   cell	   death	   of	   DP	  
thymocytes	   due	   to	   negative	   selection,	   but	   I	   have	  observed	   that	   sorted	   splenic	   CD4+CD8+	   cells	  
from	  LBD	  mice	  are	  capable	  of	  proliferation	  and	  survival	   (a	   trait	  of	  naïve	  T	  cells)	   following	  TCR	  
stimulation	   in	   vitro	   (Fig.	   32).	   	   Identification	  of	   the	  effector	   functions	   (e.g.	   CD40L	  and	   cytokine	  
expression	  in	  CD4+	  T	  cells,	  perforin/granzyme	  expression	  and	  cytotoxicity	  in	  CD8+	  T	  cells)	  that	  do	  
or	  do	  not	  operate	  in	  aberrant	  CD4+CD8+	  cells	  will	  allow	  further	  dissection	  of	  the	  global	  impact	  of	  
Dicer	  deficiency	  on	  lineage	  commitment	  and	  function	  of	  CD4	  and	  CD8	  T	  cells.	  	  
	   Potential	   impacts	   of	   aberrant	   peripheral	   CD4+CD8+	   cells.	   The	   biological	   impact	   of	  
circulating	  peripheral	  CD4+CD8+	  cells	   that	  have	  yet	   to	  undergo	  complete	   lineage	  maturation	   is	  
not	  understood.	  	  Previous	  reports	  of	  CD8	  lineage	  cells	  that	  are	  CD4+CD8+	  due	  to	  deletion	  of	  the	  
CD4	  intronic	  silencer	  element	  did	  not	  note	  any	  detrimental	  effect	  of	  peripheral	  DP	  cells	  (33),	  but	  
this	  could	  be	  due	  to	  multiple	  factors	  in	  the	  analysis.	  	  One	  possibility	  is	  that	  at	  steady	  state	  these	  
cells	   have	   no	   impact,	   but	   infectious	   challenge	   could	   reveal	   context	   dependent	   effects.	  
Alternatively,	   aging	   the	  mice	   could	   allow	   identification	  of	   subtle	   defects	   that	   are	   exacerbated	  
58	  
with	   longevity.	   	   Additionally,	   CD4+CD8+	   cells	   in	   CD4	   silencer	   deficient	  mice	   represent	  mature,	  
lineage	  committed	  cells	  that	  happen	  to	  express	  CD4,	  whereas	  aberrant	  CD4+CD8+	  cells	  in	  Dicer-­‐/-­‐	  
mice	   appear	   to	   represent	   post-­‐selection	   cells	   that	   are	   not	   fully	   lineage	   committed.	   	   This	   is	   a	  
critical	   distinction,	   particularly	   if	   aberrant	   CD4+CD8+	   cells	   maintain	   lineage	   plasticity	   and	   can	  
undergo	   lineage	   re-­‐direction.	   	   In	   this	   instance,	   cells	   with	  MHCI-­‐restricted	   TCRs	   could	   receive	  
sustained	  TCR	  signaling	  from	  peripheral	  antigens	  or	  tonic	  TCR	  signaling	  required	  for	  survival	  of	  
naïve	  T	  cells.	  	  Such	  signaling	  could	  hypothetically	  result	  in	  re-­‐direction	  of	  MHCI-­‐restricted	  cells	  to	  
the	  CD4	  lineage,	  consistent	  with	  my	  observation	  of	  MHCI-­‐restricted	  cells	  re-­‐directed	  to	  the	  CD4	  
lineage	   in	   LBD	   R1	   OT-­‐I	   mice	   and	   the	   skewed	   CD4/CD8	   ratio	   observed	   in	   LD	   mice.	   	   From	   a	  
population	   standpoint,	   re-­‐direction	   of	   a	   large	   fraction	   of	  MHCI-­‐restricted	   TCR	   bearing	   cells	   to	  
the	  CD4	  lineage	  could	  generate	  gaps	  in	  the	  TCR	  repertoire	  of	  mice,	  leaving	  them	  susceptible	  to	  
pathogens	   that	   require	   a	   CD8	   T	   cell	   response.	   Hypothetically,	   all	   the	   cells	   bearing	   TCRs	   that	  
would	   normally	   recognize	   MHCI:peptide	   antigen	   (and	   should	   be	   cytotoxic	   CD8	   lineage	   cells)	  
could	   be	   re-­‐directed	   to	   the	   CD4	   lineage,	   rendering	   the	   mouse	   incapable	   of	   mounting	   an	  
appropriate	  CD8	  response	  to	  specific	  pathogens.	  	  
	   An	  alternate	  possibility	  is	  that	  aberrant	  CD4+CD8+	  cells	  could	  become	  autoreactive,	  and	  
indeed	  the	  presence	  of	  peripheral	  DP	  T	  cells	  has	  been	  noted	  in	  humans	  with	  autoimmune	  
conditions	  (126).	  	  In	  this	  scenario,	  a	  cell	  that	  normally	  is	  selected	  on	  MHCI	  in	  the	  thymus	  down-­‐
regulates	  CD4,	  precluding	  the	  possibility	  of	  the	  T	  cell	  recognizing	  peripheral	  peptides	  presented	  
on	  MHCII.	  	  In	  the	  case	  of	  aberrant	  CD4+CD8+	  cells,	  however,	  the	  same	  thymocyte	  selected	  on	  
MHCI	  will	  maintain	  CD4	  expression	  for	  some	  period	  of	  time	  while	  in	  the	  periphery.	  	  During	  this	  
period	  the	  cell	  could	  encounter	  self-­‐antigen	  presented	  on	  MHCII,	  and	  because	  of	  the	  
inappropriate	  presence	  of	  CD4,	  could	  become	  activated	  and	  initiate	  an	  autoimmune	  reaction.	  	  
While	  aberrant	  CD4+CD8+	  cells	  are	  unlikely	  to	  arise	  at	  high	  levels	  in	  mice	  or	  humans	  that	  are	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miRNA	  sufficient,	  it	  is	  certainly	  possible	  that	  amongst	  the	  billions	  of	  thymocytes	  produced	  each	  
day	  some	  infinitesimal	  fraction	  could	  possess	  disruptions	  at	  a	  key	  miRNA(s)	  and	  anti-­‐apoptotic	  
genes	  (such	  as	  p53),	  permitting	  their	  survival	  for	  an	  extended	  period	  in	  peripheral	  tissues.	  	  Thus,	  
at	  some	  low	  level	  autoreactive	  cells	  could	  escape	  the	  thymus	  in	  a	  manner	  analogous	  to	  the	  
aberrant	  CD4+CD8+	  cells	  observed	  in	  LBD	  mice.	  	  While	  I	  have	  not	  observed	  increased	  
autoimmune	  pathologies	  in	  my	  LD	  or	  LBD	  mice,	  this	  could	  be	  due	  to	  the	  inability	  of	  Dicer	  
deficient	  cells	  to	  survive	  the	  proliferative	  burst	  that	  accompanies	  antigen	  encounter	  and	  likely	  
would	  be	  required	  for	  sustained	  pathology.	  	  Identifying	  pathways	  that	  regulate	  thymic	  egress	  
and	  lineage	  commitment	  independently	  of	  cell	  survival	  could	  allow	  formal	  testing	  of	  this	  
hypothesis.	  	  
	   Summary.	   	   In	   aggregate,	  my	   results	   describe	   a	   role	   for	  Dicer,	   and	  presumably	  Drosha	  
and	   miRNAs,	   in	   mediating	   appropriate	   lineage	   commitment	   of	   developing	   αβ	   T	   cells.	   In	   the	  
absence	   of	   Dicer,	   lineage	   commitment	   and	   thymic	   egress	   are	   separated,	   suggesting	   these	  
components	   of	   thymic	   differentiation	   are	   distinguishable.	   	   My	   results	   also	   raise	   significant	  
questions	   related	   to	   the	   ability	   of	   thymocytes	   to	   retain	   lineage	   plasticity	   extrathymically,	   and	  
either	  receive	  extrathymic	  differentiation	  signals	  or	  maintain	  memory	  of	  intrathymic	  signaling	  in	  
spite	   of	   delayed	   lineage	   commitment.	   	   In	   addition	   to	   the	   contribution	   to	   our	   basic	  
understanding	   of	   mechanisms	   by	   which	   miRNAs	   promote	   lineage	   identity	   and	   regulate	   fate	  
decision,	  identification	  of	  the	  mechanisms	  that	  mediate	  this	  process	  in	  T	  cells	  could	  be	  of	  clinical	  
use.	  	  Numerous	  disease	  conditions	  could	  benefit	  from	  the	  ability	  to	  generate	  bulk	  naïve	  T	  cells	  
on	   demand;	   for	   example,	   bone	   marrow	   transplant	   recipients	   that	   receive	   radiation	   therapy	  
display	   a	   prolonged	   suppression	   of	   the	   immune	   system	   and	   are	   particularly	   susceptible	   to	  
infections	  that	  are	  normally	  cleared	  by	  T	  cells	  (128).	  	  Similarly,	  recent	  advances	  have	  highlighted	  
the	  potent	  therapeutic	  potential	  of	  both	  in	  vitro	  manipulated	  and	  genetically	  modified	  T	  cells	  for	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cancer	   therapy	   (129).	   	   	   Standard	   in	   vitro	   culture	   protocols	   are	   capable	   of	   generating	   large	  
numbers	   of	   DP	   thymocyte-­‐like	   cells	   from	   hematopoietic	   stem	   cells	   or	   other	   precursors,	   but	  
current	  technologies	  are	  incapable	  of	  fully	  and	  robustly	  recapitulating	  thymic	  selection	  signals	  to	  
generate	   mature,	   naïve	   CD4+	   or	   CD8+	   αβ	   T	   cells	   (122).	   Understanding	   the	   requirement	   for	  
miRNAs	   in	   lineage	   commitment	   (or	   mechanisms	   that	   bypass	   this	   requirement)	   might	   allow	  
investigators	   to	   circumvent	   current	   blockades	   in	   the	  process	  of	   in	   vitro	   T	   cell	   generation,	   and	  
provide	  a	  first	  step	  in	  widespread	  use	  of	  T	  cell	  therapy	  in	  the	  clinic.	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Chapter	  Four:	  Materials	  and	  Methods	  
 
Mice	  
LckCre	   (130),	  EμBCL2	   (90),	  Dicerflox/flox	   (79),	  Tp53flox/flox	   (131),	  Cd4Cre	   (130),	  Rag1-­‐/-­‐	   (132),	  MHCI-­‐/-­‐	  
(101),	  MHCII-­‐/-­‐	   (103),	  OT-­‐I	   (133),	  OT-­‐II	   (134),	   and	  Droshaflox/flox	   (82)	  mice	   have	   been	   described.	  	  
C57B6.SJL	   mice	   were	   from	   Jackson	   Laboratories.	   	   Mice	   were	   maintained	   under	   specific	  
pathogen-­‐free	   conditions	   at	   the	   Children's	   Hospital	   of	   Philadelphia	   (CHOP),	   University	   of	  
Pennsylvania	   (Penn),	   or	   the	   National	   Institute	   of	   Health	   (NIH).	   	   Rag1-­‐/-­‐,	  MHCI-­‐/-­‐,	  MHCII-­‐/-­‐,	   and	  
C57B6.SJL	  mice	  were	  on	  a	  pure	  C57BL/6	  background;	   all	   other	  mice	  were	  on	  a	  mixed	  129/B6	  
background.	  	  Unless	  otherwise	  indicated,	  studies	  were	  conducted	  on	  littermate	  or	  age-­‐matched	  
mice	  between	  4-­‐8	  weeks	  of	  age.	  	  All	  studies	  were	  performed	  in	  accordance	  with	  regulations	  and	  
approved	  by	  the	  CHOP,	  Penn,	  or	  NIAID/NIH	  Institutional	  Animal	  Care	  and	  Use	  Committees.	  	  	  
	  
Quantification	  of	  Dicer1	  Deletion	  
Cell	  populations	  were	  isolated	  by	  FACS	  purification	  of	  lineage-­‐negative	  cells	  and	  genomic	  DNA	  
isolated	  as	  described	  (22).	  	  DNA	  was	  used	  as	  a	  template	  for	  qPCR	  measurement	  of	  Cre-­‐mediated	  
Dicer1	  deletion	  on	  an	  Applied	  Biosystems	  7500	  Fast	  Real	  Time	  PCR	  System	  by	  quantifying	  
“floxed”	  Dicer1	  Exon	  20	  sequences	  and	  “non-­‐floxed”	  Dicer1	  Exon	  19	  sequences	  and	  calculating	  
the	  ratio	  of	  Exon	  20	  to	  Exon	  19	  sequences.	  	  Primers:	  Exon	  19Forward:	  5’-­‐
TACATCCAATCCCAGCATCA-­‐3’,	  Exon	  19Reverse:	  5’-­‐TCTGAGCTCTTAGTTCCTCTGC-­‐3’,	  Exon	  
62	  
20Forward:	  5’-­‐AACTCCTCGTTGGCTGAGAG-­‐3’,	  Exon	  20Reverse:	  5’-­‐
TCATGGTTTTCTAAGGAGGGTCT-­‐3’.	  	  	  
	  
miRNA	  quantification	  
Cell	   populations	   were	   isolated	   by	   cell	   sorting	   and	   re-­‐suspended	   in	   TRIzol®	   lysis	   reagent	   (Life	  
Technologies).	   	   RNA	  extraction	  was	  performed	  using	   the	  miRNeasy	  minikit	   (Qiagen).	   	   Taqman	  
miRNA	  Assays	  were	  obtained	  from	  Applied	  Biosystems	  (hsa-­‐miR-­‐181a:	  Assay	  ID	  000480,	  hsa-­‐let-­‐
7c:	   Assay	   ID	   000379,	   snoRNA202:	   Assay	   ID	   001232).	   	   Reverse	   transcription	   reactions	   were	  
performed	   using	   probe-­‐specific	   RT	   primers	   according	   to	   the	   manufacturer’s	   instructions.	  	  
Taqman	   qPCR	   reaction	   was	   performed	   with	   probe-­‐specific	   qPCR	   primers	   according	   to	  
manufacturer’s	  instructions.	  	  	  
	  
Flow	  Cytometry	  and	  Cell	  Sorting	  
Single	  cell	   suspensions	  were	  generated	  by	  mechanical	  disruption	  of	  organs	  using	   frosted	  glass	  
slides.	  Suspensions	  were	  filtered	  through	  70	  μM	  nylon	  mesh,	  and	  red	  blood	  cell	  lysis	  performed	  
according	  to	  standard	  protocols.	  	  Cells	  were	  stained	  in	  DMEM	  supplemented	  with	  1%	  FBS,	  at	  a	  
cell	   concentration	   of	   0.5-­‐1.0x108/mL.	   	   Invitrogen	   LIVE/DEAD	   stain	   was	   utilized	   according	   to	  
manufacturer’s	   instructions.	   	   For	   intracellular	   staining,	   BD	   Fix/Perm	   protocol	   was	   utilized	  
according	  to	  manufacturer’s	  instructions.	  	  The	  list	  of	  antibody	  clones	  and	  manufacturers	  is	  listed	  
in	  Table	  2.	  	  For	  Cell	  Sorting,	  a	  BD	  FACS	  Aria	  II	  was	  utilized.	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Quantitative	  real-­‐time	  PCR	  
RNA	   isolation	   and	   cDNA	  generation	  were	   as	   described	  previously	   (89).	   	   In	   some	  experiments,	  
overnight	  precipitation	  of	  RNA	  at	  -­‐20°C	  was	  performed	  by	  adding	  0.2	  volumes	  of	  3M	  ammonium	  
acetate	  and	  5	  μg	  RNAse-­‐free	  glycogen	  to	  the	  aqueous	  phase	  isolated	  during	  standard	  TRIzol	  RNA	  
extraction.	  	  Precipitated	  RNA	  was	  pelleted	  by	  centrifugation	  and	  washed	  with	  70%	  ethanol	  prior	  
to	  re-­‐suspension	  in	  RNAase-­‐free	  diH2O.	  Primers:	  Cd4	  Exon	  1F:	  5’-­‐GCAGAGTGAAGGAAGGACTGG-­‐
3’,	  Cd4	  Intron	  1R:	  5’-­‐	  CAGAACATTCCGGCACATTAGC-­‐3’,	  Ptcra	  Exon1F:	  5’-­‐tcaggtgtcaggctctaCca-­‐3’,	  
Ptcra	   Exon2R:	   5’-­‐CATGTGCTGCCTTCCATCTA-­‐3’.	   Primers	   for	   Rag1	   and	   Zbtb7b	   were	   previously	  
described	  (135,	  136).	  	  	  	  
	  
Adoptive	  transfers	  
Splenocytes	  were	  labeled	  with	  1	  μM	  CFSE	  [carboxyfluorescein	  succinimidyl	  ester]	  (CellTrace	  
CFSE	  Proliferation	  Kit,	  Invitrogen)	  for	  9	  minutes	  at	  37°C.	  	  B220+	  cells	  were	  depleted	  by	  
incubation	  with	  rat	  anti-­‐B220	  (BioLegend,	  clone	  RA3-­‐6B2)	  followed	  by	  goat	  anti-­‐rat	  magnetic	  
beads	  (Qiagen)	  prior	  to	  antibody	  staining.	  	  Doublets	  and	  B220+	  cells	  were	  excluded,	  and	  the	  
following	  populations	  were	  sorted:	  	  TCRβ+CD4+CD8-­‐,	  TCRβ+CD4-­‐CD8+,	  TCRβ+CD4+CD8+.	  	  2x105	  
sorted	  cells	  cells	  were	  transferred	  to	  Rag1-­‐/-­‐	  mice	  via	  retro-­‐orbital	  injection,	  and	  recipient	  mice	  





Bone	  marrow	  chimeras	  
Single	  cell	   suspensions	  were	  prepared	  from	  tibia	  and	  femur	  bone	  marrow	  of	  donor	  BD	  or	  LBD	  
mice.	  	  CD4+	  and	  CD8+	  αβ	  T	  cells	  were	  removed	  by	  magnetic	  bead	  depletion	  (Qiagen).	  	  Recipient	  
MHCI-­‐/-­‐	  or	  MHCII-­‐/-­‐	  mice	  were	   lethally	   irradiated	  (900	  rads	   in	  two	  450	  rad	  doses	  4	  hours	  apart)	  
prior	  to	  retro-­‐orbital	  injection	  of	  donor	  cells.	  	  Mice	  were	  analyzed	  8-­‐10	  weeks	  later.	  	  	  
	  
Western	  Blot	  
Cell	  pellets	  were	  lysed	  in	  1%	  (vol/vol)	  SDS	  buffer	  under	  reducing	  conditions,	  separated	  on	  a	  10%	  
SDS-­‐PAGE	  gel,	  transferred	  to	  polyvinylidene	  difluoride	  membranes	  (Immobilon-­‐P;	  Millipore)	  and	  
analyzed	  by	  immunoblot	  and	  chemiluminescence.	  The	  anti-­‐Runx	  antibody	  was	  from	  Epitomics	  (#	  
2593-­‐1).	  
	  
In	  vitro	  cultures	  of	  aberrant	  CD4+CD8+	  cells	  
Splenic	  CD4+CD8+	  T	  cells	  were	  isolated	  from	  LBD	  or	  LBD	  R1	  OT-­‐I	  mice	  by	  cell	  sorting.	  	  Cells	  were	  
cultured	   in	  T	  cell	  media	   (RPMI	  10%	  FCS,	  1%	  penicillin/streptomycin,	  1X	  L-­‐glutamine,	  55	  μM	  β-­‐







Runx3-­‐MIG	  was	  generated	  by	  inserting	  a	  ~1.2	  kilobase	  (kb)	  EcoRI	  fragment	  containing	  full-­‐length	  
Runx3	  cDNA	  (from	  Runx3-­‐pCR	  BluntII	  TOPO,	  a	  kind	  gift	  from	  Remy	  Bosselut)	  non-­‐directionally	  in	  
the	  MIGR1	  vector	  backbone	  digested	  with	  EcoR1	   (137).	   	   Insert	   directionality	  was	   screened	  by	  
restriction	  digest	  and	  the	  sequence	  validated	  by	  conventional	  Sanger	  sequencing.	  	  	  	  
	  
Retroviral	  vector	  production	  
293T	  cells	  (ATCC	  CRL-­‐3216)	  were	  co-­‐transfected	  with	  plasmids	  pcgp	  (expressing	  MSCV	  gag-­‐pol),	  
pHIT123	  (expressing	  ecotropic	  env),	  and	  expression	  plasmid	  (transgene-­‐IRES-­‐GFP)	  in	  a	  1:1:2	  ratio	  
using	  the	  calcium	  phosphate	  transfection	  method	  (138).	  	  Transfection	  media	  was	  aspirated	  4-­‐12	  
hours	  later	  and	  replaced	  with	  fresh	  293T	  media	  (DMEM	  10%	  FBS,	  1%	  penicillin/streptomycin,	  1X	  
L-­‐glutamine).	  	  Retroviral	  supernatant	  was	  harvested	  24-­‐48	  hours	  after	  replacing	  media,	  filtered	  
through	  45	  μM	  filter,	  then	  used	  fresh	  or	  frozen	  on	  dry	  ice	  and	  stored	  at	  -­‐80°C	  for	  later	  use.	  
	  
In	  vitro	  Runx3	  rescue	  by	  ectopic	  retroviral	  expression	  
Tissue	  culture	  plates	  were	  incubated	  (37°C,	  5%	  CO2)	  with	  anti-­‐CD3	  and	  anti-­‐CD28	  antibodies	  (5	  
mg/mL)	   in	   PBS	   for	   a	  minimum	  of	   1	   hour	   prior	   to	   stimulation.	   	   Splenic	   CD4+CD8+	   T	   cells	  were	  
isolated	   from	   LBD	  R1	  OT-­‐I	  mice	  by	   cell	   sorting	   and	   stimulated	  with	  plate	  bound	  anti-­‐CD3	  and	  
anti-­‐CD28	   for	  24-­‐48	  hours	   in	  T	   cell	  media	   supplemented	  with	   recombinant	   IL-­‐2	   (40	  units/mL).	  	  
Stimulated	  cells	  were	  re-­‐suspended	  in	  retroviral	  supernatant	  containing	  polybrene	  (0.8	  μg/mL)	  
and	   centrifuged	   at	   7500	   rpm	   for	   90	   minutes	   at	   room	   temperature	   in	   a	   bench-­‐top	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microcentrifuge.	   Retroviral	   superantant	   was	   aspirated	   and	   T	   cells	   cultured	   in	   T	   cell	   media	  
supplemented	  with	  IL-­‐2	  (40	  units/mL)	  or	  IL-­‐7	  (5	  ng/mL)	  for	  an	  additional	  24-­‐72	  hours.	  
	  
Intrathymic	  injection	  of	  retrovirally	  transduced	  hematopoietic	  progenitors	  
Bone	  marrow	  was	  harvested	  from	  WT	  or	  LBD	  R1	  OT-­‐I	  donor	  mice	  (CD45.2)	  and	  stained	  for	  cell	  
sorting.	   	   LSK	   (Lin-­‐Sca-­‐1+c-­‐kit+)	   cells	   were	   sorted	   as	   singlets/TCRβ-­‐TCRγδ-­‐B220-­‐CD11b-­‐CD11c-­‐
Ter119-­‐NK1.1-­‐Sca-­‐1+c-­‐kit+.	   	   Sorted	  cells	  were	   re-­‐suspended	   in	  2X	   stim	  media	   (DMEM	  30%	  FBS,	  
2%	  penicillin/streptomycin,	  10%	  L-­‐glutamine	  supplemented	  with	  20	  ng/mL	   IL-­‐3,	  20	  ng/mL	   IL-­‐6,	  
and	   200	   ng/mL	   stem	   cell	   factor	   [SCF]),	   an	   equal	   volume	   of	   either	   empty	   vector	   or	   Runx3	  
retroviral	   supernatant	   was	   added,	   and	   polybrene	   was	   added	   to	   a	   final	   concentration	   of	   0.8	  
μg/mL.	  	  Cells	  were	  centrifuged	  at	  5000	  rpm	  for	  90	  minutes	  at	  room	  temperature	  in	  a	  bench-­‐top	  
microcentrifuge	   and	   cultured	   overnight	   at	   37°C,	   5%	   CO2	   in	   a	   tissue	   culture	   incubator.	  	  
Transduction	   efficiency	   was	   analyzed	   by	   flow	   cytometry	   ~24	   hours	   post-­‐transduction.	   	   Sub-­‐
lethally	   irradiated	   (600	   rads)	   recipient	  mice	   (CD45.1+	   C57B6.SJL)	  were	   injected	   intrathymically	  
with	  1x104	  cells	   in	  a	  10	  μL	  volume	  of	  PBS	  by	  opening	  the	  thoracic	  cavity	  for	  visual	  guidance	  to	  
the	   injection	   site	   (139).	   Recipient	   mice	   were	   euthanized	   and	   donor	   cells	   analyzed	   by	   flow	  
cytometry	  21-­‐28	  days	  after	  injection.	  
	  
Statistical	  analysis	  
Unless	  otherwise	  indicated,	  two-­‐way	  Student’s	  t-­‐test	  was	  utilized	  for	  all	  statistical	  comparisons.	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